var title_f3_47_3824="Cobb angles";
var content_f3_47_3824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Cobb angles in kyphoscoliosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 322px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFCAc8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiuT8R/EHw7oMj2896Lm/BKiztQZZi3ptXp+Nc3e+PvE2kWyazr/hQ2XhzzAkri433MCE4EjxgdM9RnPNAHqFFMikSaJJYnV43UMrKcgg9CKfQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcl4n8YSeGtUA1LRr9tFKAnUrdfNWNs8h1X5gOVAOPWutooAo6Nq2n61ZJeaTeQXds/SSFww/Sr1cHrPw8hS+k1XwfeyeH9Xb5m8gZt5yM8SRdD6ZHI7VFpvj240m+i0nx9ZDSb2Q7Yb5Dus7k/7L/wAJ/wBlvUUAeg0UisHUMpDKeQQeDS0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4r4J8SeHPAkWvadq4jXWbbV7mFBHDvurmNyZI3OBkgq2M9K5Hxh491j4l6jHoHh3Tp1sWkUSWbZElx6+aw4jjHcZyf5ehfG3QbVjpPiG4083GnWU5/tdbYbJ5bdl27iy/MyocErnkVrz+J/BPgPQbY6d9ljhuIhLb29im+S4XGQ2ByRj+I0AL8O/EOpHWNR8J+JLezt9U02GOaD7GCIZbcjaCoPI2n5a76vnfwz8UbC/+J2oeJNWsruxsYdONjH5cLTnPmK+XKAgcCvfdI1K01fTLbUNOnS4s7lBJFIhyGU0AW6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqpqunWerWE1lqdtFdWky7XilXcpH+e9W6KAPMJdL1/4dM9x4e8/W/C+4GTS3Ytc2i9zCx+8o/unnp7mu58MeItM8TaYt/o1ys8BO1h0ZG7qynkH2Na1cF4p8F3UOpzeI/BE66frzfNPA3/Hvf4/hkXsx7OO/XqTQB3tFct4I8ZWniaOa3kiksNatPlvNOn4khb1H95T2YV1NABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA2RFkRkkUMjAhlYZBB7GvEbrwBog+Ksfhy1jfTtJm0s6g6QMQ9ywmKmLzDyqAEHauOK7Xxj8VvCnha5+xXF+1/q5O1NN01PtFwzf3dq8KfZiK4DXtE8f8AxWvLC6fTofA2n2jMYLuaVpNRKsMMAilQoOBlWwR69cgHU+NfiF4I+GGjnTUW08wIVTTrULk8D7/oDkcnk89a8y+BXxYMIv8AR7Hw1rF9ay3Mt3braLvW2ViuIlB/hzvOeME9Oc1a8H/BLwr/AMLQ1vTdWN7qCaZbW8o+2zZe8eUFmlyMfKCNvHfqa+hNE0XTdCsltNHsbeztx/BCgXPuT1J9zzQBjeDvGdt4lvdRsTY3um6jY7DNa3iBX2uMqwwTkcV1NeVXN5bTfH/TJNBcXUx06a11jyhuWFB88RZhwGLYHrjFeqggjg5oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5Dxx4NXXXi1TSbk6Z4ls1P2S/Qdf+mcg/iQ9x26ik8B+MG1trjStat/7O8TWGFvLNj19JIz/Eh6giuwrkfHvhE68ltqWkzLYeJdPO+yvQPzik/vI3PHbOR3BAOuorlvAPitfE2nzR3UJstasX8i/sn+9DIO49VPUHvXU0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUF9eW1hay3V9cQ21tEN0kszhEQepY8AV574r8Q+P7zX7vRPBXhiC2igKq+t6vLiA5UHMca/M+M9ecEYIrPsvg3Bqt3FqHxI13UPFt8h3rBM3kWcTf7EKHH5nB7igB2o/Gayv7yXTfh5o2oeL9SU7S9ovl2kR/2524A6cjIPrXFXsPjbxN8StO8K/ErXJNE03VLKS6tbPQJPLSZkPzwPKRuLBRlsEjHTGa+g9OsLTTLOO0061gtLWIYSGCMIij2A4FedfH/Rrq48IQeItGXOt+GbhdVtiOrIn+tT6FMkjvtAoA6nwd4G8NeDbbyfDej2tkSMNKq7pX/3pDlj+JrpazfDes2viHw/p2sae260voEnjPcBhnB9x0I9RWlQBxHjLQtXTxTpfifwvFbT6hbwPZXVtPL5a3EDHco3YOCrZI4/iNZmqab4y1q2d/Ems2HhzRUUvcLp7lpigGSDKwAUe45r0quR+Kfhq58VeEpbGwkjW6jmjuY45SfKmKNny5MdVbp+VAHCeG9Lk8RWZ0zwNDL4f8Hhv9I1UAi61Ijr5ZPOCc/OfU499DWrO5+Fl9ba5p11f3nhaQrBqttdTtMbcE4W4QtyME/MPf8ALQt/iJc/YodPs/COrDX0URtpwh2RQnGATJ90R+h9O1Z+u+H9W13Tpbz4na7b6ToAIZ9Ls3CoRnhZZj154wODQB6yDkZHSivNofGXiLxISfA2gr/ZaD5dQ1NjCkuMjEaY3EcdfatzwJ4uPiBr7T9TtDpviDTn2XdkzbsA/ddD/EhHQ0AdbRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRUUtxBDLDHNNHHJMxWJWYAuQCSFHc4BPHYGgCWiiigAooooA4H4haBe22oW/jDwtFu12wXFxbqcDULb+KJv9oDlT68eldT4X12y8S6DZ6tpkm+1uU3DP3lPQqw7EHII9q1a8vu1X4ceOBex7YvCniGcJcqM7bO8I4kHosnQ+h54oA9QooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACmyIksbRyKrowKsrDIIPUEU6igDyH4JO/hfxB4o+HV0zbNKnN9pZY53WUx3AD/cY4J9Wr16vIfjaj+F/EHhf4i2qts0qcWOqBRndZTHaSf9xjkD1avXI3SWNZI2V0YBlZTkEHoQaAHUUVh+NfFOl+DfDl1rWuT+VaQDooy8jn7qIO7E/4nABNAG5XmF7ZWniT4x3Wn+Jf3ltpllDc6ZYS/wCqnZi3mTEdGKkBcdq7zw1qcmtaBYalNYXWnSXUKym1ugBJFnswH/6/UA8VR8WeEtO8T/ZJLw3FveWjFre8tJPLmiyMEBvQjqDQBc1zXtJ8O2fn6tfW1nCowvmMFz7Ad686sbuTxj8TtC1/w/pd9aafYxTRXepToYluoyvyxBTgthiDk9Ks+INB8O+A7L+27mzvPEGtzzJaWQvpPPllmfISNMjCjqeB2q5H4Z8Z69AG8R+JV0yORRvs9JiAKj081uc9sgfSgD0BbiF5PLWaNn/uhgT+VS1494+8A6d4U8KSeIPCkFxHrejul6JjO7vcKjAyJISeVK7s16xpt7BqWnWt9ZuJLa5iWaJx/ErAEH8jQBZooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKhvLq3srSa6vJ4re2hUvJLKwVUUdSSeAK8B8b/FPW/FrWunfDtZdO0C81CLS5fE0ybQ0khI2wKcHjBy/b/ZOCQDuPiX8WLHwtepoWhWr694uuMLDptsc+WT0MrD7o746n2BzXByeEfGOga1ZfEjxvNbeIr6zO6fT4lbGnwsOTbgHaWTvwc4Jzn5q9T+G/w20HwFaMNMha41Kb5rnUbj5p5m7knsCSeB+Oa7RlDKVYAqRggjIIoAp6NqllrWmW+oaZcJcWc6h45EOQR/jV2vHfGenr8LbqDxP4cuGh0qS5WO/wBHL5SUSMAWhU9HHXA617FQAUUUUAFZviPRrPxDoV7pOpIXtLuMxuB1HoR7g4I9wK0qKAOG+FWr3stjf+HddkL65oEotZ5DnM8RGYpuf7y/qOa7mvOviGP+EY8U6L40hG22DDTNWx3t5G+SQ/7kmPwavRQcjI6UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBm+JNGtfEPh/UdH1Bd1pfQPBIO4DDGR7jqD6iuD+AGs3Vx4Qn8O6y2db8M3DaVcg9WRP9U/0KYAPfaTXp1eM+NbqH4dfGXTPFdzItvoHiSD+zdUkPCR3Ea7oZW9yo2/QNQB6r4h1rT/Dui3eraxcpbWFqhkllbsPQDqSTgADkk15R4L0XUPib4ktvHXjC2e30O1Yt4f0eYEbRni5lHQucAgcjoewJr6PZXPxr8RQ69rMMsPw+02YnS7CVSp1KUcfaJR3Qc7R9R/ez7gBgYHSgAooooA8++N5W08I2etOSP7F1Wz1DA/ixKEI/KQ113iHXdM8O6eb3WbuK1t9wQM5+8x6KB3PHQU/xBo9lr+jXWl6pD51lcpskTOO+QQfUEAj6V4/rXhe6g+IOiaHo+r3eoX8NtJerJqxE8enwZ2BwvG+QsSAWPGKAOpvPidpOp2txb6Routa4roySxQ2LhSpGCCWAGCK1fhDpN/ongDTbLVQyXCGRlhL7/IjaRike7vhSB7dO1UX+H+oaiwHiHxhrF9B1MFvttVP4p8xHtmso2Enw58c6ALG9vZvDetyHT5oLqdpvJuSC0TITyN2GBH1NAHqtFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRXm3ivx9rng3X7p/EHha4n8JZUw6tpjee8A2jcZ4uCBnJ3DgDA+Y0Aek0Vi+FfFWh+LNP+2+HNUttQt/4jC3zIfRlPzKfYgVtUAFct8QPHeh+BdNS61q4JnmOy1s4RvnuX/uonfkgZ6DI5rlfGHxNuJ9al8K/DayTXfE4+WebP+iaeOhaZ+hI/ug9eOvym94A+GVvoWpv4i8S3r+IPGE4/e6lcDiHP8EKdEUcjjnHoDigDnLTwd4j+KF3FqnxMD6X4dRxLaeGIJCC3cNcuMEt/s9v9nkH0jxL4T03XPCU3h9oUtbIxqkAgQL9nK8oyAdNpA6Y9K6CigDhvh34lvLma78NeJ3jXxNpnEhHAu4v4Z0HcEYz6H0zVvxr42tvD80GnWMDan4guuLbT4T8zf7Tn+BfUmrfivwbpXiaa1uL0XEF/a5EF5aSmKZAeqhh2Pof6msW68MReCfCfiC/8J2ct74gktncXFzJ5s8zgcZY9cddo64AoAx4dESxuo/FXxX1izkvIMNa2e7bbWZPPyr/G/bPPtnjEkR1v4l3bSxXF9oXg+M4iaLMV3fsD97J5jj/U/niX4b+EPDOqaLpfiKV5Nfv5og7Xd/IZSshGHAQ8JhsjbjjFemUAeWedr3w1u5Bci+1/whI+5Z8mW6sc9d3d0zznqPyFd14X8TaT4osTd6LeJcRqdrr9142/usp5U+xqbXte0vQLRrnWL6C0hAzmRwM+wHevN/B7rr/xTm8TeHdPnsNC+wvDeXM0ZiS+k3ZRlU9ccnd/jyAet0Vyi/EPwq2vRaOms2zX0knlKqtld/Zd3TPbFdXQBn+IdJtte0O+0q/Xda3kLQyD2Ixke461zfwj1W41HwdFa6kxbVNJlfTLzPUyRHAb/gS7W/Gu0rzzSh/YPxn1WyHyWniCwS/jHQfaITscD3KsrH/doA9DooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGyyJFG8krqkaAszMcBQOpJ7CvnbxrBrHx9i1O28Oymz8F6WJDbXDJhtVvVUhduekSscZ9/X7rviz4g8Q/E+113RPh3Cbjw9o6FtSu1Zl/tGVeTaQlfvDHXHXgdCN27H8XPDyeDNJ0n4a2ovPEF3Ctrp+jQqQbNguCZsjCqnJJPXGc4ywAO4+DniSLxV8OdF1BIkgnSEW1xAq7BDNH8jLt/hGRkDsCK7SvCfhTZ6n8OPiXP4U8QXwvV8S2g1WG52hVa+Uf6SigADkfNnHRV75r3agAooooAK808WXY8JfFG18SXsF1LpV/pR06R7eFpTFLHIZEyADwwZgP9016XXD/GK6u4PByw2N1LaPe31rZvNEcOsckqq209jgkZoA5W/wDjrp1s7J/Yt9E65P8ApUkUOR7AtnJ9K5i4+Jdr448T+G4NVW10XStL1BdTkuZrpTuaNGCKO3JbmvZNL8C+F9MsorW20LTmjjHDS26yOT6lmBJNaj6FpDw+S+l2DQ9Nht0K/ligC1Y3dvf2sdzZTxz28qhkkjYMrA9wanrzz4MQxW1l4rtrVFjtoPEN3HFGn3UUCP5QOwyTxXodABRRRQAUUUUAFFFFABRRRQAUUUUAFcbp/wASPD+oQ6nd2z3h0jT4pZpdUa1kW0YREBwkpGHIOeFznBxnFdfPGJoZImJCupUkHnBGK+eNB+AWqWtlqFhc6jplrbtpE+lpPZeYZL1nkLxy3CkADZ8owC2cdRQB1mq/Fi51OaGHwNpl1d3McZmuYLvTZzIQyq0CgKRsWUF8TNlE2/MORVH4oSL4i+MGkeCvEGuXWk+GLnSTdiK3n+z/ANoXJnKeQz/xDaM7Rz+JFdH8NPBOtaL4k1HXfEs+nG8nsLXToobB3dAkK4Lszqpyx5wBx6mqvx81Xwsvh+LQ/EOmz6xq2o5Gm6fZLm6aTs8bYPl4OPm+ow3IoAzvGfwn8E6BpP8Abmk38vge606LC6pZTsoAHQSKT+8z6febpk9K8svPHfxG1/wvanXRqkPgZ53ju/EOkafsurq3HR9hb92h7uABzjnBU+h/Dz4RaxqVvp2o/F3VbrXJ7T5rTSbifzobc+sp6Sv27j3YdPc1UKoVQAoGAAMACgDivhH/AMITH4Uhg+HctlJpiYL+Q2ZN5HWXPzbz/tc/hiu2rzbxV8H9C1TU/wC2fD81z4X8Qg5F/pLeVvP/AE0jHysD36E9yayP+Ev8c+Af3fj7R/7f0VP+Y5osf7xF/vTQdvUleB70AewUVieFPFeheLdPF74c1S2v7c/e8pvmT2ZT8yn2IFbdABRRRQB5hdW178PPFWo6lpOk3N94X1XbNc29mNz2dwM7pFj/ALjDBOOhH0y7UfiJP4hgOn/D6wvLvUpT5Zuri2eKC09XcsBnAzgDqa9NooA8Yv8ATdD8M65DFfWuoeNvG0yeaqyrvEQJOH2n5Ikz9SOordl8NeLvF0e3xTqkeiaW/DabpjbpGX+683b/AID1Bqfxrp2o+HvEq+NfD1q16TALbVbFD888KnKyR/7ac8dxx71sx/EHwu+gJrJ1i2SyYHG5sOCOq7eu7tjGaAKniX4eaPf+Brnw9pdpb6eu0NbSRrgxSryr7uuc9+tSfDHxRceIdIubbV4Rb67pU32PUIgeDIBxIv8AssOR+I7VhzeJvF3i1Cng/SRpenuD/wATTVQUyOxSLqfqa0PAtloPhW6vLaXxDDqPiDUZRJdzzSqJJWAwoCA4AAOAPf8AIA72vPviv/xLtR8G+IVyG0/V44JXzhUguAYpCfbla9BrjPjLp7an8LvEkCPsZLRrhW9DERJ/7JQB2dFUtEv01TRrDUIv9Xd28c6/R1DD+dXaACiiigAooooAKKKKACopriGBolmljjaZ/LjDsAXbBO0Z6nAJwOwNS1yvxF8Ead450VLK/kmtrq3kFxZX1u22W1mH3XU/zHf2OCADqqK8m8D+O9V0TXoPBXxNCQa22F0/VUGLfVF9jgBZOgK9yexIz6zQAUUUUAFeN+O9f1H4g+JLnwB4IuWgs4fl8QazGTi2TODbxnvI2CD6cjs2LnxL8XaprGu/8K/+H8oGvTpu1LUQTs0uA4y2R/y0IPA6jI6EgjuPAnhLS/BPhy30bRYisEeWkkc5kmkP3pHPdj/gBgACgDG8F654D0RLPwf4Z1jS1mtS1vHYx3CtKXXJfIzktkMT75qFPHHgS0bVtT0WfTb3UUMYuRpyxm4nLyrEnPG4GRlXcW2gnkisf/hCtT8Q/FHWte1qyTTtPsbJ9P0QB0Yu8qkS3RCElTztAODg9ARXN/DP4c67Frfh6PxVodrbaZouiz6XN5ksU8d+zylhhAT8mPm+cA57d6ANr4tF/FHw4svGfhyCaLV/Dl22oW8cygSKYJGS4hbaSD9xs4JB2DBINen+G9ZtfEPh/TtY09t1pfQJPGe4DDOD7joR6irNrYWdpYJY2tpbwWSJ5a28cYWNV/uhQMAe1eV/BJ38L6/4o+Hd0zbNKnN9pZY53WUx3AD/AHGOD7tQB67RRRQAVwvxrhlbwBdXcEbySafc219tQZO2OdGc474UMfwruq5/x7r48MeE7/VTa/a3iCRx2+cea8jrGqk9gWcZ9qAL+na3pmo2MN5ZX9tLbzLvR1kGCKkudW062QPcX1tGpOAWlA5rxeX4ba0rNeXnhTwlqEsp3tbW8stsVJ5xn7v5cUxNCh0gebqnwkDALl/sN0LrA9gW6/0oA7L4IOs2keJbiJg8E/iG9kikXo67gMg9xwea9Grn/AWp6Rq/hLT7zw5CtvpboRFCsfl+WQxDKR67gfr1710FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUb28L3Ec7wxtPGrKkhUFkDY3AHqAcDPrgelSUUAFFFFABRRRQB5x4v+EWga3qJ1fR3ufDfiJcsmpaU3lMT/toPlcHv0J9awf8AhL/Hvw9/d+PNI/4STQ0/5jmjR/vUX1mg/mVwB7mvZaKAMHwh4v0Dxhp/23w3qltfwjG4Rth4yezocMp9iBW9XnHi/wCEWga3qJ1fR3ufDfiJcsmpaU3lMT/toPlcHv0J9axU8U+P/AChPHOkDxNoqddZ0WP9/Gv96a34+pK8AetAHsNFYPhDxfoHjDT/ALb4b1S2v4RjcI2w8ZPZ0OGU+xAreoAK8p8d6Xp8Pi7S9N8MaHpS+JtV8yeS/mtw62kKY3Sle7EkAepr1avOPHk0/hfx1pPi/wCzTXWmNZyaXfiFdzwIXEiSKo5YbgQcdsetAEj/AA3nvm3a54u1+9yMOkUot0b8EH9a5v4p+APDejfDvVpdK0q3t7m2g86O4UEyhkIIbd1zwefeux074peEL1lX+147V2+6t4jQE/QOBWV8ZfEGmH4cautvcwXct5D9lhjikDM7yfKuAPTOfwoA77RLtr7RbC7cYa4t45SPQsoP9abr9kNS0LUbEjIubaSHHruUj+tM8NWUum+HNKsblxJPa2kUMjj+JlQAn8xWlQByHwguxefC/wAMSLjCWEUPH/TNdn/stdfXnf7PkjSfCDw+znkCdfwE8gH6CvRKACiiigAooooAKKKKACiiigDn/HHhHR/GugTaRr9qJ7d+UccSQvjh0b+Fh/8AWOQSK858PeLtY+G+s23hX4lXJudJmby9J8SNwkgAGIrj+64/vHr3z96vZqzvEWh6b4j0a50rW7SO80+5XbJFJ0PoQRyCDyCOQelAGiDkZHSvM/in44vrO/tvB3ghI7vxlqSnbk/Jp8OOZ5T2wOgPXjg8BuD8Q634y+B2kXWnpH/wkPhmQeVpGo3T4bT3ZsLFcHugB4PA4xkZwvpfwj8FW/hjR31G4vl1jxBq4W51DVt4f7QxGQEb/nmM/Ljr144AAND4a+B7HwLoJs7WSS6v7h/tF/fzHdLdTH7zsTzjrgdvckk9bRRQAUUUUAFNEaCQyBF8wgKWxyQM4GfTk/nTqKACiiigArzv4kSHxB4k8P8Agy2JInmTVNRI/wCWdrC4Kg+m+QKB/umvRK8w8Qz3Og/EyXxBpVqdain05bO9srWRWuoSjlldEJywO7BA6YJoA9Prkfi3q0+ifDfX760bZcJblI2/us5CA/Ubs1HovxK8K6qwjTVI7W5J2+RdgwyZ9AGxn8Kyfj1cwy/CvVI4ZEleeW2ijVGBLMZ4+Bj8fyoA6/wbokPhzwrpWkW4wlpbrGT/AHmxlm/FiT+NbNFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAee+MPhPoGvagdX01rnw/4iGSuqaU/kyEn++Bw4PfPJHGa5z/AISf4hfDz5PGml/8JXoKf8xjSI9tzGvrLB39yvA7k17LRQBz3g3xp4e8Z2H2vw3qlvexgAuinEkfs6H5l/EVwuhaPbfEnXvEOu6pcXkmkQ3P2DSVhuHjVViGJJk2kA7nJw3titPx18JNA8Qzy6tpnm6B4kVWaPVNNkMDl8f8tAvDA9yRnHevPvCvizxt8JtLttH8ZeFzqfhu1GyLVNHAdo13dXUcEknP8J7nNAHa6j4G8SaacaRqFjr2nqMJZa9CJXQZzhZcZ/E1g6M/hrQvE1j/AMJX4Gh0DUXuFFtfRHzLYy5+XDDgHPTIr0/wf428O+MdP+1+HdVtrxAPnQNtkjPoyHDL+IritSKePPiha6VbuJtA8POt7fOvKS3YJ8qLPQ7eSR7EUAesUUVQ1+9Gm6FqV8xwLa2kmJz/AHVJ/pQBxf7PsbRfCDw+r4yRO3HoZ5CP516HXIfCG1Fn8L/C8a4w1hFNx/trv/8AZq6+gAooooAKKKKACiiigAooooAKKKKAK9/ZW2o2U9nf28VzazoUlhlUMrqeoIPUV4rJb6v8DrwzWS3er/DWZ8y2+TJcaMTkll/vQ55Pp9eW9ypsiJLG0ciq6MCrKwyCD1BFAFXR9Usta0y21HSrqK7sblBJFNE2VYH/AD07VcrxPWPD2r/CPUrrxD4Etpb/AMIzsZtU8PIeYD3mtvTHdfQemNnqnhLxLpPi3QrfV9Au0urGYcMvBVh1Vh1Vh3BoA2KKKKACiiigAooritf+JOh6Hrsmm3f2pxb7ReXMMJeG0LDKCRh0J/TvQBQ8ZeLbzU7258KeB1Nxrb5hur3H7nTlI5Zm7uAeFGTnr2Bc3wm8PJpcEVmbq01aEmRdWhlIuWlIwzsxPzZ7g8HmsfTtVk8Ealq+pRwHVvB2tXraiuoWP71rWSQLvEijkpxkMPX349F0TxFo+uW4m0nUbW6Q4/1cgJBPYjsfagDzfX9O8UWFrIPEegaR4z06JcG5RBFdiIHn5SOWxz8pArQ8HeBvBGsWej+ItAtp0sty3MEAnfyhIpI+ZCT8ysD+IrV+LmuXOneG00vRyG13W5Rp9koOCrPw0nqAq5Oe3FdJ4W0S28OeHdP0exH7izhWINjBcjqx9yck+5oA1KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPNvGE9x4x8YQ+D9MnuLfTrHbda3cwMVO0jMduGHdup9h+FRaj4L1bwpINV8AXtzKYyDcaReztJFcoOuxjyj+/f8MVHe3r/AA78ca5qV/ZTv4Z1sxXDXkCFxaXCrsfzAOQrfKQemfxr0fTdSstTskvNPu4Lm1cZWWJwykfUUAeJDwh4C+Jd9ctaWl94V8Ywx+ZMLXNtPH/Dnb911yBkj16gmn6FN4y+Dmnrp+o6BD4k8KxMznUdGj2XaZOS80JPzn3B4A5boK6XwWB4o+KviDxMjBrDS4/7Hs2TkSNw8rZ74OAPqa9QoA5vwV448O+NbL7T4b1SC82jMkIO2WL/AH0OGH1xg9s1R+MmoHTPhd4luAu4tZvABjPMmI//AGeqHjX4T+HfE16NUt0n0TxAh3R6rpb+RMG9Wxw34847ivK/iPqfj3wtBo2g+MvJ8TaHPqEM327T4tt5NDCwkkR4RwTtXORxxyTQB9D6FYLpWiafp0ZBS0t47dSPRFC/0q9XN+CvHHh3xrZfafDeqQXm0ZkhB2yxf76HDD64we2a6SgAooooAKKKKACiiigAooooAKKKKACiiigArx/xb4K1fwbrtx4x+GEStLKd2q+H84hv1zkvH/clHPTr+Yb2CigDmfh/420fx1oa6josx3Kdlxay4Wa2k7pIvY8H2Paumry34gfD/UItcPjP4dTR2HiqMf6TbMcW+qRjrHKOm49m49yOGG98NfiBYeNrKePyZdO12xPl6hpdwNs1tJ34PVc9G/PB4oA7SiiuH8UeMbsa7D4d8H21vqWtshmuGkkxDZxjHzSEZ5JOAvWgC78RfEl34f0yzh0e1W71rU7lbKxic4QSEEl3/wBlQpJ/AcZzT/A/hRfD2hXFrfz/ANo31/K9zqFxKgxPK4+bj+7jgD0ritU1ZPGthHoupM3hrx3psou7RJT8vnIDhkbo8bAkHHY9OK6Hwz8Q7WaWPSvFUZ0TxCgCyW9z8qSt/eifowPbBzQBDd/DcWFzLdeCdZuvDsspLSW8QEts56/6tuFJIGSO3SuV0vQdP1Hxe/h7xjoFrp/iL7O11a6ro7mBZ0DYLAKRtbnuDXsV7qFnZWUt5dXMUVtEhkeRmAUKBknNef8AwttZ/EGr6n491KN431IfZtMhcYMVkp+Ukdi5G7/6xoA1/DXw90/Q9cTVpL/U9TvIY2htmv5/N8hGxu28dTzz6HFdnRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5/4+vNavfF+g+GdC1U6MLu3uLya8WFZXIjKBUUNx/ESfwr0CvOPCttJrvxN8Ravqtwxn0OdtOsbQDCwxvGjmQ+pfj8BQBEPEninwuj2njDRJNYsANo1PTU3hkwMmWLqvXnHU9BWTonhnwH4zu75vDl9qumMGP2zTrSd7QMT1ZoSOhzjjA4r2KvMNKtYtZ+PWs6girGug2ENoxTgzSzAvliPvAJxg9DigD0DRNIsNC02LT9ItY7SziHyRRjge/qT7mr9FFABXntz/xOfjdZxg77fw9pbznH8FxcNsAP1jVj+NehEgAknAHJNeffCAf2nB4g8UuCTrmoyPAx6/Zov3UQ/wDHWP8AwKgC/wCIPhr4Z1vX7PXJbJrPWraZZlvrGQ28smCCVcr94HGDnnHQiuyoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvOviX8Ojr15D4i8LXY0bxnZAm2v0GFnGMeVMMfMhHGSDj3HFdD468Ux+FtKjmWBrzUbqZLWys0bDTzMcKuew7k9gK55/HOs+HZ4D470SLT9NnbYNQtJ/PiiY9BLwCo7bulAHAv8Sb/xV4i0bwV4gnm8HaoWlj1dEOGlZQvliCQ8BJMsQeTkAZPBb2rwv4a0nwxYfZdFtEgRsGST7zyt/edjyx5PX1rlvip8NdE+J2iRNK6walEu6x1OEbmj74OPvIfT8Rg15j8O/ibrXw/8QDwR8VleNkwLTUSdysmcK27+JDj73UdD0OAD3fxP4Y0jxPY/Zdaso7hRyj9JIz6qw5BrzqGI6Nq1v4O+IEMes6JfOU0nU7pQzbj/AMsZG6h/Rh1r1lbmBrUXKzRm3K7xJuG3b659K8q1C5n+LGpwWWlRmHwhYXSXE+pMMNdyRnISD2z1f8vcA3B8JvCplXzoL2e0Q5SzlvJGgX6KT/M13kUaQxJFCixxooVUUYCgdAB2FOooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuJ8T+C7mfWZfEHhbVJNJ12RVE24b7e7CjCiVPpgbhyBWTdXOr+OvFur6bo+rzaToGjMtvPcWyBpLq5IyyBjwqoMZ75I7GpvsHxG0MgWWpaZ4itlbOy8T7PO3tuX5R+VAEj6v8R7NPLfwvpWouvHmwagIlb3AcZFaHwx8PX2iabqN5rvl/23q97JfXYjO5Yi3Cxhu4VQPzNQ+EvGWpah4pm8O+ItEOlamlmb6PZMJY5Iw4QkMPdhXcUAFFFFAHG/FvVZ9M8EXkVgf+JnqTLptmo6mWY7AR9AWb/gNdD4d0qDQtB07SrQYgs4EgT3CqBn8etcXd48UfF+3th82neFoPtEvo15MMID/ux5b6tXotABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfxF8RSeFPBuo6zDAs8sHlqiM21dzyLGCT6Avk+wrpKqatp1pq+mXWn6jCs9ncxmKWNujKRg/wD66AOS8LeCpI9XXxF4qvl1bxBz5TKCLe0U/wAMKn/0I8muzu7aC8tpbe7iSaCVSrxuu5WHoRXnHhjVrnwLqkHhPxTOX06T5NH1SQ8Sr2glPQSDgA9xXpgORkdKAPLf7O1r4Z3LPoNrc6z4QkJZtPj+a4sD3MWfvJ/s9v52dbsvBnxo8MSWTzLLLEd0br8l1ZS84ODyOh4PBx9K9JrifGngLTNauk1S0eTSdeiO6LUbT5XB/wBsdHHqD1oA81+G/wANPEEcmoeFfHF5q82i6dtNpNbXAS1vYmJ+Qj74IxyucD8i3vGn2Vtp1lDZ2MMcFrCgSOKMYVVHQCuW+EuvXniPwLY32qsj6gry287ouAzRyMu78QAT7k12NABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVleK5ry38LaxNpeft8dnM9vgZPmBCV4784rVpksscKbppEjXpljgUAch8HoNOh+HOiNpL+ZHPAJ5pScu87cyFz/e3ZBz0xjtXZVwF38OLVLqW/8ACetahoNxM5l22riS2yxyx8lvlyfbHtVW4074l3do+lyalocEbja2pwo/mBOh2of48c56UAR/DVZPEvjLxB41nLC2y+j6anQeRG4Mj/8AAnH/AI6a9NrJ8J6Da+GPDtjo9gXNvaptDOcs5JJZj7liT+Na1ABWV4q1y18NeHdQ1i+OLe0iMhAPLnoqj3JIA9zWrXm3i4nxh4/0zwtB8+l6Syanq5HKsw/1EDfUgsVPYA9qANb4TaJcaT4TS61Qf8TnVpW1K/JGCJZTu2+oCjC47YNdnRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcp4+8SXehxabZaNaLea5qtx9ms4XbagwpZ3Y/3VUEmsa48SeL/AAyxk8TaLDqem9Wu9HLM0Q/2om5wPUZqPR5T40+JrazCd2h+GxJaWkg6T3bjbKwPdVX5fqa9IoA5eC98MfETQJrdJLbU7CXiSFuGQj1HVWH4Guak03xT4C/e6FJceJPD6/f0+dt13APWN/4wP7p5rb8TfD3StXvP7RsXm0fWl5W/sDsYn/bXo4+vX1rGm1bx14QTfrNjD4l0pB81zp6+Xcooz8zRnhu3TgYoA63wz4t0bxHpi3um3sZTo8ch2PE3dWU8giuF1S8uviV4sl0XRNRuLXwtpq/8TC9tTta5mJ4hR/QDOSK2LPw94B+IETa5b6faXrSsRLKm+J9/cSKpB3fUZrtdK02y0ixjs9MtYbW1jGFiiUKB/wDX96AIfDui2Ph7RrbS9Jh8mztwQi5JOSSSST1JJJP1rRoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACisvV/EOj6PF5mq6nZ2iZxmWZVrmLz4seELWbyxqMlyScBrW3kmU/ioIoA7uiuEHxO0iQbraw1ueP++mnS4z6cio5vix4ctlP21NVtnH3lk0+bI9P4aAO/orjrH4meD7wLjXLWBmIAS5PlMT9Gwa6q1vLa7QPazxTKRuBjcNx68UAT15XeQW/xO8ceTNbvceEtBMsUxckR3l4fl2gD7yxgHn1NeqV5t8DNQto/CMeh3DiHXrCaYX9pJ8siyNK77sHqDu4NADj8PNT0p3j8JeK7/S9Oc/8eciCdIv+uZbkD0HSnfDjVtcHizxD4c1zUE1VdPjgmjuxEI2/eBsowHGeAa7jWdRt9I0m81C8cJb2sLzSE/3VBJ/lXE/BbTLldAuvEWqgjVPEU326UH+CLGIkHsEwfxoA9DooooAxvGPiC28L+G77V73mO2jJVB1kc8Kg9ycD8axvhb4fudF8PPd6uM69q0pv9Rc9RI/IjHsgwuPXOOtY11jx38R47Zfn8O+GJRLMf4bi/wD4U9xGOT/tHFel0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVLWraa80a/tbSYwXE1vJHHKDgozKQG/AnNXaKAOC+DGpWMngyz0eGFbLU9JQWl9ZNw8cy8Mx9Qxy2e+a72uN8VeD9O1/UY9U06/fSvEMICx39ow3ED+GRejr7Gs6PXPHGgp5et+Hk1qGPA+2aVKNzj/rk2Gz644oA9DqrquoW2labdX9/KsNrbRtLK56KoGTXK6H8SdA1O9FhcyzaXqedptNQjML7s42jPBPsKx/itcReIdS8NeDbWZZjqd6txfRxtn/AEOLLuGI6BiAB6kYoAl+DOn3Mlvrfim8t/sR8RXIuobMLtEUKgiNiP7zA7j68GvR6bGixoqRqqooCqqjAA9AKdQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVzfjnxXb+FtOifyXvNSu3EFjYxf6y4lPQD0HcnsKAJvF/irTPCuni51KRjJIdkFtEN0s79lRepP8q5K38PeKPGIN54q1S70PT5OYtJ06QJIq84MkvXdzyBx2rT8GeDp4L8+I/FsqX/AInnHXrFZIf+WUI7e7dT/PuKAOR0n4ceE9MkaWLRra4uHGHmuwZ3f3JfPPvXU21vDaxCK2hjhjHRI1CgfgKlooAKKKKAKGoaLpeotu1DTbK6b1ngVz+ork7r4V+GGdpNMhvNHnZtzy6bdPCW9iMkY9sV3dFAHnf9k+PfDwDaXrFr4itl5NvqKCCY9gqyLx+JFc/repeGdf1G2Txvp2peFNfT5Ir0OYSw7hZ1+UqcYwa9kqvf2VrqFs1vf28Nzbv96OVA6n8DQBwSfDDRtSEUmo61rer2QIZYJ74tC4/2goG6vQ4o0ijSOJFSNAFVVGAoHQAdhXnk/gK+8PzPefD7UjYHq2l3ZMlpJ/u94z9OKveH/H8Fxqa6N4ls5NC13+GC4P7ubnGYpOjj9etAHb1x3xL8SXOjaZb6fogWXxHq0n2XT4v7rH70rf7KDknpnA710+qX9tpenXN/fSrFa20bSyueiqBkmuE+HNjc+INXufHWtQvHLeJ5Gk20q4NrZ5yG9nf7x9sc4NAHU+C/Dtt4V8OWmlWhZ/KG6WZuWmlPLux9ScmtyiigAooooAKKKKACiiigAooooAKKKKACio7ieK2iaW4lSKNRks7AAfjWD/wm/hfft/t/Td2cY+0L/jQB0VFQ213b3SB7aeKVSMgo4bIqagArgviX9o1LWfCvhuO9ubK01W5mN1LavslKRQlwgbtk4yfau9rzzxBcHWvi34b0zT/mOiJNqF/Kv/LISRmOOP6tuJI9ADQBYb4U+FUTNnbXllP/AM/FteyrIT65LH+VQN8P9Ws4/L0LxxrdpH6XKx3R/NgDXoVGRnGeaAPKfEHw08Q+ILI2mseLYr6DBA8/TIyw9wQcqeB0xWL8PdAu/hx8RNP8P407UU1e3mkkvERluYUjGQWJJG0nC4GOeT0Fe2yTRxf6yRE/3mArzZb20uf2gbd7e7hmA8OSREK4O1vtKH88GgD0yiigkAEk4HrQAUVSuNW062ZVuL62jLcKGlAzVuORJV3Rurr6qcigB1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV514CtR4k8Vaz4xvv3hiuZdM0tD0ggiYo7j/AGncNk+gAr0Wo7e3htkKW8UcSFi5VFCgsTknjuSSTQBJRRRQAUUUUAFFFFABRRRQAUUUUAFZXiXw9pfiXTHsNatI7m3bkbhhkP8AeVuqn3FatFAHk8vw/wDEN5qlpoesawdR8EQSfaiJj/pMu3Gy3kb+JAec98c84x6uAFACgADgAdqWigAooooAKKKKACiiigAooooAKKKKACszxNqFzpWhXl7YafNqN3En7q1h+9IxIAH05yT6A1p0UAec2vgjUfE14mofEW5iuUQ7rfR7VmFtDx1kPBkcdPTjjrXVHwh4bMflnw/pGzGMfY4/8K3KKAOGu/hb4ad2l0yO80a4Y5Mum3Lwk+2MlcfhVNdN+IPh7/jw1Kw8SWajPk3q/Z7g9gocZX8TXotFAHnN7rXxCvbU2dn4VttOu5gF+1y30ckcAPBfA5bHXFV9J+FdzYXF7P8A8JhrJnvnWa7kjVEaZwMA5wcAdh0A4r06igDz2fwHrkZxpXjrV7dHG2UXEUc5I/2TxtNPHwu08Kv/ABPfE3m/xSDUm3P9eMV39FAHAJ8KPD0j7tUm1bVR2W9v5HA/Iip7j4V+EHt0S20oWM0Z3RXNpK8c0Z9Q+c/nmu4ooA88/wCEI8UW/wC6074gahFaLxGk9lHM6j3ckZ+uKePhzJeuJPEPirXtRfGGSOYW0bD0KoP616BRQBx1t8MvBtujKmgWjhupl3SH82JNZV18PLrRZDd/D/V5tJlXk2FwzTWkvTjByyZx1Br0aigDD8JXuuXunu3iXSY9MvEfaEjuFmWRcD5gR05zwa3KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKx/F3iPTfCXh671vXJmg0612ebIqFyNzqg4HJ+ZhWxXFfGbwpfeN/htrHh7SpbaG9vPJ8t7lmWMbJkc5Kgnop7HmgC/oPjnw/rVlqFzBfG1XTpBDeJfxNaPbMeQHWUKVyOh6VrXWt6VaWUN5d6nYwWk2PLnluEVHz02sTg/hXnGv8AwmjWzt59BnF9qqavFq10dbmaRb8ojIEkZVO0AN8uFIGOhzXMat8Gdel8OaPbWNxpQ1O0kvZhKLiSKO0Nw+7y4kMTq8Y6FWVSccEZoA9i0/xZoWoa3qGkWep28uoWCRyXEQJG1XUspDHhhgEnaTjvjNXLXW9Ju7Zbi11Oxmt2k8lZY7hGUvjO0EHGcdutePX/AMHdUuJ/E8S3GirHrekWtmb6OAwzQTwx7W2Rqu0RyH7wDDA4wcVVsvgxqUv2QanbaEIv7Zsb+8hFzLPFcRQRTI42NEqgkSqAuMEA5Y8UAe2/2xpv2u3tf7Rs/tNygkgh89d8qnoyjOSPcU1Nc0qS/msY9TsWvYQTJbrcIZEA67lzkY968p1z4S31z4qu5tMbR7fR7u9sLtZijJdWC2qqohgVV27SEAHK7QSMGs2++Evii98dHWbi70Z4ku72VJVleNzFNE6IhiWPaCCw3NuYtySexAPXrzxVoNnYahezavZG3sIDc3RjlEhijAzuKrk8jpgc9s06HxPocumWOojV7FLK+ANtLLMsYlyMgDcQc89Oo9K8js/gnPBptnaoui27nwrcaJeSQof3t0+0rNjYN4DDduOGzjiqeq/BnW7+00Nnh0DdbaQdIurCO5khgOHLeckghJ3PnLDYOQPm4zQB7fqetWWn295JJPHJLbRtI9vHIvmnahfaFJHJUEjOPXpSQ65p0n2BJbuC3ub6JZYLaaVFlcEZ4XPP4Zry+L4SzsPHM91Fo82o6vpUVhpdzIGeS1YWH2ZyXZCyhj3UklevPFZl78HtanmMS3WkNDeQaUk94+83Ng1mqBhbfLgh9mckpjceDQB7bFfWk07QxXUDzKWVo1kBYEYyCPUZGfqKb/aNlnH2y2/132f/AFq/63+51+97da4/4feBk8O634o1bULbTZdS1PVri7t7uJN0yW0gjxEzlQR8ysSoJHPWsUfDO7/4XAfEP2u2/wCEZ87+0/sHzb/7Q8ryd+Mbdu35s5zu7d6AO4sfFOlz6JZapd3Eem292SI1vpY4mJyRj7xBPHQE1pf2hZBipvLfcJBCR5q5Eh6J1+8fTrXgjfBHXF8OeF7WS50q9n03TbjTrq0luJIoWEkpffHIImIOCAcoMgdauat8F9auNQD2Gp2VtaLp9rMkXmSErqttAYYpMlTmPBBLE7iQDigD3S3uIbgObeaOUI5jYowbaw6g46EelS1y3wy8NT+E/Bljpl9LFPqOZJ7yaLJWSeR2dyCQCRlsAkDgCupoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAMXQPE2la9Hq0mnXG5NKvZtPu2kUoI5osbxk9QMjnpVfU/G/hnTdCn1m51uxbTIJEikngk88K7sFVcJk5JI7dOegJrgND8FeONHPjbT7SXw2NL8QalqGoR3MjyyzQmdCIwYjHsYAqm4EkYLdeh5eH4I+IJtB8V217Loi3eqwWPkfv5ZkE9vJuZmJiXaGGVG0cBiMY6gHvT61paT2kD6lZLNdjNvGZ0DTD1QZy34UsusaZCkzzajZxrCGMpadQIwpAbdzxgkA56ZFeLeIPg/q+p+JZ9UWLRfs97FZ77RbqWBbCSAAAQlYiXTIyB+7OSfWtY/CzUIPD3jMaeNDi8R6zq9xeQX0kAdvssk6SiF3aMsv3ewYK2CMkZoA7+/8ZaNayaKI7pbyPV7z7DbS2jLKnmbWblgcAYU+tbU17awyPHNcwxyJEZmV5ACsY6uR/d9+leK+E/hJruk3enyzzaXHHB4k/tloo7mWXEX2fyyoZowWfd64BHcdK6P4x/DrUPGl1pVzod9b2EwSTT9ReQsDNYylTIq4Byw28A4HzHkUAdxbeIbGa51RGfyYNPEbSXUroIWV03hlbd0weSce2etWbfWNMuYklt9Rs5YpEaVHjnVgyL1YEHkDua8l8VfCTUtVuPFrafd2Frb395pl1YQEvsK2kIQxTALwpI4xu6D6Vl3HwY1mTRbOKyn03TL46hdG7Ed1LMjWd1Csc6q5jU7zsyBtVQT165APdYb21nkWOG5hkkaMTKqSAkoejAD+E+vSp682+Enw/vvBuo65c6rd2115xjs9O8osTDYxFvKRsgYb5+QMj5Rya9JoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematized posteroanterior chest radiograph (left) demonstrates the lines constructed to measure the Cobb angle of scoliosis. Schematized lateral chest roentgenogram (right) shows the Cobb angle of kyphosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from McCool, FD, Rochester, DF. The lungs and chest Wall diseases. In: Textbook of Respiratory Medicine, 2nd ed, Vol 2, Murray, JF, Nadel, JA (Eds), W.B. Saunders, Philadelphia 1994.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3824=[""].join("\n");
var outline_f3_47_3824=null;
var title_f3_47_3825="Bile acids in PBC";
var content_f3_47_3825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 499px\">",
"   <div class=\"ttl\">",
"    Role of bile acids in primary biliary cirrhosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 479px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The immunologically mediated T cell attack on bile ducts in primary biliary cirrhosis leads to the retention of bile acids. Bile acids eventually accumulate in high enough concentrations in the liver to cause chemical damage to hepatocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3825=[""].join("\n");
var outline_f3_47_3825=null;
var title_f3_47_3826="Patient information: Malaria (The Basics)";
var content_f3_47_3826=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/39/33395\">",
"         Patient information: Avoiding infections in pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?26/42/27298\">",
"         Patient information: Staying healthy when you travel (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/52/43843\">",
"         Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/2/16421\">",
"         Patient information: General travel advice (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Malaria (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H71683739\">",
"      <span class=\"h1\">",
"       What is malaria?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Malaria is a disease caused by an infection with a parasite (a type of germ). Mosquitoes carry the parasite and spread it to people by biting them. &nbsp; &nbsp;",
"     </p>",
"     <p>",
"      Malaria is common in many countries. It can be mild or severe. Severe malaria can cause serious health problems and even death.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683754\">",
"      <span class=\"h1\">",
"       What are the symptoms of malaria?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Chills",
"       </li>",
"       <li>",
"        Sweating",
"       </li>",
"       <li>",
"        Headaches",
"       </li>",
"       <li>",
"        Body aches",
"       </li>",
"       <li>",
"        Tiredness",
"       </li>",
"       <li>",
"        Stomach problems &ndash; These can include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Loss of appetite",
"       </li>",
"       <li>",
"        Nausea and vomiting",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Skin that looks yellow &ndash; This is called &ldquo;jaundice.&rdquo;",
"       </li>",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Fast heart rate or breathing",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Severe malaria can cause other symptoms, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Confusion",
"       </li>",
"       <li>",
"        Seeing or hearing things that are not really there",
"       </li>",
"       <li>",
"        Seizures",
"       </li>",
"       <li>",
"        Dark or bloody urine &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683769\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See a doctor or nurse right away if you get a fever while you are traveling or after you come back. Be sure to tell your doctor or nurse where you traveled, including any airports where you changed flights. &nbsp; &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683784\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If the doctor or nurse thinks you have malaria, he or she will order a blood test to look for the parasite that causes it. There are several different types of the parasite. If you have malaria, the doctor needs to know which type you have so he or she can give the right treatment. A blood test can also show if malaria is causing other health problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683799\">",
"      <span class=\"h1\">",
"       How is malaria treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors give medicines to get rid of the parasite that causes malaria. There are several different medicines. Some people need to take more than 1.",
"     </p>",
"     <p>",
"      Most people can take pills by mouth, but people with severe malaria need treatment in the hospital. They get medicine through a thin tube called an &ldquo;IV&rdquo; that goes into a vein.",
"     </p>",
"     <p>",
"      After you start treatment, you will have blood tests every day for a few days. The tests are to make sure the medicine is working. If not, the doctor can give a different medicine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683814\">",
"      <span class=\"h1\">",
"       Can malaria be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you travel to an area where malaria is common, taking medicine can help keep you from getting it. If you plan to travel outside the United States, tell your doctor or nurse as soon as possible. He or she can prescribe medicine if you need it. Take it exactly as the doctor tells you, or it might not work.",
"     </p>",
"     <p>",
"      Taking malaria medicine is important even if you travel to a place where you used to live and are going back to visit friends or relatives.",
"     </p>",
"     <p>",
"      You can also reduce your risk by preventing mosquito bites. To do this, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Stay inside at night &ndash; This means any time after sunset and before sunrise.",
"       </li>",
"       <li>",
"        Wear shoes, long-sleeved shirts, and long pants when you go outside.",
"       </li>",
"       <li>",
"        Wear bug spray or cream that contains DEET or a chemical called picaridin.",
"       </li>",
"       <li>",
"        Sleep in a building with good screens over the windows and doors or air conditioning. Or, you can sleep under a bed net treated with bug spray.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People can get malaria even while taking medicine to prevent it. If you get sick during or after travel to an area where malaria is common, and you were taking malaria medicine, see a doctor or nurse. Be sure to tell him or her you traveled to an area that has malaria and that you were taking medicine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683829\">",
"      <span class=\"h1\">",
"       What if I am pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pregnant women have a higher risk of getting malaria than other people, and they can get much sicker. Malaria can cause the following problems:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A miscarriage &ndash; This is when a pregnancy ends on its own before a woman has been pregnant for 20 weeks.",
"       </li>",
"       <li>",
"        A baby that is born too small, too early, or infected with malaria",
"       </li>",
"       <li>",
"        Death of the mother or baby &ndash; The baby could die before or after birth. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If possible, pregnant women should avoid areas where malaria is common until about 2 months after the baby is born. &nbsp; &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H71683844\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?26/42/27298?source=see_link\">",
"       Patient information: Staying healthy when you travel (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=see_link\">",
"       Patient information: General travel advice (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/47/3826?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85721 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-CCFD8525CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3826=[""].join("\n");
var outline_f3_47_3826=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683739\">",
"      What is malaria?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683754\">",
"      What are the symptoms of malaria?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683769\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683784\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683799\">",
"      How is malaria treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683814\">",
"      Can malaria be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683829\">",
"      What if I am pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71683844\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/2/16421?source=related_link\">",
"      Patient information: General travel advice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/42/27298?source=related_link\">",
"      Patient information: Staying healthy when you travel (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_47_3827="Fibroid embolization 5a";
var content_f3_47_3827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F81418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F81418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sagittal fast spin-echo T2-weighted pelvic MR image",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 494px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 38-year-old woman presented with menometrorrhagia, dysmenorrhea, urinary frequency, pelvic pressure, and increasing abdominal girth. Sagittal fast spin-echo T2-weighted pelvic MR image obtained before embolization shows a large fibroid (arrows) occupying the entire uterus (20-week size).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3827=[""].join("\n");
var outline_f3_47_3827=null;
var title_f3_47_3828="Acute cutaneous lupus erythematosus - malar eruption";
var content_f3_47_3828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 376px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF4AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDz2K42TDYTx1qVzGS2wneehY9KooRw7nGehA61OEZ/mwR6tUI9e12aERiW0Gcece/oKz9x3EhenNWFUooU4yauXdpboFkRwGIAZaTGvd0ZnRK4lOzBI5Oe1aVvg4QMM9c+9VpHRDJhNu4g49at6bCxkO7BPY1lKVtjS2lzQgjQbck4q1sx0BOOhpiRjPILH9TUq/KwAPWsnJ3Mbag0IYZIz6VKLYSYyNoxkEVLGDxnnHp0qywHVgc4pXuMrx2ykbn6nsKl8jJCcgHt2qxEmQo+XHapyuB6noQexouySl5bMRlcqOGAqq9kLi4Teoxndgdq1o3UswHy46samgh8uNt2GL8gj0poDOuQsaBUQ47EdqqWVvsv0IA4GMH9a2mjUsuQRzk07ygki/LgZ54/rTuICP3h+bcARk+lWNqGRijpGMAg44p0G0NxGfTkcUEFRghcdM4pisY95bFdThmQ8DBJA7e9bERQbWkLHcMAgYzTG8tT+8cZYcnHOPSoHuUxsiRpOy+1Fx8ty6A3JG0KpwpJyao3EoF2JZ3AXHzEd6QrcvkhhGP7pqe304E75gWA6g0N3EkluVvtPmNi3jL46MecVOIJp8G4k8sH+FeK041WFWKgKdvOBzULXD7I/LVVxwzPzn3p+oX7EawxQruVVB6ZJzmia9YQN5URjY8Fj1NNfY53DcCepHIqMIJZV+ZvxoD1M6fc7ZOBn1quyDIAxg1ryR5B3gfLwBVZ4Soycc89O1ZyRpFmfFAScEbiOV4q2kRZdxXJDc5qxHH8+4qVVvU9KcwdS3lg/L+tQU2V5CzxlkBA9R2FQSOFUMAxJ4NW853FTsJHI7VAVJxsAxjkH+lAyGVZcYb5Qvb1FGdqlU6Y5qQtkDkjH96qlwuSdr7STk49KhloaQBMcKce/SoJeH5IOelSTzjIGMKB1qi0m8kkc9qErlIswgHr1BxVhWIjK7VKjuBzVNHbYF4z1z6VIgLIUyQeoNdUEKVrl2N2d8Y4HHpWrY3rWmY8KyjsD1rCijeTO1uR97PGaswuu3hfmzjrV8pEkmdXa6ktyhiu1SIDkccmrktzBsVY0Cs/JOeCK5uJY/LBw7XHZRkj/wCtV9pYpEQSKWK/3uNvtQoGPKWGuN0jxyopT+ErwcVlX8Z85ChyByCOtBLuXA3lMkYz92mThoyPIcyREdG4IPpUTjoXFDLe4BcA7t2TjtzWkXWWB5Ub99Hj5fWsh33soZQHHBxxirtsgKK6SHOMDHBrmZbROsqyIpZRuTO8Edaj3OZ/3h6jg+g9qew3KF9ySV61HHGpVyyMWUcEGkIv2yxNLtUBVZfvk4P4mrSYUuFxg4Kt249DVC2L7xHI258cMeRn0NWQDIqqVUgMSqs2AfpW0WZS3LltcS2++4XLwk5YE9fQ1bj2u6zR7G8zsGJ/CqMSKVQTnaT0jOApxU8G5JpJAqxqpyQR1/CrRmyeUqwaKRAWIIUZwV9/c1zGpWqMW2noetdDPJtmLRjELkFSOSD6VQuIAxkAXDA5I7ge9TJFQ0KOmSiEYZNw3ZUnoK1rlUuEw2zBPKEcis5MCQFAMDsa0IJSEWNGBKnOWGeacQktblG7sYXH7pthHftzVGVpYW/eoRnowHFdHcq/mEyCI4wcAYBPpVGSFprgbtmT/CvPHoKrl6iT7mbGrvloWWXjO08Yp0ZJG3auerHOMn6VYmso/MJVJI8dMcc+9QkSKMSIHjHIcDrS2HuWrfYsTy8gjjB71DckPDG2wbC3zA9QPWh44Z02Qyuj4yBu60pikWPDITnrj5s0XCxH9ijmkGANjDqn8NFSWzQpIFVFjYdc5BB9jRTUieVHh5OGUrxirts+7j+8Rms5N3mKzd+laMTKM7uO3FdJuidjmVsnce3tRCvnY3cKB0/rTyoS23KgJY9T3q/aKgXft4PY1nJlmdLZuSHBLBegz2rS0lSygbeAO9Txp1zjFXLOIL2wPWsWwcrx1JljbcWx90VKseVOeSeTmpbePDleiH1p68yFT9zH51L0MxbeM4BbgD9aseUJDlf1709AMKv8P61MMZA4HPahiuMhiZlxgAjtUxUAgn05oX5XLK2eKVck8nCGiwhEjVWJ28GpEwHC5OR0z2FC/M2FB2qcYpyBQfmyMHB+lCAcY4UYsOT3OOtNJ5OOcc4qwVVUCnB54qJnVW2qBgnqO9OwCRhiw+QjI9ahnjmAId8Dsoq4jZB3HGKeOOHxluuKtRFexThtIw2SrfOM5bnmrccakFSoUDjI600yFGESMCM9PSnsH8xTHmMjPvmnyiu+oTQrGhZ8N0xk96k8/dlYV2beu7nNDiCIoWlJOcnAzjjufWozcokiTyEGLOVjHGfrRYREPkcu4Ckj5QeSarTSCKP5HxITycUt9dM7qIUUFuQxPIFVlLKrMzAqOMHmlYtRHpL5BCt6DnJA+v1qVJy5bAATse9U2LqQJPMbJ4JOakTc+3dt+9wpFFirFnGQznPzdB2oQMUK/fBOD7UjM2/aFDADAJ7Grqsux/NwrBBtK85NRJE2shr22wkcbscY54qjIck7VIT+daLXHmupAEabeB68c1nznKlVche2ahqw43I1+aFhhQqnioCEBJIJboMcCpZgV5bAYDJAqoT5jqxOHzyvbFS9DRDZ5Cyt0AHTFUZX28gYB44q9cFSeFyP4gKpTLnG0bU7D0qGWitJuONxAwM596qpnfkjjrirDuBnjC1VLlZDnGKqJS2LNuDI+cDb3zVrzEjIABBHQ1nJOMHBwSccVK8mW+bhQO/euhOxLXcvfaBNINxG5RtUDv8AWrKyo0RVI87fmOB396yI9hOcFPxq8soG1QyiIDoOc1e5LXY1U1BfLTkAgYyrY/OrkV9EYSiKQ5+8S2d3vWHC3lncSnlngALmrMKFmaVHQJj0zzVJ2J5TUMx8lQVjZuq7etZ896mSGHzDqT1qvMhaMSxAg4z8vSmRlJEAkwWXkGs5yHGNyWW7WYLhRxxx3qzaTKrqGzgnoOMVQUICwOAOwq5CqiBfvGXtXM9y2lY0W+VybZ8oByD+tROR5Q2sVlJ+8OmKYg7E/vCM5XuPQ0wy7opInJ27hj1qSbF9TIYSkSCRVG9sEZOKktJxKFR3TazZVW6/gapxu/krAjAKScAfKfoTUsbbvLMo2gHYflyRitEyHE0Yi1pshnYswYkrIASPoa07fzVmB3IqDlihzz2FVYYxOEe3Rcn+Lf8ANjvwabCkkbMhSNsH5SGwyGtEZtGlHGu1RE4Lklj7Z7VXniLFipBXO0qnXH1q3lHO9sqcY25xuPepVVOUMKoxHysTjHvVE3sYslooUMD8hJAz2ojXaoaNSGGc45OK0bq12XIYPuUDkt0zUVvbmNsR7WGMbweTn1pDvcXIkhQSE7WHG4dqijjWLaxIRDjaBywH1qW6j/fqqI8jAZOeMfSpGCIGbYRtXBXqTVXJIobRmuW8sl+T8zHt6Cqz27mTYJFZ+mBV2L99gJOyxoMsAcFf9n61JMI49rxEMx6HptNMDGktUlfHlhW243L1z60iw3ESbFkWQjggn+tT3sss2wRZY55wMA0rQvBtDrvUDeRjrntmlYZWSWNCPtEPA9eQT7mirLsv3TGUzzsI6UUuUD5+PEoLcE8AVZKkuoyeeeKqu2JdqE7iOc9qvW77sF+wwK3ehvEtrC0uCo+UDqelTrOFkSMDKjhvrTrO4ZLSWF8BCdxYjvUJSOSVRGSvQk1D1Lgn1NNZMMdw5Hb1q9asNnJzjkCsyRCwEg4zwPoKmgnLrtU4PU/Ws5IbjdaG/Fkoc8AnNWIwvmBQMY5LVk20ziMjt2FX7aQmMcc561LMWrFrLFjgkj6U8MpIAyfwpseVySV59KkJG5duCRQiWSooZcYJPriplQBcc5/u1XWbbLsPG4ZyKlNwFIBJ54zVcomTKNpIDZPfFQGQ72DemB702aTZH8rYAqCWQlAqAbu7f0pxiOKbLUZ2EbjuAH4GltQcvtUZU9D2qlHcrAoMgOMHB7E0yK7NxOiWsign7zdsVpZbFcr3Nnz4rYHe+zB7461X+3gSsUcSBuQQO9UGggklUTyCTecZB+6aqXVnFsaWF2VMkfKetVbTQSUb6k6XrLNtAG4sWOK2oZy1qxVhtc8nuTWFZJC9qGPyuhxj1rTttsbASEBD29KmzKlFdCS4AGV3sq4yQe5rOMhSNnYb3ORvan3UowWywY8MPWo4UDl0c/LjkCpsEYkFrdPOu0L05z6mqvm6lFc+cuNhJx9atxlU+6FRQdwB/iqQSn5g3zc5VBz1oZotNkQQXjYOMBt3zZ9a041A2MeXJyTVdrWOS1xtAkXpjuKSJpAsce3G7j60WB2exoxuAzZYAAYzUzXSGAou1Qi8EDqao3BYQLvyrqQCo44+lRSTEx+UgJU9R6/jWbRHKOFzujJkJOD8uKpPK8jffySQSO9WDAI4QZBtBPr1qjLdqZCsAO7OFOOgqeXuUkTyRNENxJAz1JpVHG45JHQVE0bKy+cwcHn6GnM21eMH3x0qZRAWUsz/ALtQoYfnVOdSFxwfWphu+dicEDGe1Vb5vLiIzknjNZjRnzk7iFOTnnNVJcxyHkHP3adIucYbJHeoSFJ+dsgdBVRRoiW1xyXJJHSriAD944yfT1qpEyA5L47YA/rUyTBcjGR2Iq2D11LChy24oFb3Hapo1JUZ2gZyWFVzMRbExn5u56k1PbqIhF5rFlYZYelaQuJky7j/AKtkU45OeMU0T3EYzAfmB5PYip44o5jtRo9p4LAZ/SrEcUaKFDhlX+IjmnJkrTcha6lMSozsrAcDGOKrxzmKQlgM/wB0VLc7Tzks3QZrLuHcOmADkc46isJ3ZcUmjYeeOSTeny5xkYq/ayjKbQOuMntXNJc42quQPU9a17SZXQKG+U9c1CFKNjUQMZBJwATjg0mxftKCcMVGchf0NMteWZc9SMMKmkVpmdvugfL70EXGMiyIVkkxKOQ2OcelW9OkcRSGRwCF5z1qruC7Sy5A6YpZZAjq+R64xniqEy5BOseDGwLk5I6c+1aEE0bHzjHmQ9SwyT+VcvO4dg4OFPY/41b0+8nilwGZV6A5zitE9SHDQ6+3jlnG5UMo6kAYxVksHMQEJhAwMtzn61gQXbpcYYbnXqR8ua1re6lbeCsipjoSKoxcTQlk35ldY1KDaEVf1qHzFZlBRSjdccZNSw3ERVRE8bEjayA8j3qOW2WTawIR1OQVbJNAWEuE2D5Wxn5RtYZ//VSrEoZGZd0uOVxjP41NBIMDzUyRkK2Af0pgjJB8xGVx8wwc8elMRVMaSzCRUaMH5gQQeR3PrUyqipJhCQ3IPXnufaomhYZLfKh/hCkAe1WLZonibycKACpYjPHpihMTM+5VydgVtjrnLcEDvWRd6nbWcpt3yJFbEYJ+VRXQRqz7BdSfI2Yw+fmH4ViXHh9NRkuGeRC0fG7IGQK1XkXC32gtnt5WDHcVPDFTnJoqhbWRsAqxNIQxGVPp6iirsOyPGEyONoznr3q3EvyjcPcVTiyByM+/erlv8yuM4AHfvUM2ii9blJUII4IxU0UAigMjkZzgY6is+3mWIEyDA9qspeGaIh0yW6DvUmii+hbZzEQSwaM9AO1PsgSS/Ru1V7ZAUJIOc9DV+AgnjrUyL2RoW3yxkk81bhIz7A1RjzGcckjpVhCYm+cruxn2qbGNrmgzDy8kHPpUalkcbjtGM8mqjzKMlySW4+lQTXE87OLeMsqjAPc1aVhKBf8AtZVizDB6DPpS/ashiCAenNVVtWMaXE033wRj0xTvIhuYwqsQeMelXZj90mm1eMCNApbnBGKatzOwKeS4CnJOKhnsHSVGcgbRninPKyxPESwYuGbntTQ3boPuLeWaC3kuJMQsuAo9fer8lvCtpbpbR4bq0o4IqvIVm8ol8IvrSG6ISSBDwevpiqWjI10IWXMhCnOR1NSqjJH5AP7rAcIf51Gm5Y2mQYgHG49zVeJzJIWyVBGMk0y7Gzc2sQtYZ4SV4Axnoe/FZpuDG5Uykt2K9jU3lmWJ1ikJC+p6iokhA2Mwxj+JqmSvqTFW3JmnYwrwxOOSajbcillJVhzxU0bh1bccn2HWmOQELk/vM8LUNNlqyK4DNGQqlmc/eNS2sXz4YsD0z3NSyoY5FaRtrnB+XoDUrvuHmJGRtwAc9T60JWG2TywC3RUkY+Yf4c9KW4iaWGNYt+4e2DVe2LyyGRj5jngDrWjC7gmPdsUD8fzoRm9CAh45CJkJYAA/41A6FWO0hT2BpJH3KCSxBONxp5fc/mZBC/wjvR1GVZY3m4kkkftg8ACkDRIh2rh+n0qS8ugPm8poiRwD3rLldy28456Y70tCkrlhDufmTgDIHXPtVwJttw+w8Dn2qlChkbIyMDoO1aedsYWTOcfMPX2rKYpaFSR9kWHP1PtWLq1wo5ycdq17thIhwMLnp6Vz17tZicdDuC1lYcNyrFKS+0nBP5VW1K3ld1KH8BT5bhGkYRKBnpkdKkDuUA+XNa8potCOMOFG4EFRzmrMWHAIP3uwqBiAG3fxUsTjAKqfl7jtTK3L9mkcChnZtx6Cp55Xdw80ZMffbxWfG7lvlxg9M0t7HKqZlLLkjg96u9kFrs2LMBI2KrgEZHtTmmV1bcWEmeB0rOgLAL8xye2e1XkRAAS2SDkHv9Kyd2S1ZkiJuxkkGqUwZ5yI12r7VoLKrnDcAHoKJEUEnHTsKSs0JSszBmt5BKducVety0WGPzAckVbkiO4KvAI/GofKKk46+9Qy3O+5q2U4aMFckkYB9DWsJco0hALjGTnH/wCusG2UoMAEbhnJ7Vt/Z5YraCSeMeWeVJ7ilFGE7IkRMwbUG/dlhjt61Ay5ztB25wP8KsL5RVtrFHU5BzgYokgZYfNR2weSMcVcVqRczpFYZjcJtzkc06AGedoUkXbjcAOtVb4edEyxMwkHPIwRWfb3FyI8OFyufm/vCtNDVQujp5POWPIYMAME4xmtLTbqRYYvkPTB2nNYenRzxWe+ZCyOMjnpW3pqMELNIkBC7gdp59s1XLcykrI2IZ4ROqeX5bnGWIJNO88gMx2JhiMkEHFQwymZwZ7dLmVFz5iMTke/pVW+1KztGjWdWl3N88XOMexo5WZWu7GnHel3j2oEizy4A5/GrSNMJIyzfID8p3AmucIhk3S25kWMnOwN0FX1nkAiVFVNi8se9FglE2mkn3EIGEo5PHH1zVRo1UgRsfPf7xAyv4VDFqAkKAtx0OOvNGURy0RJA4II71JNivdRq0m0smQeccE59armfcTbykLGvK5UDn0zU96TLgA4BIGDWTcG5N7wqsyrlvQgd6uLGlcvSSBYVcRZGNqsOCKKpi5RkwTtQjaFzuz/AIUVpcLM8QTqCemOas2x4O0HaaRrVURSD8xGSOw+lPt45DuAz6jFJ+RvB3EmJ8pRtIz04qbT4WZxLn5R96nwyCeNYj8yg9+1X4IjFF8vQd6lm6lZWJYtvC569MVbVAvJAXFZ1uzC5Hydea1o2TBJQMehOahptkS0JIpFbktjI61Vd/Ncqj4jXq1MuwRGQmAvTNLBEFtw3UDjFVFDSS1LcLKzmNkMmB8p6Yp0coR5AwAY4wR2qrZPJ5pD8LkAAnnrU1zFh5HPyrkjHfNWyWk2LJLJ5SFRlQSRUkTqih9wBHRTUWnkTKBKSsYJPvgVBflUm2Fg2OD6Z9KLMdk3YtG9eZRsYsynJNALJIrMQzE/Mx9PSotzRRhIzH8+C23nirNuPOtJVjh3sozmqjuS9BlrMsbSuzj5TlQed1S6Yv264lknYqkalnxxms3flgkrA9toHf61IZWiYrlgDyQKdynE0ZrlZAsAVY4EOVQ8j8feqEsqldsWFOeo71EUaQs4BfPPXtS29sShcNhTxg1N2NRsjTRwuRjDNjj+7iplX7QCJwQAe/GagA8vDHlTjA+nanyzMUO35n649KGybIueSgBychV4xTBvlERKhV6ZGB+dVizvCqE4UDcB71YS4Z4zHkBfvBVHp70ydSdbczs5LhSMYx3NSQ2jC1O7JlZ8Bc1XtpQ8zSNn+VaEYQCPLHeOc9qLCcmRrbYQFFw44OD0qSaDy1UwK25uNp5qdY2uJ2MKhEYg8c5FTTKqTNtc7VIXj1pOJPMZssBDCMbip6gnvVa7bbsVRgjPU1evpwSyIp81WPPXNYs86LuRiSTwSB3pPQpO4lzKNgLvuZfxp1mizSBWXKgEjjvRbxF1PGcDpWjbwYtgNmHB5I9KhtIq+g+0jDgkkBh3A7dxUF4AshPUdhVoXCwxsE6Hjp0rGvJyZHYNnFZSkZq5Bcu3O7p3FY18QWZunbjvT5bl3d8g4HvVG5LPH8vUdqg02ZDGgQ/OfwpJ5SRgYAHcUKT0PJ7n0FIBuySML71qjRMMufmYfKeR/jT2ZgwVF49u9P2nbk8gDgetJHIUCgD5qZUWWoH2gkjDKeM1buJBcupk+divNUVZWGdwL55pUbLen1prsOxYV/Lxxw3H0qzl43yRz+hrNMpHAG5AauRMphV2fdkcD0qeg2updi2uxO7B9KfJMdoXAArIuJDldpI5zxTbS5fJV+TnrWdg5L6mmHKLuxg9qkQlmU5G01SMmWyG69RmnxSFZBg8elSZyVjWifD4dSRjirz3MkkSxGQlF5CntWakuOWzjtU0Z3SAg0kzN2e5qWxE0QC/JIOACODV23kVoJIJFw/asYu0bAt930FXLeYMqbiOP4u5qk7MiUS55SGHCIHeQ8kDnise4t1DeWsYAGQV9a27LKRuuR8/KHOM1WuEUt85KFSATjoK1WoRbG2ZZIlXcyrjBzW1BZtJbSG2ywC5wT1rG85IWMYlVyO1XNPvDlsFlCjsOtXewpJvUu+H7Z/meSVIDgt8xyD7VR16fzLhIAd8/AGV4H0rahmgmwjiME85UVDqS2891EYUkJHAOzoRTTuKMtdShHYTRWquiuspz86MMcdsU6JzEkq3YLykZUqcYrU+zhY0kdxEc8+aNooYRTrMTIiYXcisuQ30IrSwnO+5CjwzWvmW0sb7QNySEBkPtTbaKWLE+XI55Q8H86W006165FxMRnbFyv40mpxPa24igmmiEi5KMCUJz0zUuAm7uyLi+UswaRXypy53DIqpqEEi7tiZZhu654/CsptckgdkuIFWTAB285x3ofWC2yKKFwWGT2yPrUqNmNU5bkOpRyoMhBtUAh170Vags5JbxjOWQkZVXHDCitLF6HjEc8kkWMYG4sRT4ZXRiQxUdDjriqukvmMhgGccbTVy4jaKT96NmeQKTVgjo7EELETkIfkPPPWta1uOdo5z0FZ6qpbeDlu9LbnZIG5BU8D+tSdG6Nx9gUM7DjnFRrKxugiHIqqkfmSKJZTluxqy0RR0MfbqaT7iVki1cRlBvDHIbnuKdGdwxu29yKdcjKBlBINHk5BIYcgUPfQV7kZwk58sbmGOR0NTuGkLAE8jg+9V9qg9cHkZp5mZUPlfNxjdR6gV5ZjH5kR5kJ+U0tsjGNiSf7zH3pUA27jHvY8c9qsx3DzWrQbAkbcs2OSRVaML22F06UgSJtG11I3elOhfyIp0jkJYcDBwDUCzGBWji5dhjpRPGERH3/KV6e9MVtSFd7HOOcg59KkbcWLDORwTT1aLYMZEh7DpUqSJyZD8/wDCB0pFXdxsKy8HICt29qu/Z0gIIDD+6D0NVbZ8kHOD2qw8/wAu9icAY3Hrmn0E9SaMl2OxR0wcn9RSFfLZsOWJ9KWI+ZEZRhOCcDvToUDK7Y+bOAe1SkxEynev7lPm9T/Wo508qVIpDufIPWrscW2IFD+8fjI7VFNsiIULukHU44FUkSncI1QMqjIGcgL61t2yPJDvEaqq9iMZPtWbBbldrIVD9SD9O1abSkCOQStIAMY7A1REh8BmiZxuEXU+uPaqUl0du0Kc55Oepq7Os0MGyPZJNIcyEHOB7VnQQ7pnMykoBtJz90Ur2EkgLeYwbADPwSO1ZkkYE/CEAnBzya19SYbUWGMiNMbSvp603RoYpZndypwcKpPX3NQ3cq9lcbZ2B3o7Fjv6H0q/MY7X5M5fHOalciBX2yZcHGG71g6pdjzOuG61jN2M7uTK13LtLordeprJu5hsK5x6E028uupyeRWLLcPkh2yxP6VktTVIfNMqDaDn1qm9wWbCkDFQTM7OfTPWkETMevB5zW6jYpKxchIYuQ+0+3ekZsIR69vWmoFQDH3qYoLycmqKRYR3ZQAcAVKuFPUc9yKjVuy07rkdfw6VL12LSJhGpVSuN460jglSdwJPpSIBnHOak2BnXA+Y9RSLSsQQxtGevWp3DKgw232xQ8RD4B6UySTEeMk4707FIrzEsRsJDds0kRVCxlBY4wPrUgBZGJAAHQ1HBhjtYn6etBRawgkLw4MZADAnkGnCTa4AOW7UW0aGNgcZ7GkEAQtIeD2rKRlKzNSCdmj2kZA9asR3ID7VOHP5VkxykL1wasLISTgZ461LMGrGsZ2aM7/0p1rP5fzg4OM8jiqBdmQYJpUkJ6A9OgpMR0NvcKwEi7xL19q1LiOO6ZRGAu8d65W2uf3hAzk10uk3Jk8uHYu5e7VcJWdiZJmVNaCFpHI+b+Fwe471oWhkCx7o33P3HetbVbJY4xIsgKSg5+XIFUrN8RxmFmKDj5hya26iU7otw4jI2sSw7svQ+lWZ7yVnVhtVz8mV4GPXFVhEWjZ9rBifuAmrCW1xGvmhUkDYGG6Bfw71a0Iui1PdyRKsF5E4gON3mLnPuDUjw2GFNlNEykbAD8rD6fSsfXb5haiCWZ3QYACnIz7UaZAJ4YlZ9zg/xNjAPoau+octlzGjpwEEkrGc2+0EfKuTIPrSX2qvPp7W0rO+ANrjGQPTFTtBJpkYXUbaU25J8qdOfwNYSXEM15PH5Um8/wCr2j71DJiru5jJaXFxcA9V9D6VuwvDazI0yhHUAqQu4MD7Vs6RHHbWTi6KF84AbgjPb6VT1aOJgkUCISDnLdAfQe1SkU530KRv43YGeJgQcAg8L9KKpKpklkiMew5yMnr60UahZHkenWBUsI3JlwBtP86mvVk+0gTMHZRjiqn2r/STJExUEAcHrTWuB5yuW3HPNXJodJO5dX5XIIyeDTyxjmRgQSRgqR0qlPdAzoAMLj5mq7a4kdXZOnQ1F7m+qLNuhMo87ke9aLuiWxSJsnqTVBTiRgQPUUsbHLFRkd6mTtoO19S7JdAxIuwjHpT7aUHhhgA5H1qngt0GPSpoQwCk5PPX0pMLJbEgBkZk24LE4NMVjEsi7PvAYPYVbdyrKTjIHUDvUV3IANjYweeKaJvfQbbSxtEybyPf3qze2/2WFAZVMzAEovQVlIq8s2SB096fHLtmeTBYHgKTmqQ3DW6Ibl5ftChMhtvUUKkgVdzkg9j1qe1d55/MI2queMUwnJJC/KCSCKZV7Owts21yOpB4q28ischdvvVePGQ0RB7+9T3G5XXdhSy5xjvSH1J4G+XY4AB6etWHtzt/TBqhbn+KUjB4OOorUsVEg3jLHHBJ4pky01HxWrJCssgOGO0DsatWCJJMWL7UTOTjjNPMct3CDKUSOPkAHGakjCtA7ABY1JYA8GqSMrtjITIQCQT81XLWJZC7spCrnIxUcW97cgAYLZBHYelbdiyjTZLUAJPKf3jkfMo9BQTJ9jOWKMfKGYE5Jwc7eKld57TTlgdo1DtlgBuP402GxUfKzsEblmHJrQt5o96KUxEvBcj73uKCblWB0Ay2UKDLMq5I9KpylZd7OD5rdWHp6mp5MJckR/uxL8vzHk0jmZYmj+Vv4W9TUsaZULSSwLECQEPGB2q9Fp62aK6k5PJIPFO0yHaWYSFuw44NR31wYQ6M4IHTPFYz0G3d2KeqXOE2novP1JrlL+93OSAPTJq1ql3nIXjPvXMXt1yR1FY2bZcUkLc3RPVvm6VUlbC5ByagMgY9KkBXb8/X1rWMbFDQVVeW+Y09HOzABx1qEfM/yjNW4VOMNxWltCkgTLcHj696mCiLJYdRxUywqI957dqQDA3EE+ntU3LjqNxuAOPerSldoAwG96jFs8rAoCRVqOIAMu0cevWk0aWRCEYOSQSfanlGWQsp69avpEFjBHU00QMoJGcHt6UhXKa9eR+NNlALN8uT3xWiYx5Z+QDjPTmqpTKb0PHp1qug1Yp+Ywjk2nah4wepqJ0GxWB5x1q9Na5jAkG1T3HWkW0jQlY97jGRuqAukzOimZWJAz6irwfKBj0bkLTltwFUIvOec9KjuBmQg4/CiWwO0tiL5g289KkR3Vs/pSOSy7BgAdDUsYBj2jbnpzUWMpDorrjGeRVhJjjK8EjjFUZV2MDgY9qdHJhCWwc/pSaINMMJXU4wRWrY3JEq8kBeBWDbzZcnPFX4WPUcgHpU2dweuh2dtf8Am4jZmeNOhzjn6VYu4RHbboCPMBJ/d+tcvaXIAjckFgcla6+zuluNm2IcjOemD7VrCXRmMlyu5Fpl3etBJJdIQNu0cc0x72awM0McxKynLHuvtW06RrbkqCJCM4Pr61jXukTz7nRxJ1YBeua2i9CU03coW8sF7I0U+Rgfxc/Sr1lazXYdWCKqnaP6VzhgazmZJZCsqckjnPtXUaBLLLb7EAYNyuc5Jqou5c9FoaKXEsVibWeXMQ4+dvlPase20kvqQSOYpMHDKM5GPrWi6mYtFIqkjI29MEVk20l4t07WysApwYiAT/n6U2ZxdtjqJLiSK3FvPGQjEjzJV5Lf4ViSWcsjecxUjHAU8flUvmX2o2jEE7FPKbv6HkVDZpJ9qKbZGHClWHI/KloJK2tymIy4kZyF2EYQHJoq+0SRyMwdgGGwr0ZT6Gigq58620mVcMDv7U9I9ttIR1U5pz28iSgFSH/iq4kOQWPJA+7QaR0dxsMCyQB+453dq07R9iIxw49+KzIrrZEQ43EdcdqsRvIU3L8wPPTpSL1a1NGa4WVR+6CsD/CeKlt1dTxgKeSB6VQXcgyVPupq8JJGCkrsBXjtmi1x9LE7nBJH1AqViQqgMPXFRxnevAG5eKQlygVl5z29KklMsEGRA24lh29ajZyWKkAbV+8aTzX3eW3B9QagZvMk2pwSec96aGtxihgGCc98mkjRpH28jPOfSrBGEYdMnqDSI6qjKwIYjhh3NUy7voS2uQrCM/vXOAewqlIzwyvGz4IOD71Yt0e5kSJSDIeMj+dTXFpsunRG8zYcbvWmLRSsxsCKyAkYGM5FOcie43Hk7QAD6UI67iUUkL94e9TwIsqg847+tKw/MetsJcyLkAHOKv2zrGAkSqTjOD602OTyYmgwMdST60wORgKMdSWHYU72I1e5I2bqdvOGCDgADgVq28LTbQyYZFyOeKr2iFV3RfNt53Hk1o2y4fcqlyxGPrTTIk+xZtFEAEs42sT8u7gZ7VdlkV/IY7cAlnVfX61mXlyJJ9rKfLB3NntVi2MMls6PBJkvksDghfpTM7X1LNs8bSTkHAA2hOufrUSPI0Tb4mC9AFGRj61StpZMtFCnBPVuuKnuVkMas1wmwHDRjI/Cle4JFqVZGhVY0RWbox5KjvWRcSKrFYZZHPcleCas3LobcGNFyR3eoNNhDYePczqew4qJSsWlbVl22Zo9jSZw2MgVz3iC+VWZgQASRzWxqt4YoWXIBA9K861u/wDNLIBubPBzxWLXMyY6u5W1G+38K3PrWVJIxPPIHepEQyBixAAGT/hUYiO4YPA6VoopGiAqHA2jAp7E8qDUyoMBCKdFDuPTOKo0QlvCSpJHTrV1VUEk89gKkigfbhevvVdlkWdAR7AVDkVGPNsXgGC4wSPT0qaFEaQDOD6HvTraASEyKfl6YqwYdjo64yvSpKtYcqtChHQMcn60yOB3cuv/AOunxky7vM556jir9rEWTKqR2wKfQfwkEEDuBntzVh4QBxnpV2G28tQSOe+TTyiqSNgYHvzxQZt3ZjFFUFXBz1pHIZAkaADHPvV2aLfIcLhsj8BVOa3KsWU5HpjvQaKzEidRFscnbjBFQFcS88D+EZp6I2enznpTVjeTZvxk9PYVNrjSGSR4jOGPNVPL3EZ5A71osnB4yRVV+PvcKKd+giq0XOOetTCHC8fXmlO0ODkkHg0XLeWyryCaT13JldkE7sqZC5rOS7VpWBBzWy2PKOSQTWRLAgclfvGna4o2LNvOM46Gr8M+c4bAPUVjPlJSwwQB27VLDcLtyeD/ACpOAmup0kEgaM5wT2rf0S6ZZI9zYA6c9fauItLsxsAx4Poa3bG7wVCk8tms2rMza0PTVA8kkHzC3XPakxiINHxsJ3FDyPwrP02832qGM4z8rAj7xq4w++FYAfxe9aRlYwaMW6t1lu33/dPPI5NX2lVEUwQuSoAY46D2qzuiLYnjV2x8rdDis9UuDJlMpGDkfjW0WPcvwT2qifz5WijUZTC5JOOBVGwmecYVHRs7kdeefcVm3UUsOogAjOeQTxXVeHoUuLaSKDLORyoHU9sVUdUKUVFXKSOWSSQxP56kCSQHhj9KbMXF/E1qW2ck+W2CSO1dHDpN5EhTci8g7iOh/u1T1TTIniVXi8mVRhmQgZ96DNSVzHcicSwzq6Pu3gP1z3waKkuNNkNw8SuJUjTeHVuSP8aKDS6Pn9pJAwOfvdQe5qbzERVLHBPWqzHjfjLDqKjjkNxISfuryR6UlqVHuWUtgk3mMD5b81e8xUIT7nFVLd2f7x+makEJlnQknCn5qGarVamjew/PwdwIHIqATSbUR23EHCk9hVq5dRt3MChHOKqfK2QgJ56kUP4gjsXv9Wxdmyp561MZTJE3l7QayTIXcdh6VaQMsW0n5s7j9KHYaQ53LOCAxwMcdqiTeGOV+bs3pTlfYcBWIPJFWJlwqsMKMdB1qbsvZjFj823yHAkB+6vpUTM20gEc9TVqG7EUe2KBd/RnPWoyhP7v15qgVzS0cw2umXMoj/0hvkR89BVW3bCBN2WD7iD3pLZHYiNjxzgD1NWDbeVcAE7W44NMjlV22QyELctj5VY5IFX7JkRJPMTJP3T6UXKxvMTtPYDHNOjiLMVOVoKvoLbjecHOepOKv+UqPuZfnAwB6ZqKJ3TgKGBGMjpVkjzCZU5AABBobIJ4itqj22QWbHT0qWFgXSVC6hOF44zTYkhdfMnU8dh3FSKV4Ayqk5IxwBSuSWItkpZpUyDyx65IqZrppOElUIV64wR+NVbm4ERX7NIXiYY24xViSWHyhAITuI+Z8f0pLUl6EVw0AIaKUvJ3OOtQNtETSbywHVScUsqKrM25Y1AxjvVaH/SMb23IDkKO9DlYpIXyZrhwUXhh8orQgZ4IjFgJt6kHrU1sATk8E/dA7e1Ramfs0DHcN59KyeruRJ30OU8UXZKFIslu/tXFBGeQsWz71p6zfTT35YSDKfLgjrVAgrkIOvQCrirajgrjWBGFBGT0p0QITkdaktog5OeT2q/5QZd57Dinsja1tCO2iWTaoH1NS/Zwj8HIz2qezi6BT164HSrrWpUnPpkVm2TezKg2ltpyKqzRt9rUn7pGAT0zWotuqIXc9KsfYEukBzxSNoSUdRNNtkRARxn071prZiRWTGSf0qxp9kCoUADbxWxb2i+WcEgn5elDMpVNTBg07bIFZQVx+da9vZoEX5Tz+lXFt0iUFwCE71egAfbgAJ1pkSm2Zv2McgD2zVW5tSmRGpAxyM4Brqo7VpMhEJ49KmGklUzMqjcOM96ZKqHEJaZXOTux9arXMSo4V+DjOMdK668sYra3Lx58wHBA9PWs66sIyiSOdxkGQTRY0jUTZzrQDzEcKDnpxUElv5UnzrtYk9OldNFZKsajIfJx9KbeWJ9AQ3rSK59Tk/KA3d89OaqyQ4kwRweTWvcW7RSnyxyp7iq627PI2Rz1pNmiZitCS5GCB1qR0DYL4JXoasXMbI4HJGe1U5VchwAeTmpvqXuPlUeSSetZEm92zHkZ71pQo0yFHzVeS3MLY+Yjtx0qk7kpKOjMoD5WUn5u5pVX92w6jsfWppY9hfjrRaRFVz19CelXcppbldM9wBWtZXRicFj2qig8qQFlDqTyDT5CFdiThewpSiZvU9B8O34fYvGPQ120GZbZhwygfdPevGtBu2hmVWYgE8E16j4fvHmtiUI39OazSOaorMkmdFTdHyf4h6VV89llJEhV8cMKu3EWFdiOG9OMVlO+MptBA/unke9VGVhpJol1qFb22jk3bJj8rsOh98UmjajdacyCymAZlKsetRXFwjWo2NufIBBGMCrejW9s1yWIaP8Au88Gt0r6hb3bNFqy1nVZZ5PtNzIwX5imM5HrV4JNeSgNdAo7ZwwwvJ7ntU+jbLq/EdwoRt3ltgc/T8avQ30Et8LSKxxFI/lmM5BGeMj3FUjnk7PRFW5tYrclYJg7DnYMjj2PeioYpB9quLTeuPMMcbZyxUHFFMD5ncMqk8/NxTtLQLMxeQrC42kkVGrGQhUJBHPXvUjHd+7ycE857moWhrHVWLbDylIAzzw3qKtwsFtBjADcnPWs62z53kncw27hnoKvFVKYjBI6ZNDfUuwZ8wMCQB2zU6jYACCapvGPl2g++atozpHtb5s+vapuaWGxptk3Y5FWkGcls/N39KhiByNp575q2hUcucmpcuiGOMZ3KDwO5ouD5nyKOe+KbJtkUjcWb64qQbUiUDIA70XGhlujiQZYbR2x3qwwYSh3A3MeKWXesa+WAGHP1ot2JkXzckgYBx0pX1Lvctxgkrz83UVIqZ+aU7nznNOgXMZc/ezxinBsbBwCT+VFzNkpj3IGBxtI7evWpxHl97qFA796aHWM+WxBA5+tSPN5sYJkCgU02TqIoBBAzxzirkBEjFNpUkckdPpVJHKJvA/eHqT3FXEzLZxqHAYE7vpVIGrE9r5k7mKBeF5NaTQjbE0tudrY3AdSPWs63t2sy0iENleUzzj1qdJZnMUkZUrj5k/pVEO7HTCNHaIxnyycrj7wp5eIMkaKpIGQy8n8aalyDclZNgGPvAcCqs2cYVRxn5l4yKWwblW/fzblA7klskknj6+1DK8GFG3A5BPWobGIT3zKZiI2HOByfatSKJWkIddwX5QzHOKyvcttR0L1sUWFd20swzgdqw/E14IocAhhg8HjBrbeIqMxD7o+961xXiq5YIy7QxYdW7ULcx3ZyM/7yfPXBPNP8lzgHKg+tNgjZyd3Az2rUjhLRHJJ7VUmaw0JNKgUIec44+tX/s6kEEcUllFuUcAYUdu9akMIKbC3IGfrUt3CT1M62h/eqvQA1bdNx68dqsRxRAk459aklVAuFHWpbJvdlEwqytjJPQ1qadAqHPzHP6VXhT5dtaVquCM9u9A3J2L8Srg7ec8/jViFZSOQcE5JpkagBSh/H1q7DIjdSc0iBZo/kUZyD1xVvSrbayl/nwfu5xSIynHHPTp0rTs4wrMYxuY9aq5DehowRD5nAOR2xWwtp50SgHYCOSBVW0G5COjDGPeti3nQAIVI3d60ic05M5bVNCfzHYNuQg849qxb7QZoobNCxBkbAL9B/hXoV1cRiQQqC2Rye1ZuqPEyOhzIOxPY02rFQqy0TOEurN7aSRJMfIfzqGSB2yZAR3Kmti9IaQ5TlmySarTOC5BJO4Yz7Vk2b3ZzlzbK0mxWBz/Ef5VC0AUnI6eneteaJUD7QGPbHaqYUu5KAgDuahs0TZkParIXYjk9vSs+SDb1X8q3ZIm3E5wB37VFLEBgyKOelI05jnVtSkuQMg9KJLZdxZzgAVvLEFY5X5fWqmpQcYQde9VF2Gp3ZyN8oOWAyc0RQnyQqjGeavRWxknKuuBnvV5rYA4XgCnzamjloc1dRMMk4yPWoAMkbxx/exW5fW+8Hj5e4rNa3AX5c/jVXFe6Il2q6lDgA13/AIOut6kecY2GCCea4MxY4bjvxW/4UlP2kKNucjqaXW5jPVHpM7lwEkIMjdCvSsu4s1gkJcElj1HetCCXzwN42+pA/lT7pd0PAb/ZJ7UpIzi7HMSv5M5zwW9T0q9p1ypvYiyl4hhQBxk+tU7y2JbcMEA5xVZD5dyDHuQN69vpWkJG7XMj0JBJPqlpCQAsjZWQDHP1rZv7lHEiRaosUpX76w5PuQRya5rw/cXjTWpaG4lhQg+ZGhIGOoz0rehht470Oul3wVunPyj9K3OGas9Tnp4raQPsmjSdCAOCMj1A96KtapCJL8iWEg7sKxGGz9aKC00fMSP84YDPtVzhOSBu6jis8D95GgO1utaDjMYLHJ9azexUGIrYn8xRz6VeikOBn5fpVC3kDSE8ZBwRVrfiVBnqeT607m5KdztgEbTxUkYAf5vu9MUwg5OeDnn/AAp0YBJXPHc1D0YLVDmchyg+7U0LByu373IxTPLBbAzjGM1bsXSJGWRN4xkc4waSWpVxEjKkBs59qnfOU+UADkUYVUDdD3okdt2WwUxgYp2Ki7iysGJfO4gYqS1UBGAOZMbgvtUKOquAF2hhyaWEt5jYb5ehPtUpdRrY0LUtyM8ckkdRUobcuSQSo7+tVxIiqvXGcY9aniSOVZPmwDyPrVWTAnicys3A4GPxpH+UNxk9801d0BX5e3HvT2ZiwcgM2OVahIkW3yeeg7/SrYLomIkIUn7x6ikjZXi3MDlOQAKtQmNIVyGK9AwqkiXImso7mQoFKlmOM9x9alhtJHmlhwGl5JCmoBcCAlT5hhYZBA5zTopFJwj+WmPvdWzVEu5ZacRxDEQ8wf6wk8cdsVnXF4XdTgbR1AFLJazYzGXZeSxaoHultopF2JIrjA571JUUixo8ebiSVUyrce/4V0sCiBP9UDn9DWXpVtLFBG4BDMOmelbS5VNrcOF49DWRnUd2Z91MnGCUb0PeuD8WAmQkDBBOAOmK7K7b5cuCR9K4/wATI0kZOCAO3rQSjAs48qQPvGtq0g+QZGW71k2oXYoUkH0restyEHr2NKTuVexft7cqgIIOe1WTGiLgcD1FNjAeRQoxU8iA+vHpUML3KkyAsOcKD6U8KuBzjFSojsT8ox60jAYH64pXAkihGzdjOaswkjgjjpVO3PzkZ4HQVcDMxI3Y+lNCLds7ZUBM4HHNWo1x820H1YdqrRDY42uGUAYxV1CQ3I49KYidZGVMhcnNa1ozopfG0sOlZUTjeeNo7VbWVsEBs+h9KS3Bo3oL5FiBYjf2weRUsWrMgw2Wz3PesOGRJB860+R9qAqAATx61fMZOJ0MVxlPMUgMR9TVLUL8JgZ4b+LHU1lrc8qGbjt702W5Rz6k/eo5wUNSKfEkoYZxjOTVeWRs7VIA78U/zN3tn1qC5YDaN2CDUM0SF3qOw9KqlOWwQq4qaQMq739OCD1pifMpbBz6GkUVpYl2YIJJ7elRiEOcMQT2HapHZ3cqo47GpAowqkcqckikOxXMW4AY4zzkVWa2OeQuOmD6VqNhQSfyqNtkkZyDtB4I60wuYjWoV2bAz2NVbqEZLRjI7kVszREsuDlexqtJb9cjBHP1oKTOakgdpDuyVNU7q32AZroZEAYHBrOuol2sTnPpTQ3K5gTheMgin6VJ5epKN2FPWnXgy/ocVHpabtUhJGUz371og6HrmjFXsFMpPsfark4UxkjOT0IqppEDtbRgFCcZVOmavAq7Y5RgMhR/jSkc/Uw9Sg3p5i8dyaxblR5BbHIHIFdjexgp8u1gwywrnbxPJf269OtQnZm0Jaj9L1OaK2hH2uaCLrsRyA/5d62YtcvJR5EN9Psb7r5JZT6ZrmfL8kho+UZsFO30rfsLN55UmhtJXaE5lgRSMj0PpXXF3QpxjuzXjvJWtQt3PyDnIXduPrk0VTMqLOEayMagHciMW256Hmincx5T5nCGSVW7g5zWhKyi3HfjFUQdpAFTORgA/dqAiSxIIlDtx2+ppRcEptYc5zn0qs0khRVJyinIBqxgLGJcKfamdUdjSSaObZtyG/iNTtbbZAS2GIzzVK3kjWFXIzjnBqdJmndW4BIyPWk7EpNPyLVuDkiQtnt71ZG2J+ASSMYNVwTkFqmkODz1FQ2MkmIKHnkjt2NQR5yM9eh5qwqFiRgE9j2FRrG2GzgHPUUrlRZIpKuCAGf1zUgwT0+XdkZ61C0fPyHp+tT2r4UkqCff0p30LuTRYLbyNwBxj1q4YNkSgNyTnj1qqGVQXjB461NFK7L1BB5x6UIT1JZd8YXc5ZsYBA6Urkkxl8sWXPA5H1pi5mc+WxZF65qeGR4mZsrg/Lz1xVpWETJIRJEocgY4A5q3FKyRMZAEIPy/SqkccTgyD5XBwoBxVpMyqqFgvzDLMev0pkMuLNLJbb0XzEU856VDNI8yIcohHoOlOiURll87yyWxgDjHrQ7o0DJGcMDy+MZouImvL6IWrRRZaWX5QSOvrWKp2kxzhXTqGHP4VPZ5Ny0skf3htVQ361FJArSsYY9pJ+7jOR35qHqVFJHQ6FO7QKWLLIfuemPUmthWxbNjO7JXkcCqHh6RFj8uUIcc4I46dK1meNwcECNQDtzxUtGEn7xzwnIEqBBuPAJ71i+J7XCbSQVx68g10V6FkH7skKWOQR0NYM9o1xFM87nCHbiktSjj7UANtJ+VTzW7apkqe3SsWaMW10Qc7WOCa2rBxjGcjtSeoM17bAABAx2qwT8uO1VFwV4Az1pvn7Q3sKLE3LYIAwT19KqTkJKeeOwNQ+fuLAFfl65NVp5GZcgh+cADtS5BKWpfR8gtIQR0xT45dr8HAHY1lmdgBuj2jHTvSRXQkyG4Udu9Fijo4JgJAcAe/rWiswMecH0+lc5bT7sZ7dBWpDMNozyaEhM0YZv3e3IPPU1cVgybcY981lKRxnkHnFWIZBt2g9e3pU8o2zSWXYuF6ilSY5Al4aqauFGevpR5rMw4HFIVi5MwC8fNVcSlc5xjHFMEyk85DHtUEs23jjbnpTsUSSuzHJbjGMVFLIdq7t2DxgVXmnyxyxI7D0pn2jCbMnHXJ6ikBckuMR4xyOB7VJAWdQFPznqaxzdA5YsfTFMj1Bg20MQppDsbwVFlbnK9MU+4YgKVyO2B3rNguxsUgcU2a7DDqGI6UWEXpcbTuAyRyM1BDuRcy8IemKrxybyvOec81ZILxjIP0osPYHO/BRcAdBVacM7rtyMDkVbljBxsbHHSqjsPMIPWmIoXSM5yx6cVm3Q27nPTH51r3GVRjnJrKv2CRndzkdKENMwbpPvMTyelP8PQtJelgMqqluTxUN6+UPHOOtafhe3dEY7siQ7fzrRaF9D0bTQkqI+SMIBnP8q1ZYl2Y445z3rN0dfstqA6q+DwK09wZT5e4AjgkcfQ03qc/UqyKUgVmBK564yRWNqKLuZywyOOa3uDvVGPqV9axdTjR5WCN2ztHX8Kg0juUdJnit9asLi5IaFZQ78Z2+9dJHPDH9kt01iNpBcte3dwrH5ueF9zjtXKaHHFP4hsYLlsQySgMM4z/s+2eldkWuZm0eQ2EPmm5lheFYtoVM4IP0Hc1tTehNXcxXvY7q6nuI98KvKzL/u54z+FFJfFbS7uTaFGiEjKrDngHAFFVdDR87o24twCKk6jPAzxxVeNisgwuQevtUiho3ORgE5AptGcSWSMhVC5x9elWNjEdBxUWflXAYMx6VahQshYnJ9KlnRF6EphXydzEZGABVzTrSS6uQkScgZz2xVLftCjZz0ANXtOnmhuV8rgv0NCCTaRKMKx3qSc4qRiuSWyOKddxlLqQAH73PtSSlGI9F9al6DjqKk2Y8Z4piSsJWHUn9aQIrEn7vFSIN8gPQgcGos2ykSCLaqyO2RU+NqqY8jsaIgJE2M3Q5JFBcAeo7gelNlJk4j+5tPykcioyojzs5zwCe1KhJztGEA4Jp8eJFZcggcj3NOOpRNZqyQBwDsHLe9WJVVlV2AyeRVexZoblRcJvjAztrQYkxMFUZU8EelaJmcnqQxzCRV+U+cG4wO1WEMqyKQ6yKOCD/DUSEwAuduCOD3FSJH5gHlEISdxJORmmncNCwkY3YUs+e46/hVt7dnUiRWA28E9qWzmVI3RYg8mfm4449KshTcW0jRbVZcMU7n8aRm2UprQokaAfPgEEU7e8b7tqcLgAevrUEF2WmKv8/OACf51Z+zCWUKMvjrg8Couh2tuXdJtjbRiViryPwM84rTbbHGhcBmA+XPf3qsN0UcargAj7xHeoprp5QjFMIG20jJ3buEr7S7OCASM8dPpWXqRCHfGgMjdW9K0r6VRAFU5wcgt3rJupFk2hQWxzmltsVFdzm9SgWQsehByf/rVStJzE4DMcLXSzWm5ySMgjNULjTEGT1PXGKhSZbVySC7EgPIz7HpUUzuxOxuoxiqEtlLCWMbfL6Uls0ozvAA6c07k8hp21qmSZCeTXU6BY6YFmm1FScL8ig9/WuRguACAHzjp71pW9w2RlxzwaXOJ077Fq+sYpJGaH7oJI9vasRrYCU+YCHP3dvQVtmbKbR17mqszCROBkk1Sk2NRsjOhdo/ds/eFa1pMNmQeT1rMeJ1YmEgH+72NT2hlVgrKAx9Kq19ETJNGn9pZ8bsCp0kzLu3Y96zzLh2UjpxxSJ5qnPXnI+lDTM0zbMxx85wOwqRZSEJOBWSbjeBk0onJXkjjjip5R3ZombkFj+PpUPmLzgkg8VSafOA+fXApPtHyjbnbjH4UWKuWnl2vk84HAqncTF84yGz370ySVQgEhJB6Y9aasEsysY0baOpNHKHMMeYiNRkDn8aikOULK2D61s2+hzSN86YXHc8ipP7HQfK45HWlyBzGHHejyiGZsY7dSabHdjoqOD9K6CHS0Kj92AAe9bEXhcXMasjqoK8D1PpRqNyijk7e7RiqRtl89K1Le8bYAwOegqTVvDD2A86MMVxkHHOa5xrye0k2yDep6H0oXmLfY6nzQw79KrySKuQoz61kwXyyjejgoRUn2hByXA3UASXUo2/KDnNY15JjII5POannlL7hG2cfyrKKyXN0qc8fyosUiCKCS6uVCA4zjNdzpNnHHHBGgZgOvGBnvVPRtMaEhsbAo3Ybv9K7jRbFUkXgkEbvYCqFKVh1hbtChjC5LcgY/WrFwFfCfNgf6xQO9XLuLlgxIYYKMKowSzXCO5Yqc88YzQzJMqnaiZXsccdRWXfACQMGO71Hat6WJim8qFkPJGc5FYV7Ficb/wDVseMdqlGkHqYn2M3eu2lszeX58gUOi5I98V11lcefO2nL4ouZ1Y+VgwYGfQPnPNcpcTXFlrllPZqJZ4mDKhGd3bH49K6Sz09rOcX1r4Z1VbrIKwyTAxI3UH1wD2rWHYupqlf9CpqVgljbJNDcG4s2cxn5NrIw6qRRUN1qnmWotYrd1lWZ5rncQ2+QnBx6AYoqxRi7anzqoLR5Q4/rUoYuUZh939aiQk7Sg+X0qa3AOR2zzQzGLLOR5IZmOT2HUVas8qoUkZxVJQFb5m+U8VaRSu1UPy+vepZvElxmQOeQpztrQlv/ADGiWKJUKc4UZI96oFW2gsflPcCprO7+yFl2DD96I32KaubVrKXVImUszffdu5qOYJvOT0pPNBjLRkgHncKgMi7wCDj1xQ+wooehUKCfvHqKVGJlIHb070i7Y33Mu4GkdiBuVSp71CRotywC3BGVPf2oyFlIB4Iwfeq6Hcc8/MOTU0ysuDnB9aTt1LskSRMGbCk8ds1KEY8gkHvUUXAyvLDlvar6OPLO4deaYXsQwMdxJY7gODV+1lZ2TzOeOgNUiG8w7SFqaEh+CgX1JqkDVzTSM/Z1jOx8Pu9/oDUqttMe6PYGHIJqKGUhUKhSgbcnqPrUqF3bLjcmcBm9far0sZtFgM0b7YG8sNw23nP1p0iFQ6pISTwCD1FNVF3NkN/s4Henwr59wrAKAvWk9iR9hZR4YTopBPU8c1qW8aQRPFH1OAwA60EFIcAKSDypGdvvmnp5aKjnO5Tj8Kz0M5SbI5ZXUlSC4fgLj7oqOJkgk2Firt/Cec+hNXr7CwjJAd0ycdhWIT5Y+8CzYJbPIA7VNwjqUdXuJcztt3Mo+QdqpWEsrQB7kkOeOKsXsqmaQdQW/KqlxMkKA5zz0x0qehunpYvNMACzMenQ96Y0hYfN0H61Ujn+0PgLgjoT3p/mEcuR/hUisEpV+APaoTbgNyDUm9GcAYGOc02S5RSx/KgCmYkjkwAcdeOtWYJMSEAHbjmqzyqrfeyx5z7UF95JQ4PrSsVY0ZLjco28Eiq/n7htbg+1U3m2gBTk+tLnhdw6n15xT1Gol60RmuSxYkYwPpXT2sELRK0vzHHHGMVz1q4i7hcfrW/ps6hApxJK/T0WqU7IxqJsZPpO5Q6JjjODVK5tbi2w5iO3uR0rqbVzKwEhBCgjBrahtYJraHevUlcMKtSOd6bnmgg3xCQ8ODk+tOW2l2uxYKo45Hau01PRomICqqYPJHf61jXlg8QKEMQT17GqunuGvQwY1LDLngcZpEZj3AXt9K0J7cZ56ZqeytI5FO5RhRuHNJySKSbI9E0JrqUtLuKHnHYCu3s7CK3ifYhII6kcDFU9NIhX5OGUZAPQj0rWdgzCRs7GG0LngmpTJa1KEjwtHMNoQr91s9eKyJTtiVpMEkAkg9PrV+7RYSAPnTlsDofasO6aPzyUztcfd9/SiUjSMSSK8y5JxhT2q7HqhSIsOp6Y7VhuGVgGyGx+FReeyowJzz0qOY0cEbF/q11dxKs0odcdBXNXltHcOSmNxBUsemKsSkogccLVWWFwqlyV3cj3pXuNRS2MmWOWJP3ZXaOAo4qJGuZiMRtjnHtXRWuno8ZZxxkYqeJUhJAHH0qktBXRk6doV5dnn5QexNdXpGlR2A3SR7y3B3DpTLe4RGQhiD7da0xN5sRDqeejZ5FWrIzldlzyIriUORhtoTOMAVpQukbmNVwowA396sS0uCjcsVAGPm5zWms6lfKLg9M7R60IhouTPtf970YYDDkA+lVZdvmmQlkHTaO9QiTLSRJkqOQScDrTWCJLKy7imONx4FAJBJcADEedw5yex9KzLuPzJsMCGboD0qfSUNvO0jv5gc4c9Rg1NdoJFaMKVUH5SxwfpSKjZOyMDR7+K21+znumxFbtgnrt5xk/TrXQWplk8mCHVYjPZXhkklabCyQtgnBP3h14rCstPjfVreK+YJbPIFkz8vH1q9Jc2kcpifwxCuxtu1i+RzWkXoXUSvoYdxHbNfTras6QiVimTj5SxxRUreTJcNFInlREnGOsft7iim7l3Z8/2xOMN3q7HkjAPH86oWUrMhDD5v5VoQp0J4xzVSOSIKrO2wMAPetCEYUBudv61UQY56E1aR9/DEA1BvFkwZgDu5XPAB6VFcxszEqQAOadGeqj15PrTZmBwTlQOtPoaxepoabOrwiJiQO3vVyNC2U52jrxWXBh1BBwo5q+XKx7gcYouG70LTRkYwOelROCDiTOM0kUzCMNubcOelWwvmxCQcuPvL3pLcE7blaLLSKCOParOAQS3Kg4pjAYBBAwepp0b+XJg4ZScfWpaLuOClugwOlWYx8oVwcGqrFhKuDwTV1csoDKfrQgYscHzYY/nSqGYsNoKg+tMaQqybn+Xpj0p6zbWJRdwXpjpTug1J4Id4OwncOTg8VpBi0CBcsD8zKei1nI2H2oOOp7ZNXbdkH+sJVCckZ61SYmaEU80ER2BCx5B61Pb4GWYjkY981TvVMSxLhsv9zHYU/zepQYAXHPrSkzNao1JJF+zqclQTgDqTUN5KNhCnGBn3xWW1wsX+sOR1Ud896el0jQgAk5zuJqSeW1mSPdmeHcDkuuMeoqheyrHMYlH3Rhye1QwygykKSsanj1zVC5cm4mLsA5OP8A69RuaxjqJLdHzgqdB1J70Oyrh3bfn9KpHdiRs8g4OKhkvgtxEkiHJ4GB0otpY1aVzUiuUViCAB3JqrLdGTocCklAYg5+VgRk/wA6zJP9aqhiBnG6jcSSepqx3KjKnqOoqve3ICgRqcnoe1Vn+fLqMkcFjUTSk2218lQfSrcQsiWSXZGseT5h5OPSnR3RRQgP41WVywYDBAHy+tPgRHX7+JOu3pSlG+oNo0riWEvH5bZAxuOMUCRCodzjrgetU3Hlocjj0FRGQMIwSQx7elZtsEjdgueQRwCMH3rSt7s7wIwVXHOKxYVSSFAhfCDGPerttEzsvluyNjB4/nSJdjqLO9liZApHIyCSOPeukstWIUOxQsvYdPc/WuUtbAy2pdWw4GBvOMmoszxRxCQFAc4PYitNkYOKkdjJdK8cz43MG3gH09KIybr72V+XIHasS0nLwKiNggclu5rUt2kDnyhgAZPv61KdyGrGVfRCORwy8ZqnBL5W4Jn3p+r3XzPkkt7mqVu3mj5toAqJmsI6XNmzutzJvJ54YnkCulNwI4A52bAoLb+cY6VyFkASvzHr07Vs2srSFo4EVjjLM3X2+lODJmiS+uBJC8USg5G4OvQZrnXnxC6Oq7WbJI6girepXotLqUO0iOQARnOazUKPK5ICs33Q3em3cuKsh7Tb4+pyckEiqrTDcCSAM9cdaJyyphSMDr7VUlmB6noe3SpsUtS35+WYNtYdQfWhbmORwrN8o4we1ZEg2J5jEp2GOjVUW4cyYIIYDP1FVy6FclzpY7hVyoOAT+VT7iRgldvdhXMxXTO7BuBnAxVoXTodq4OBu69qcU2L2Zsx3CCUgLznrVlLzBJJYDjGKwDPkHEhGR096tadcs0Lq+1mHGPb1quUUoWRtG8yQCCQehParsc7REO7/IwxuHUGsVZs5LAKCantpt0mwjK+h7mpV0yHFHRtcBBGc5zzz900izsY8SIFLNkD0HvWVPK32cW5iOAdw7flUcGqtPMYZM4j/ujGfaruiFA6QEJEzBxhgDgDp9Kr3MyrKgCrIWPzA9AD3FU7W+URKVTKluGAzmrFzJ5dtkrnB59cU0Ry2epZs1D6pbOURoUcEl8c4+vFSXSeIWnkkt9YhKE8AXSAY9s9Kitb2yjtttxaids5zvK49sVCb3SLaNiujRlT1HmsetWFnfYwnDNK73B8yRXO5gQctnrnuM0UyLb9rl2qYoJCSijnaPSildmzdj57tWRRkHBJ6e1aqAhATkhuntWHBlUUrxnqfWtu0O7ZuPGK1kcUWJGeWGTx3Pep4skjIGB1JqB0xITnGant2G4+Zguvp6VmbxLCbS2ATzU8qB4VBx8w7VDEd0gYcVOJRFKcgHj86m5omIsXlRqoJC9M1dVTsw68nnPamo6NFyCR1wPWpo/3h68AcUy7jcloz/Dt7etTW5lR0Kde3vUMkLPwoxzmpInkgUqcn2PamrDaualwkdydyqFbuuehqn9mdWG48A81HbTnzyFbOPXrWpIVUgNhwRk4p2TQotrcqkjG3HerVuXYbEb5uoJqhNLvIAHBNTwusZTH8I7+tJo0sWPJaReduSfmPpTo4URmBbAAzwOpp8DDbnBI7gVKWjkQgKQx6GosF+gltnLOxA+vWtG2YMEMwXYv51QgjA2bsDBwfetRVUQPEqr/AHie9UiWXvPjmQRlMsfuA9qrXkbRSsixjB7ZqkkkgdQjjdjrjtT2lkdl3t6jNErdSeVkNxbNLIlw7bQBwg6kU6a7EdwgjTEX3enb3pGDGPaQ2R1Yc8VXsn3GRETzB06c0JDb7ljV2SFiqqqnbu+WsZ4mA3k5L81anbzIWDttxxiq6bJIoyZDzwR3FS0OLsipKu7lSAO/vUONmJAORxk1bdgCyRkc8A+grMmkcptQAr60rdC0y2ZPMRVIAU+tVZ2RHwRn0NNM2cB2VRwNoGahmI2sRu3fwlu1Uo21HsSR5dTH5gWQcDngirs+mzRWBlZ0ZCei9ay7JI/OgFwpaMsc7Tzn1zWlPeSwkwSIQgyY8/w+9aqz1ZjKT5rIzySpULww6e31qa3kSFg8wBbqcVDbkySMpYkZyTjgmrvlRIxXBfd03daVluU5CKC4dsn/AAoSMqOY8u5/ECr8caopO3IA6dqrxk+eS3OeOKwk0mUmS2SgKNzHdngE9RXQ2ZdsoGWNSOcDHFY6RLGy45Hpipra5EZdsEbOvNZN2E1c7GC8VLbnypCCNvPIqC5KXCuwYMd3UnkH0Fc1/aDYLKACwxz2FWV1JOCSDwDyMc0+e5HJbU3LXckgHf35z9a1rd9rZjyXUH5SeOa5m01BBJgt1+8CetXpNSiaP5slgfvbqaJkijqsLPcHaejfe9c1EjNbgAr8w6ip7y5DhWZgAOAorIuLze5PBFTIuOqsbMNwZNzlioUcAetX7S9cwlYdquw+c5yWrlo71icbvk6Y7CraT7QcOysepHTFSnYbiaGrzSosflBVUdWxyKx3maMIrvvYHIJFW1uAw2Ejy2G0seoNU7hQYZN33U5yf6VqtWVB9CxE/wBpkMasFZ/y4qHeqkwlTkHGRWfMTLbqw5Yj7wPQCp4pCxXe7cDGeKrlC1gvI1VNis2wHIDHNLNZMka4cHjGD1PtRczK8qKDyMghu57VFcXJEvmMCCPyqmF2kTxCJR5eNoxwx6Zpk3Q5UMVAwR0IpXZPuDlG6NnoajgVnkERbGORk9aEmK5pJgrFImxkHVe606GQReZsABf7rY5/GsuKZo5SpJZCeQO1WopPOh2gYOTg96bCxb8yQblcHeo3YI/pVq1m37G39OQQvT2rLZZpSr72BGVYnqRVi0BU/KwBTqvqKVhM3ppJZYeGxIOvsPamTiK4VDEpiwOW7k1WWcyumR95eMdfxqQtsRkzgRjIHY1ZI2zlltr1oiDLEw6+lbxuUVSM78rg7uoNZ6KEkErMcuu3AGcU9MSKd/Xplhx9aUY6Clq7j9N043E4lk1O2t4/MO2GXduOO/A6VtyaNDM5YapZqGxwM/4VS0i2Emp2FvcyhkeQfIBjcPSuot7mNhbyLptuA07QSIsfK9MU0jKcmnocDc20iTyOvzBWKkJ0OO4ora1qTybm4hAVmLkZXpnP8qKRaldbHy0hAITOUBwGrVtjmMrkYH61z1vP50MTqCVYCtVHIRWDc91AroqI4IPQ1FTf24PQ0sSYYgck1DGx/wAanXCsuchjzisLm8XYsRPt27hgYxipJE+ZHXkVX47DvkVZjJZuOnTFGhvFj7Z9pIAOT+lXoGyQDwKorFI04QlQp6Y71Yj3Ry7Xx6YpNGm5ckJXJJ+lPbEiZBGSOaqNIG+UsQKWKZVjGBkevrS2BIWSFY4t7MFdTxWlC7JAoJ3Nt4wOtZJjJnUufkJz9K0S+6KNIzhY8gEcEiqjsU+iIZN2cAYJ/SkiZlOOSAaESUlhkY6n6VIsRUrsJJzkUmzSNiwkzeV5mTtHBxVu1lcbScMB0BqokOAxPXtVjbiPHII5ANK4aF2GTzTsXhu5q5CEWZHJYKDtbHes3T4JGEjrhQOTntUi3Dx/u2AIY/kaaIl2RekiaK4kZRgHIBHIAPapI7RyqOSNo6nNZs08zZy53dQABzUbX08XyqWBx0IqlYjlk9EWJspNMy3GxFHB7EUz7c8cAEG3JONwGDisq4uym7fyAu0CltGAAEjEFgTkUrpGjg7XZamyzs6ojNjOT2qpEdwLzD5icACpJ2LW6AAsycsRxVVnCiVkJxt4o3ERPKFEjsd2PlAFVskF+eo+7inh4lIVUJOcZq7bnyLYjCfaJeMnoq+tXGJE522MpYNsiED7xzn2ptwY5FcHcHzhR2q9Z208zEblVIernpSyxWsUqM655+bB6inykuetivo4CyqkrlITkbutamq3kN4kcCRfu06HuazZChd9gO0k7RUttHujEjdM8e1KU0kJxu+YdBCkJOOP9n3qVJN8zA4ZiMDHamFmAIX5jnjPar0UK+Tk9VGRgda5pTbNLXIpImZVA3ZzyKYsYDgZIPoauw7SV2MdxqJwfOxJ94frWdik7EqJJJlEICd89ac1uI4mGfmPJFSNIEbC9PaopXJZieOOB61fIgA2xNq0gddo4yetZrW8gG7Jya2I5cxrjBGMMPepGieYEBgVxnOMflUez6ofP3MJpJk6ZPek/tCccdq0Xs5AQxUBTxxVdYELBmjb0I9KnVFJxe5Se8nlYgbvepFErYJJ+grTSwPmFERucc1p2+iyMo4HmHoO1UoSewnOK2Me2ty8ZB6k9Cea0009tqsVYIccg9PrW7p9jFDcFpUUuGwQK0ZzEqZZF5O3iqVJ9TKVXXQ5idDG4JwMcg461FLGJc+aQOM+xropBG4ETRdeA3pWdc2EkYJj2jB6GjlcQjO5z/2ZNmAwyASuOmaZFCY4NsnzMw+X61eMbA5KHKn+HvUXCyZ2kknIOKalpqXcge0Lgjrnkk9jUboWiwz98cj86vpJsQ+cMZ447VXuoxJE23aXXnJ4q6bvoS33KNw2GURQt8w2nJ4zV15EeO2M0RSRFIYnv9KzrqO4gmjXHmQk5BBySTWjcwb4RMhJKYLAkdq6EgbKcJndg1uCUDEHNGGjLFWIKMCcn9KkYlQrxSbWznA6ioYvNy80ZLjo+7nNK3Qafc1EnY+YxcMmBjHUCpI5kaMuikPHw3+0Kzo2wQ6sCSMY7Y9auIq72dm2Njoeje1Ra7BmlBMPvwjjOSW7D0q9525/ljBixgnHrWZYlZgyRN8rjkehHerUcpWJVbgn5Rnmh7EmrDOzRKkRXrlMjkfWo45xEGNwjb3PBzxSWs6s7HAC/d3Y7+tIzeajJ3U8mmSty3pZN/rlnbxzYZnADr1XHOa6Sz1WI65N5VxdrDcsI94ILb+gYjHNc5ZWc4uLO5imtYCZNisWwyMOQzegrqDLKk++KTw+lyTn7QJMNu9QOmaLWIm02Zd5bqlxOJvvI7KzDuQetFVPMCTyI7+buLYIOckHk570VI1c+SdBnL2YgBwyHOPat2AksM8CuW0S7+zXIVlUMRjPrXVwrvYEnbk11TR51N6mwmJGULxxk+9OkBCoRyWPWo7QcE5wE6n1qwRzk8DrzXO0bp3JduYwX47ZFSQDnGahZt0QAJ656U6MkYweO1TbU3iy8TgB+68j1p/yO+47vn5zVfcdpfGcU5JJRKoYAK3XPar9TRD0UByGJI9quyeT8kcXCgZ59aguFRHYBskDII6VEiEJvB+6MnIpPTQtal1UC53H5j0PpSCZwCQMBe471PEQUZzhg2Mn0NMYbUYAYQ8kCk9rjTuPt51aM/MQwPBNSeaNw2cVn7doDe9XEbBO0A5/iPSp5i7EoJHyA5Y88VMrMrA45bgVRkO05VvxFWIp/k2E89cmjQaTLLSPEGG4g9MDvTHZnb5Rk9ee1QqWGXL5OeM1JFMVY7xgtwaaQWtqXbe6HmgzLvdQMYqC5YzyM+87jQksaIJFP70nGB2FK5WQB5E285IUU7Mi9ncpyIreWZRkA9D3p8Mas+1AA3YCi4kLyKfl9iKWCJwc93PFI0b0LbJ5ilRxGAN2OpNYl7OYT5AX90HyeOTW+H8twJCsYXhhjrxxVS6tUuYXKsDLwWq4rS6MOfXUz4oUcFk/1Y+aoph+8Yn5U7Zp1qqq0m0se2CcCp7mM7FPLAjByKFKwPcjRJI41/eBRJklfWmCFthYvj60Rt5jhmXODjmrEirKjYPTtUznYlLUpAlWwV57VYgxkuWJI6Gk8hk2scccdatJblIyp2rnnJ7VjzNmlx+FI7Btv5mrFo7xshA6nP4elMeJHhR4xiRODkdfekVnQBccq2760KIuYWQkEFWA56+tST8SbtuE65ps4OcFepzgUxpdyMpGTnA96qwDrg5UlWOB196id1KhR1YVFcMVj6j05oHKKSMADvQWhUU5CgfXJ7VtuyRDeiABRg8+1Zdiqs6OeR901YMgaRoypV92CevFVHTUUlzM0i6tErKpYv8A0rS8PxxeRLPN5X3jtVuc1gXk5iMSp0C7fwrd0dAyr5WSoHZcijRyM5aRNHNvtEsQC7RyqnIpZJTbkHCpuXIU9axjL9nmkUrxztI7U+SYthmwRtxz61aZHKWFuAFYkEsG5OeDUMsrMoJOUBzwc00qNmYyGRudtVvPGCp+UnqaT01KUTQtbgq4+YfJyvPNTm8Ryd5BGcEk9axJjtYDjGM8d6ngZTsK5BAzgCluNx0Ld7CkoieIiMqOcdxVCW0ZXbqeM1cWQNKN2MAdakW4jZQuOSck56CplBPYlScdDBmgbzBgtz1GOtNRN+PM3KcY4rZugGlSRXVcDO3HWqskL+XvjYbmX7p9KhKzLUrmSU/eBRz9OcU+8QKFmyCjjBVTyjfT0p6Zjds4X2NVJyZJ2YZBx1UV0QegWvqVpZAGxJCdqryw/nUkBkhgV4W3o4yfw7Gp4YVmklMrfKV6Z746VFbERPIpGFwWU9jV2uO5HaqZRIuwrnJwPQ1ahYS2hVwSY2+Vh1IqO1eVZG8o8ZDEsOgq1MqKASEx14/OkrJDGQ4heIO38WCcYIFbEjxbRsJODwT+lZc0qsfmABxk4FXIyGYIScDAGRU7iZoRymBlwAzMeT3xVtFRTllG1vvD+7WWC43x5DMcFWzyMVozTF8BcZHXPcVDViWanh6MXuqQQFUdHlCuj9CPSpLO/wBLuvEENm3h2AK8uxPncyLzjJGcfUVk20U91cWyWblLmVwke04w2euf611wvWk22ia9bvqUmY1nWzC7m6Y8zqPTNUrtClo/+HKWsQW4sRdWsK27x3D27rGxZDjuuaKxZ9Quv3VpeELFakxiPbja2eTnuc96KllRTSPjdWMM4JGSprvNIkW9s45AcDHPrXJ3cCMQrna/971rT8M3D2vmW7j75+X2rtaPHW51cLEHHatCHlMHvWXFJlsZ6dT61fhc7PftXPNWOiLLLKCAy9V4xSHKhdvrzQJFHTqRzinR5Zj/AHT61lbqbJ2LEJR8gsQetKvzHkkj3qCNdrEZ+U9KmxxkkkU7m0XckjXy5ipU7ccVYj3R8NgKev0qsrZIGWPrVpZAU4GcdjSZoyRcr80ZIA5we9WN4ZcgEMRzWfJKQoKj8KmV8oMtjimMsYCKV7dQtL5h8rbtGP5UkSGRG3A8DOfSoInZN6uc4qdmUmWY0VsJ3PTFLEF+YvjIPBqG3m/eFsAcVPLEcBl5DDOKlFXHs2UGQAuaaAWx82QOxoWMmPJJC0yPqf5mqRaeg9N0M6scsM9MVrafOqXqmYBlk4x/dqCztjdRsUALAFgCetTWMCNIPNYqoPXPNWkzKbUkbN5Z6c9xEEjCBgDweprFtmI1JIwVBRyMnpSuSZw6FzGG2ru6ikEZW4MqJkEkkU3LUzjGy1YtxM0t0EeNVAJY5/iqtPGVdljPEvPFX8PJJvZcrjAz1Aoa2YqAcBQeD6Vm5aiehkrbmFI5N4b5sFe+KnuF+RXcZizkgelTmFPMZjgtjJpjD90ke085PNDZNzOnQNNiJSIc5B9qldfJgLBep6dzUsUShmSQEN7HgCo5CIlwxJA6Z7VL1GncZJIECMRkdxRNN5sGW4x6elVJpMvwflbnmljHOG+XPQ0kiy9Zyu6GLjJHBFOUkH5mx6g96hMpWMEgLjpjrUqHfGrqu89wKsQtxKQI2JyG4I7/AFqF3JjKLg4OQfanSIwgYMpIByMjBFQQsHBVg2/HBU96aj3BSsPCb4W3eoIzT0kAkUSD5c4wPSknLPAWUZHRiD0P0pqvuiAbhwOGx1osh3NK3iAHynAbnA7VE+fMLNggdcdTVdL1lgwx6L260jTgJvQg7l6VBSuOmVmvVRDnA/Suu06SRNK3phh0GDjFcdby7X3EEt6963LO+XyygO1B2zVxYqt2iaYFvnZuepJOaQ52hckhelRoTJE7KME+p6L61Fcv5chjLbVUfeB607Ep9C6JAeOnQE1FIgV89jyRiqtu6jhujH7xNSSSIsmGfnI5pg9x87YHIxjFNilRM8kA8DFQXMolkbggt79agkyJFVV+c9Of0pMaZovNgEA7Mjg9wKhjnBdm3EOOFIqhuZTtkbLNye9PjkHnFcA+gpBYuPcZmQSM/lkgmrzXcIjCD7xHygdQKxp5YyPLz9cdqruxLfMGGB97PSlcVrmu5EwLRqd5Gwk9M9qpz25jY7eoxyKgj1QQFVySAc47Zq/BJ9pUPuG8nkChMp3RTZlAcoow/B+tMtvnLK/3gv8AKrt5CojLqAOMgepqpbRttBI+Y9AO1ac1twvpcXyHiAkx8suQamVCctgMqj5QakVGU4yWx6/4VaQJtYkZDD6EUnO4myoYd8LBFC5APIp1kGdixbOOB6VcU7U2xlWOOc9qpIjQRMg5eRhwKcQUi2rLGgZQSMlST6VZHMcWHG3GCB1z/hUIXapRgrgZOTU9kjKQHyAB371EnqPYsWd89jNZ38QDC3fIX+96g/WtCyutB+3x3FnBqUtyJA0Vm20JvJ+Ub+pGfaobfQzf+ZcxXljbJuIWOebaeO+MVc0zw6bbUba5k1LSdscquStx2Bye1NXIbj3M2Sd21C4N6NssjuZQedr55H50VX1JhJq99LGwMTXEjeuRuPIop3ZokrHzTL5F5bgnCydxWYgntbpHTLKp6mnMJFXIHzd8UsM5PzSkEZ612tq54h1loxlhErc7+cDtWpHJj5ew9D0rntBvArNCSMMdyk/yrdVf34K8BuTWVSPU1hIux9cDv3FWSpXPGcGq0Q3HjIPSpvMITB5HQmuexsWFwMHr9KcDkc4qsGAIAzzg1NH0YtxSaNosWYEL8oBB44qWBX8oF8cCoNxDBR1PaplchGAIPqfSkbInwPu5x70/aUYSAA7f/Hqggw6Bs5I9atoP3RovYpMkiu38t0ZQqPyTVbILlcZU87u5pzgIhBBORmoELoW2HJPc9qrcuKLFuQcY4GcHIrVhxLDsUjA4GayLQOZR8uVPrxWpbRku3Ye1ZvcJD9hxtJyR2qtI+WDdOcZ9atkEzBWHHrQYV2Et8xzkAdqV7lRdhtruhbKlm5ySDjmraebK5cDar1XiR2baF4/l71sWsQ2jHVeg9afMyXZaj4LVpEwQoOeR3+tPNr5MuCfl9KtiNgEcjD+1TMgZG3Db79SahsyuU2iBTcwCsfTvUY+WMZPHoRVqUgAKPXoe1QXMyInIBz3oTuQ2Zl6FCiXBwPT60jyLy3BCjgH3ovpMRMmMv1H0rFu7zamN2ccAirJSJL65OMkBfpWVLeByMuD7Y61HcTFicng9RWe2Q3sKEjaK0L6ShvlbkHn/AOtUyuVT5SSQc4qhCGkB2VeswG+VyODyO9Vyg9C6g81CCQDtz9TU0AEKNvJDY+Uj1qmZl3sPu5GMiqsjyM+fMJXpxT2BRubsV3E4DyMScYYZ/pUcNxbiRllyY2B5AwQayYp9jEECpDICCQw6ZxT5mP2JbWWDYwVyhznHrTn8sr5aONrDOD2NZu5JOvUUgIztDYpXH7KxoCNWDAMp4yKqkAkgEDA9aYJCF+Y596imB3+ahyD1qHoWk2acEJKqqZGeTV2xLpDIjDIz19KzdPumQBd4B7k9cVp29wI5O2COR61SXUmXMiwjbYXBBJPQZxVeN23MgXIPHNT/AGxTJnaN2MEismWaQOxyDVMmKbNNFLSKVIG3qDzTIRE9xvuGZEz8wQZI/wDr1nw3LrGeTTfOYkgE4PTHrSuPldy3OzPK7bTHGPu5Xk1AkzO+7Y7KB+dJJf3ONpc4x3p8GrSQ7lxhWPUU7K4tRYllchyOFHOelTLsSNpnY8tjNVFu55o2RhiPPGKtvqAW0EZiUg8EkUrpC94dKCZcA7xjJwMVFI22PAG7PBzzUtq8citIW2t0A9RQkYeJ8PwOcVNgTKMqqqqOUHXNWNOu/JRxnJPSqsjYXBIb8ag8/wAsgEDjr3xS2Lvc7BWWeGN1YKccrUqxqy7QoUYzzXLWWoFImxgL7mtSx1dbnYpYBVPTHWnfuZtNGl5TRn5hluuaVUZ5SFU7T1PpWkBFJao2Qcjmo4I1HzFufSm0RzFUx7ACcYAwOOtQSMPLMaRhT13+laM6Ew/PyB0FV4oomfBJGf0PvReyLTHWyIyZlyA3fHT2qzFlcbnJRPu4HNTpa8DjIB6evvVuCEecxYchepqW7g5FKZY8s7L/ABfLx3xVGWSJ3chdpxwp9a7DSE0ySKZLu3je4BLRF5SgbA+6fT2NULm70nynuP7DRmXqn2lwSKtdxKbvsc1HL5pAwFk9+w70UsRie4eUwFQxLLGG+6M8DPsKKd2a2R81zoG2yQYwwyQO1VobV2kJC/Kf4TWjp9lPEevGOh71p29qqsJEOVPUV6PLrqeDzGL9nkttrpnaDXX2U4mtEZRndjn0pyaeksBYBWHdTUdlbtaM8agtGx+Xn7ponT7BGpqXIiQx5Oc8Yqd+DgkYNRMGSIDOWHWljUyICRn0J7VxSi0dcJXROjbSoUHrVpSxBVjz1qCEglTnnNS5wx9RWbRqmI3DD3p6ELJ0yKYVIBJGahkchgwAx0FKyN4O5oxcyfMR7DtViLfg/wB33qpblmxkVZkdig2jhRUM0HFd8gyQPcmpDEBHkc+hFV1VpdrE4x7VaQOoAXGPQ0XsUTKMn5uRir1nt3bOneqkOC+OB7VaRAXwvUdajmBliZG2AbRkHAI70JGWyNv41MFLx4z93pUsCHzAueCOtS2JOyI7eDJIUdeprWt4RtDqOAck1HHCNvy+nJq7GjbAo4TGcGjmsJu5LEq7GBG4sMD296idwpCheO2asLnar+xFU7kiJQf4epz2NDZJBdTkOx3BiOuKw7y8jUliOT2qa4fzHYoxBOfasTUid2372O9CDlIrrUiMgjnHBzyKyp5y5VhgDvz3onjMmcdutZ84lSUIg3A9MV0RjcnYldyxPWkAIBLrkelROLiNN7pgexzUayzsNueM1ajbRlRbZpQNHsBRsP2HpUjzNs6Kr4wTWaiOx64qQW0rcM5FOxoldlsXCiMK3LUzzMDCtTrewDH5iSK0YLGFSD2Hc1LsbKJmMWDEbGPvQFdicK/FdDDFEuOMsamESs3CDHXIqdC02jmF8xAcg5HtTy5yPlPua6J7ZfoD3NKbeFgBsBz3xRoWrnPJDLMMIrk544zmmXFreQKWeORV91IrrIleBB9nfyz147VFdTXEwYTzO4b7wJo90OZ9EciHliwXV1JGRxSi8mRch2P4V0d3avN5fmNuAG1QTwAKovYqnYZB6UaFp33Rmf2lNjG9ue3SozeSEt8xP0rWntFbLuoAx6U20lW28xUjjIcbSWQNx7elNIpR7IzIrqQ8bmx3HrVyC/8ALbDDaPQ1pQX6iBYTBblVbO4xgt+dQXmnpd3DShFUnnC8Ciy7kOP8yIzc+azZxikA3EAkYFPh0thxwMnAz0xVi90xrYhd8cnfKNkUmmZtQvZDIZQh2ggJVgeXIdoyQetZaCTcP3ec8jjpQtyYz8pIai3cl010NgoAuyM5wPlI4xVWG6eN2QrkEY+tVF1JgCPXv3pkd2N5Yj25pWXQydNrcuT4HIxljWfKp6qdq9z61KQHGS4AHvVOWb5zzlO3vRyk2sAkwQBnOeTVuzuhDIHb17VRY9COPamBmBzxmlygzvrHUmZVJOBj861LeRDjByx5rzy2vnQhcnA6Vt2esbRkgkjihuyMXE66RTISf4altUHzKR8uevrWBb6sc5bkE1vafdiUlh39KhyDU2kjBUbeSw6+lPjjG3BJZhxg+lQ2rNgnK7RxVothQMdO1CJZJBo8l6ks/wBrtoI4uWV85VfXgdKoS6RCXC/23pgB7ln/AMK0NLhv5TLJaSJDEo2NNKQF5H3eev0qqfDbzcW95ZXL/wDPKKXDN9Aepq0/IIu3U5q8/wBHuJUicMgJBZejD29jRUlzAd23Zgg8A+3rRRzM6E0eW3GlqjI0a8Y9OtJc6OBCLm3XC4+Za7O9sP8AU7FPDdulDWRs5/nGYZB37GvbaTPmE2cRZwlDkjj2rSFiHIcYKEVd1bTGtyZrZSYDyVH8PvSWb+Vhh80bdvSkuzHcxr60YHKj249KpxxsGC5OBx7V10lukwYjkMOKwLmFoZCCpyOK560Op00anchgIVvn71NkHhM1AU96k37OPTr71xyR2J3HkHY2Sc0IFKgHApqEscnjNNb5JBu5B/SoNos0bdPl5OF7UMxUY6elMRxtIx0pR6msmbJ3J7V/mAJOKsKnmSA49sVWhjcHJA5/QVeijBUggqT0B70mhtkkKrvO7t2FX7aMgswH3vXtVbyti4HBFXYSCAEPT+dSwuXrdFLYA7dfWpkAROFJyevpVeDJkXJGQO3QVZgYjeex9elSBZhG1TkKAe/rVhWc4Ukbe1VkYFTuPFTpKWQBMEDnAHWkA7zXjVt+CT0x3qF2E6sW5x0Wq2pTMFwitketRwXcbQR/uyJx37U46is1qQ3Nmsp/0fnJ5H901WuNJSIq00gOfTmtptrxl2BQgZJHQ1nC5IgeI8jf+IrROJN2zmr2JY2YBAoHGcday4vLEpOMt6+9b2qQNJLwRgHp6ViyxBCwHJz1q4yaZaimOuo1ktyDw3pWdHblnVQD8x71ouHUruK5IwMdqksniid55B5ij5QucbjWr94F7pTMJh4xk+g7UKCgyxBz0FXZFWO0BXmVzuk9vQVUUFyWGAB0rOWhrCVyaMHkd6twkYHvVO0JY8k4q+pAwrD8az5jdMm8sbeAQfbtVi2cIpBzjpVcEZ5696kJJXAHNO5VyUqMspJZT3pI4Ng4BO7v6VJGnHJ2+nvUqgo3zYLH0pjuQyhww6FRjOKqT7mk3gd/0rWeMlSRgc81A6eZjGPekmOMkUCxwfQd/emCZSQTg1YddileKrLCDg44U8471VzTQjuJRICp4PYVn3JaOQBEGO5FajIrMAinPY097AsCSCCad3YqM1EzYzwoVc8c49avQFygL8DoF71PDYMgx15yRVhYv4Su00uYU5p7CxyK6KrZwPSoJGDORs7+lTqgT7ueaeiEknHHTmldmPu3M8/PJwCoHHFRXFpHszsGfpWqI1J+bGRQ8QwMjindhddDnX0+OTOI9v0qu+mjcPLZgPzro5I8R5HNV1+/gDk9qFIlyRgS6fMgB3nHvTBZTfwgVsyyhWIYdOKgDlmzH8x9KtSRlJXM02Urtjbz+lMk064XDEH2xW5GW3FsAqByPSrTqvlKw5z2NWpIykmc7LYzxHorc9VNU5TcQNhlYDPJrqnZdgLAAgdKoXqLO2FGQaJOFiFGRStriRgN+TgcAV0mkXzgqHOAOnFZdpZ7ucjcvGKs28Tq+4YwOOa5Z6bD8jutNuzlQe/HIrbjchQOCT2rj9PZ0VMowbPzHPAFdDaN8wbIO4dTUJkyib8c1nNaJZXjyQFJDLHIi7xyMEEf1pBb6XaXIne9knKsJFiiiIJI5HJ6VY02Se30V7ixCtcLNiZ9oZkTGR9AamsoYtUvrS9tkWO8ikXz4V4DLn76j+YrXcyelzlrwtcX8k0ibTI7PgdMk5oq9qSAX14Rj/XP/wChGilc0TMN9PdNvG4D270s9oZ7cq65Pb2rpSuzgAY96qTKclkUZzXtOR86cxa2v7soyjHQgjpWPc6E0V2z23+qbquOldZeqYpkk28Nw1MkiA54PHWqTGcaIPILISRxwKztTtRJGrYwf511GpQqzhgBWVfAIo4yDVNXQ1KxyOwhiMfQGoyoAyeT6VoXceyQuclT6VRk4ct19K4akLM7qc7ofGmEI/ixxn0p5RSRjk9xUcIySHPapk5J7GuflOiMhW3IDjtU0Q3Lk9RUILHAPHapLYsvykVnJI6IstW6GOT5Rw3Jz1rRQ7mHTd29qoqwLDbw1Woyq43ZrMounL8ZHoTUkMeNoLevNV94YEKR7VYhk2/ex0xSY1sWRMiR7snaRkmpoLuOZN8JBWqnDgnIIPQU2FY4UIiAyT0qBo1kk3H5MYzz6U8TsDtDADsQKo7yGAVO2cUM5YfK4FIdi64EoI5Prz3qWG38sK20DI575qhHJxliTnqBVpJ2UlWJxkEfSgQ5myGO7juDWTdAPKfLJ2k9B61oTOu9yuSOu2qVyiN84yMjtQCKV0AoYsRkjHH86ypEVhjP3Ry3rWlMA6/MOBWfd8sxQdO3rVRkMhkjLxKVGAOAw71BMQkaovBXvUshbcqbuAOlNmQzMegXGK3UtB2Glv3QweX64quXGEQDAAxxTecuB90cUIdyYGM5rOcjSMUX9NQhipPXouK0ZI0WUxLg46H0qrpxVY5WfljgA1ZtzunL4yueajoO+pZghwCH4PXJp2z5s4x9KssfOaNQOp60TRATFUI4OMjpT2uEZESZ5LcgVOoAUMOPqKFiDDHb+dWYYcMMgAdPanqXzFbpz+GKDGSMg4x6VpQ2w3AZB56imtbPLvZRwDjpVWYlNGPJbjarkHB4HvTXt2VVAJC444reS1Ju4IWhYMv3s1rSaclzPJ1ZkHJA4HHSqSdgdWxxltb7fmHJzzmtS2i3gDb83oe9SQae8hPljdhua1rXSLlkaQptx0OKV2KdRGN5H73YisGx8wPc1FLBwcYGK6fTrFftRL+YCVw7qu7BqxdQQWTBrUrP50JV1ZOnv9aTTI9rZ2OLjtiZNhOM9z2qF8qzKDu2nrWvc2oVyUDZAyar6fGks8wlVjuQjK44pLsWp31MiR2HOB/jU8DEhS/Q/pS3EQLEdAOgNRDJQkg5U53UrjctA1CB7ePcrB4ic5FUGZQI35yDnjtWvby7h5MgwquSQ3Qg1mXsKxl2TPk7uB6UabolPoyPXbYhzIGzuAZcDAOap2B2gEKPOVsn0Na1+4fT40fBIU7HHp6Vl2a7nUjKkHk1aVmK7sacimNH8rHlzqDIMdDVeJQYGiA+dAfmJ9O1X7llEYQqquCMqeCw7GqMsTT7WT72MN71bIi9NShI+9Qg/WpbaAlgG/T0q9b6fiQ719/wrZsrLEifIMDkEisndjckiLSNI+2XCxqCA33WbjPtW7c6FDb2wOCSDg8dDSvI9tcIilWV+GyOKtGd5VLqSig446GjRKxg7t3KMFksZwN6qT8xBzxVhF2OUQkqOQakkV924qFXGc9DUkExxtCAjHB9Kh2Hcu2ckzShIGbc67Sqfxe2B1q1dQ3VkiTtFLA/ZgCoz9asaQvl2ecMGmErOY+HZUA+RT2znP0FRaHKFguDhiFKbgWzG6s20oR685BppENmdOzOzF2JJOc+p70VPeqsVxNAHykTlBxyRmildlGo9q7OduPoahMJRTlaKK9g+fKVxaeap4yOmKxvLkjMkTowVfusTwaKK0QMy9QQxoemTWHeDdHyefrRRWkBGLOpc4XlazrqIjJTtxRRWdVI3pSZHEpxyck8U5gQSQSfeiiuKR3R1HodwBY85qeF9zYb5RRRWUjeJbX5m/kRVgoVGSRntmiismaIltsocbSVPepok8z+8Meo60UVmtWW9CyMA4H/AOqnYOwNx1wBRRUvcY/oCSTkcGpFTeoCAk9faiikMli25GR+VSxsxOcqMdB3oooArvvV2Ysee1MDEgkLk9PpRRQNlWQEqQVCgnGRVV4t3VeMdfQ0UUIRntatvLHJ56jpTkxHgOPlxk0UU07MabZUlVWyF4JOahClGwRRRVJ3RtHYtRNwV5ANXoH2A578CiipBmjE4f5s7eKIXZpQE6E45oooQkbKqFiGOC3X608Rs0IIAxuoorQg3tF0uKbDSsVyM5NXlsViLQjDH5ST75oorSOxzOT5rFvT7CK9mnkLZcSbNxPpVuGxgSa8WyQLIqksN2S+BziiiqJcndkPhYQR3rH7Ojxjna3WuiuoY7yRXI+zwvwPlJLY9u1FFApP3ipFZrbpcbEXaQchkIJHqKo6joUqWYuYyuNuRg9BRRSZKk7nLzW0tx5iKR8q5IArNtrQRTy/KpwM4Y4470UVNjqTdinqsAEGIlBYfMw7qPr6Vkm4BzvU4xjAFFFRPR2NI/CQu5V2I6sOfamyyK1m67fmHT3oopIZnxsxt/LbnHT0/CpUjiRcA7iRj3zRRVIci8XMnkySOG8kbQT3HpUgZI5NrH5ckrj0PaiihsixahY73RG+Uj8/ar0FyVVVJy2OQegxRRUOTJ5USIHnfzGXAJ+6T+oq7b/vJCBlQeNpooqBFqTLhQrPgcio1YhiAMjHBPFFFMCzYaqbbfDcJI8QIkV4Ww8Tjjcp+natH+2YXCuk1zdSod0YnRY0Rv7xC/ePpRRTUnsTypmO1wxBkckknlvWiiikB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, edematous eruption is present on the malar area. Note the sparing of the nasolabial folds.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3828=[""].join("\n");
var outline_f3_47_3828=null;
var title_f3_47_3829="Mechanical pressure gauge";
var content_f3_47_3829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A mechanical pressure gauge with custom mouthpiece adaptor for measuring the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pressure gauge shown here is a Magnehelic model 2000-20CM from Dwyer Instruments, Michigan City, Indiana (www.dwyer-inst.com).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of www.dwyer-inst.com",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3829=[""].join("\n");
var outline_f3_47_3829=null;
var title_f3_47_3830="Mestranol and norethindrone: Patient drug information";
var content_f3_47_3830=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mestranol and norethindrone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/45/13017?source=see_link\">",
"     see \"Mestranol and norethindrone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Necon&reg; 1/50;",
"     </li>",
"     <li>",
"      Norinyl&reg; 1+50",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ortho-Novum&reg; 1/50",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700856",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not smoke while taking birth control pills. Cigarette smoking raises the chance of very bad heart and blood-related side effects. This chance is higher with age (older than 35 years of age) and with heavy smoking (15 or more cigarettes per day). Birth control pills do not stop the spread of diseases caused by having sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease painful period (menstrual) cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691686",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat uterine bleeding due to hormonal imbalance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691832",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat endometriosis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702479",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mestranol, norethindrone, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, breast cancer, diseased arteries in the brain, disease of a heart valve with problems, endometrial cancer, heart disease, high blood pressure, liver disease, liver tumor, very bad headache, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have not started your period.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you turned yellow during pregnancy or with estrogen-based or hormone contraceptive use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having surgery, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Missed dosing facts may be found in the package insert or call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10844 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-78.134.254.52-100471F1EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3830=[""].join("\n");
var outline_f3_47_3830=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193662\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193663\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025213\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025215\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025214\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025219\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025220\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025222\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025217\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025218\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025223\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025224\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/45/13017?source=related_link\">",
"      Mestranol and norethindrone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_47_3831="Classification of leprosy";
var content_f3_47_3831=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67611&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67611&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classification of leprosy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 328px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram representing the different clinical classifications of leprosy using both the World Health Organization and the Ridley-Jopling system. The increase in number of acid-fast bacilli and defects in cell-mediated immunity are represented in the continuum from paucibacillary (PB) to multibacillary (MB) disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Jacobson, R, and Krahenbuhl, JL. Leprosy. Lancet 1999; 353:655.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3831=[""].join("\n");
var outline_f3_47_3831=null;
var title_f3_47_3832="Hormonal contraception for suppression of menstruation";
var content_f3_47_3832=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hormonal contraception for suppression of menstruation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Andrew M Kaunitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3832/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/47/3832/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several hormonal contraceptives are available that reduce or eliminate monthly uterine bleeding. The safety and efficacy of these methods make them desirable for women who have medical indications for suppression of menstruation, as well as those who simply want the convenience of not having a monthly bleed (whether or not they desire contraception).",
"   </p>",
"   <p>",
"    Use of hormonal contraceptives for suppression of menstruation is reviewed here. Evaluation and management of women with abnormal uterine bleeding, as well as general principles of use of hormonal contraceptives, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=see_link\">",
"     \"Initial approach to the premenopausal woman with abnormal uterine bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BENEFITS OF MENSTRUAL SUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menstruation (ovulation followed by withdrawal bleeding) is not physiologically necessary. In fact, most modern women experience many more menstrual cycles in their lifetime than women in prior generations because of earlier menarche, fewer pregnancies, reduced duration of breastfeeding, and later menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/1\">",
"     1",
"    </a>",
"    ]. Moreover, this frequent, regular ovulation may actually increase a woman's risk of some diseases, such as ovarian cancer. The concept that monthly bleeding is healthy has been perpetuated by oral contraceptives (OC) that were initially designed to mimic the average length of a normal menstrual cycle. This \"artificial\" period had no medical benefits and the initial choice of",
"    <span class=\"nowrap\">",
"     21/7",
"    </span>",
"    OC formulations that result in withdrawal bleeding each four weeks was entirely arbitrary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Medical benefits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suppression of menstruation can be beneficial in prevention or treatment of several medical conditions. The mechanism involves a reduction in the volume and frequency of uterine bleeding or a reduction in normal cyclic hormonal fluctuations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduction in risk of ovarian and endometrial cancer &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link&amp;anchor=H20#H20\">",
"       \"Risks and side effects associated with estrogen-progestin contraceptives\", section on 'Risk of cancer'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Relief of dysmenorrhea &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/60/39879?source=see_link\">",
"       \"Primary dysmenorrhea in adult women: Clinical features and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28233?source=see_link\">",
"       \"Treatment of primary dysmenorrhea in adult women\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Prevention and treatment of menorrhagia &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link\">",
"       \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Prevention and treatment of anemia in women with bleeding diatheses &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link\">",
"       \"Clinical presentation and diagnosis of von Willebrand disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37285?source=see_link\">",
"       \"Heavy or irregular uterine bleeding during chemotherapy\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Prevention and treatment of excessive bleeding related to uterine leiomyoma or adenomyosis &mdash; Some women with heavy menstrual bleeding associated with leiomyomas respond to contraception which suppresses menstruation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=see_link\">",
"       \"Overview of treatment of uterine leiomyomas (fibroids)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment of pain related to endometriosis &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"       \"Overview of the treatment of endometriosis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Prevention of menstrual migraine &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35433?source=see_link\">",
"       \"Estrogen-associated migraine\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Management of symptoms related to premenstrual syndrome &mdash; (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39751?source=see_link\">",
"       \"Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3241?source=see_link\">",
"       \"Treatment of premenstrual syndrome and premenstrual dysphoric disorder\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Convenience",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies worldwide have consistently shown that most women favor bleeding frequency less often than monthly when informed that monthly bleeding is not necessary for their health (",
"    <a class=\"graphic graphic_table graphicRef63395 \" href=\"UTD.htm?30/35/31291\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Avoidance of uterine bleeding may be particularly desirable during vacations, business travel, camping, military maneuvers, special events, academic examinations, or athletic competitions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Young teens have a lot to gain from reducing menstrual frequency. As an example, they typically have to cope with dysmenorrhea and the inconvenience of menstruation during the school day when their access to pain relievers, sanitary pads or tampons, and a change of clothes may be limited [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Special populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitively impaired and physically handicapped women may have difficulty with hygienic practice around menses. An agent that suppresses menses and also provides contraception offers particular benefits to this population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cost savings",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cost analysis comparing direct and indirect costs of monthly oral contraceptive cycles to a trimonthly cycle regimen reported lower annual costs with the latter [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/9\">",
"     9",
"    </a>",
"    ]. Costs considered included those associated with oral contraceptive pills, hygienic products, pregnancy tests, analgesics, iron replacement therapy, visits to a clinician, and opportunity costs from missing time at work.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     THERAPEUTIC OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hormonal contraception can be used to reduce or eliminate monthly uterine bleeding. In contrast to surgical procedures, such as endometrial ablation and hysterectomy, medical therapy does not irreversibly impair fertility. Options for hormonal contraceptives that reduce or eliminate monthly uterine bleeding include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Estrogen-progestin contraceptives (oral, transdermal, vaginal ring)",
"     </li>",
"     <li>",
"      Intrauterine contraception (IUC) (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      -releasing IUC)",
"     </li>",
"     <li>",
"      Depot",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      injections (eg, Depo-Provera)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Estrogen-progestin regimens",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Cyclic contraceptive pills",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclic use of estrogen-progestin contraceptive pills (OCs) is a reasonable first line-therapy if the goal is reduction, but not necessarily elimination, of monthly blood flow and there are no contraindications to estrogen administration (eg, previous thromboembolic event or stroke, history of an estrogen-dependent tumor, cigarette smoker or obesity &ge;35 years of age, active liver disease, undiagnosed abnormal uterine bleeding). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"     \"Overview of the use of estrogen-progestin contraceptives\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Shortening the hormone-free interval from seven to fewer days or use of low dose estrogen during the traditional hormone-free week provides greater ovarian suppression, which may help reduce the occurrence of symptoms associated with hormone withdrawal and the risk of pregnancy. Withdrawal",
"    <span class=\"nowrap\">",
"     spotting/bleeding",
"    </span>",
"    may occur during pill-free intervals. Three monthly OC formulations, which include a shortened hormone-free interval, are currently marketed in the US.",
"   </p>",
"   <p>",
"    Women who suffer from menstrual symptoms may obtain only limited relief when they use standard 28-day cyclic OCs (21-24 days of hormonally active medication). Many will still experience menstrual symptoms during the hormone-free interval and regular withdrawal bleeding still occurs, although the amount of blood loss is significantly reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Extended and continuous use of contraceptive pills",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extending the use of active hormones continuously over several cycles, based upon an individual woman's preference, decreases the number of times that she experiences a hormone-free interval with its accompanying withdrawal bleed.",
"   </p>",
"   <p>",
"    To implement this approach, a monophasic OC is prescribed and the patient instructed to take one active tablet for 42 consecutive days (called bicycling) or 63 consecutive days (called tricycling) followed by four to seven pill-free days. This regimen can be repeated as long as the woman wants to continue taking OCs. Depending upon the clinical issues or patient preference, the pill-free days may be omitted.",
"   </p>",
"   <p>",
"    Seasonale was designed specifically to decrease menstrual bleeding to four times per year. Each OC pack contains 84 active tablets of ethinyl estradiol 30 mcg and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    150 mcg followed by seven placebo pills. This formulation (now also available as a generic) appears to provide both high contraceptive efficacy (failure rate 0.60 pregnancies per 100 women per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/12\">",
"     12",
"    </a>",
"    ] and endometrial safety [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seasonique is similar to Seasonale, but has seven days of 10 mcg ethinyl estradiol instead of placebo pills. In a report comparing the findings of two similarly designed clinical trials, use of Seasonique resulted in less unscheduled bleeding than Seasonale [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/14\">",
"     14",
"    </a>",
"    ]. Seasonique also has better follicular suppression, and thus possibly better contraceptive efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lybrel (ethinyl estradiol 20 mcg and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    90 mcg) is the first low dose combination OC designed to be taken 365 days a year, without a placebo phase or hormone-free interval. Contraceptive efficacy is similar to that of other OCS. In two phase III clinical trials, after one year of use, 53 and 59 percent of women achieved amenorrhea (defined as absence of all bleeding and spotting) and 20 and 26 percent experienced spotting that did not require any sanitary protection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Adverse events and discontinuations were comparable to those reported for cyclic OC regimens, except for a higher rate of unscheduled bleeding with the continuous regimen (21 versus 12 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/17\">",
"     17",
"    </a>",
"    ]). Endometrial histology after at least six months of use showed inactive or benign endometrium in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/18\">",
"     18",
"    </a>",
"    ]. After discontinuation of pill use, the median time to return to menses was 32 days, and spontaneous menses or pregnancy by day 90 occurred in 98.9 percent of women [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, a phase III trial reported that 18 of 21 women (86 percent) conceived within 13 months after discontinuation of treatment, providing additional support that prolonged continuous use of OCs does not delay the return to fertility [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extended use of other combination pills (eg, ethinyl",
"    <span class=\"nowrap\">",
"     estradiol/drospirenone)",
"    </span>",
"    also appears to be safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unscheduled",
"    <span class=\"nowrap\">",
"     bleeding/spotting",
"    </span>",
"    often occurs during the first few months of extended OC use, but then resolves. If troublesome unscheduled bleeding occurs after the first 21 days of hormone use, one approach is to stop the OC for three days to allow withdrawal bleeding and then resume the pill for at least 21 days of continuous use [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/21\">",
"     21",
"    </a>",
"    ]. This approach of scheduling a short hormone-free interval can be repeated whenever bothersome breakthrough bleeding occurs, as long as the patient has taken at least 21 days of active pills continuously before proceeding with a hormone-free interval. Over time, breakthrough bleeding episodes will become spaced out and stop. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22698?source=see_link\">",
"     \"Management of unscheduled bleeding in women using contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Transdermal and transvaginal estrogen-progestin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The transdermal contraceptive patch (Ortho Evra) is applied weekly for three weeks and the vaginal contraceptive ring is inserted every three weeks; uterine bleeding occurs during the fourth week with both methods. As with estrogen-progestin pills, cyclic use of these methods is a reasonable first line-therapy if the goal is reduction, but not necessarily elimination, of monthly blood flow. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=see_link\">",
"     \"Transdermal contraceptive patch\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Extended use of the transdermal contraceptive patch and vaginal contraceptive ring is an off-label use of these contraceptives. In the only trial evaluating extended use of the patch, amenorrhea occurred in 12 percent of users, but unscheduled bleeding and spotting episodes were common [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/23\">",
"     23",
"    </a>",
"    ]. Serum ethinyl estradiol levels are higher with the patch than with OCs or the ring [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/24\">",
"     24",
"    </a>",
"    ]. Accordingly, we avoid continuous use of the transdermal contraceptive patch because of a possible increase in risk of venous thromboembolism in patch users compared with oral contraceptive pill users. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=see_link&amp;anchor=H9#H9\">",
"     \"Transdermal contraceptive patch\", section on 'Extended cycle use'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data on continuous use of the vaginal ring are also limited [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. In one trial evaluating an extended vaginal ring regimen, extended use resulted in fewer overall days of bleeding than monthly use, but there was an increase in unscheduled spotting days compared with the predictable cycle of the 28-day regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/25\">",
"     25",
"    </a>",
"    ]. In another trial that compared extended use of the vaginal ring with extended use of an oral contraceptive, over a one-year period, both methods significantly reduced the total number of scheduled and unscheduled",
"    <span class=\"nowrap\">",
"     bleeding/spotting",
"    </span>",
"    days [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/26\">",
"     26",
"    </a>",
"    ]. Extended cycle ring users had fewer unscheduled",
"    <span class=\"nowrap\">",
"     bleeding/spotting",
"    </span>",
"    days than extended cycle oral contraceptive users (21 versus 22.5 days over one year), but more scheduled",
"    <span class=\"nowrap\">",
"     bleeding/spotting",
"    </span>",
"    days (17.5 versus 16.5 over one year).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Progestin contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term use of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    intrauterine device and depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    contraceptive injections are associated with high rates of amenorrhea, although unscheduled spotting and bleeding are common in the first few months of use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Levonorgestrel intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     Levonorgestrel",
"    </a>",
"    intrauterine contraception (LNG IUC) is an alternative modality for reducing the frequency and volume of menstrual blood loss. Approximately one in five users of this device will develop amenorrhea. The LNG IUC can be left in the uterine cavity for up to five years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of intrauterine contraception\", section on 'Levonorgestrel-releasing IUD'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The LNG IUC produces serum concentrations of progestin (equivalent to one-half that of Norplant [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/28\">",
"     28",
"    </a>",
"    ]) that lead to partial inhibition of ovarian follicular development and ovulation; despite this effect, at least 75 percent of women have ovulatory cycles with this IUC [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/29\">",
"     29",
"    </a>",
"    ]. Therefore, ovulation-related symptoms are less likely to be improved by this device. However, it is a good choice for reducing uterine bleeding in women with hemostatic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/30\">",
"     30",
"    </a>",
"    ] and those in whom estrogen is either contraindicated or causes health concerns. A detailed discussion of use of the LNG IUC in women with chronic menorrhagia or anovulatory bleeding can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link&amp;anchor=H19#H19\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Levonorgestrel-IUD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Depot medroxyprogesterone acetate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    inhibits ovulation and reduces or eliminates uterine bleeding. Fifty to 75 percent of women who use depot medroxyprogesterone acetate for one year experience amenorrhea, which becomes more common as the duration of use increases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/31\">",
"     31",
"    </a>",
"    ]. Thus, prolonged use of this agent enhances reduction of menstruation-related symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Depot medroxyprogesterone acetate is given by injection at 90-day intervals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link\">",
"     \"Depot medroxyprogesterone acetate for contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    is a good choice for inducing amenorrhea in women in whom estrogen-progestin contraceptives or the LNG IUC are either contraindicated or cause additional health concerns. Irregular bleeding is the most common adverse effect. Additional adverse effects, such as acne or other skin problems (related to its androgenicity), headache, and depression, resulted in discontinuation by one year in over 70 percent of women in one review [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/13\">",
"     13",
"    </a>",
"    ]. There is, however, an association between current use of depot medroxyprogesterone acetate and decreased bone mineral density, but bone density returns to normal after cessation of therapy.",
"   </p>",
"   <p>",
"    Return of fertility upon discontinuation of contraceptive injections may be delayed compared with other methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Progestin implant",
"    </span>",
"    &nbsp;&mdash;&nbsp;The progestin implant is less satisfactory for suppression of menstruation than the other methods discussed above. During the first two years of use of Implanon, 22 percent of women developed amenorrhea, 34 percent had fewer than three",
"    <span class=\"nowrap\">",
"     bleeding/spotting",
"    </span>",
"    episodes in 90 days, and the remainder had frequent or prolonged episodes of uterine bleeding. The implant can be left in place for up to three years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link&amp;anchor=H25#H25\">",
"     \"Overview of contraception\", section on 'Contraceptive implants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hormonal agents other than contraceptives can be used to suppress menstruation. These are generally used when there is a specific medical indication. These drugs are costly, often have significant side effects, and may not universally suppress ovulation; therefore a less effective nonhormonal contraceptive may be necessary and ovulation related symptoms may not subside. Some examples are:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Norethindrone acetate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    (NETA) (5 mg orally one to three times per day) also reduces menstrual blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In one study, blood loss was reduced by 87 percent in women with idiopathic menorrhagia given this drug [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3832/abstract/34\">",
"     34",
"    </a>",
"    ]. However, none of these women experienced amenorrhea during the three-month study period, and only about one-quarter elected to continue with the treatment once the study ended. When compared to the LNG IUC, the two therapies produced an equivalent reduction in menstrual blood loss, but patient satisfaction was much higher with the IUC (76 versus 22 percent after three cycles).",
"   </p>",
"   <p>",
"    In our experience, a lower dose of NETA (5 mg orally daily) reduces blood loss and often results in amenorrhea in women suffering from menorrhagia, including those with uterine fibroids or dysfunctional uterine bleeding. We find that continuous, rather than cyclical, use of NETA is most effective in reducing or eliminating heavy menstrual bleeding, and represents a regimen with which it is easier for women to comply. Because NETA is a potent progestin, its use is often associated with unpleasant mood symptoms, increased appetite, and bloating. Although available as a generic, NETA is more costly than OCs or DMPA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     GnRH analogues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadotropin releasing hormone (GnRH) analogues (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32005?source=see_link\">",
"     \"Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8761?source=see_link\">",
"     \"Gonadotropin releasing hormone agonists for long-term treatment of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=see_link\">",
"     \"Overview of treatment of uterine leiomyomas (fibroids)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37285?source=see_link\">",
"     \"Heavy or irregular uterine bleeding during chemotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Progesterone receptor antagonists and modulators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progesterone receptor antagonists and selective progesterone receptor modulators (eg, asoprisnil,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    ) inhibit endometrial maturation and ovulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25866?source=see_link\">",
"     \"Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Danazol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/0/26629?source=see_link\">",
"     Danazol",
"    </a>",
"    suppresses pituitary output of follicle-stimulating hormone and luteinizing hormone, which leads to atrophy of endometrial tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Menstruation (ovulation followed by withdrawal bleeding) is not physiologically necessary. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Medical benefits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Suppression of menstruation has medical and personal benefits, and is cost-effective. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Medical benefits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women whose goal is reduction, but not necessarily elimination, of monthly blood flow, we suggest cyclic use of estrogen-progestin contraception rather than progestins or continuous use of combined hormonal preparations (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Users of the estrogen-progestin pill, transdermal patch, or vaginal ring should not have any contraindications to use of contraceptive doses of estrogen. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cyclic contraceptive pills'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Transdermal and transvaginal estrogen-progestin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women whose goal is amenorrhea, depot",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      , continuous contraceptive pills, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      intrauterine contraception are all effective. Although randomized trials comparing these drugs have not been performed, depot medroxyprogesterone acetate appears to have the highest rate of amenorrhea, while the levonorgestrel intrauterine contraception is the most convenient, and appears to be associated with higher continuation rates and fewer bothersome side effects than progestin injections. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Depot medroxyprogesterone acetate'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Extended and continuous use of contraceptive pills'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Levonorgestrel intrauterine contraception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest avoiding continuous use estrogen-progestin pills in women with contraindications to using contraceptive doses of estrogen or health concerns related to estrogen (including women over 35 years of age who smoke cigarettes or are obese) and those who do not want to take a daily pill (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Cyclic contraceptive pills'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"       Levonorgestrel",
"      </a>",
"      intrauterine contraception rather than other progestin-only contraceptives is often preferred for women who need or choose to avoid estrogen or prefer use of a long-acting contraceptive and who are not at elevated risk of acquiring sexually transmitted infections. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Levonorgestrel intrauterine contraception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest depot",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      for women who need or choose to avoid estrogen or intrauterine contraception (eg, severely distorted uterine cavity) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although, there is an association between current use of depot medroxyprogesterone acetate and decreased bone mineral density, this spontaneously reverses after cessation of therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Depot medroxyprogesterone acetate'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/1\">",
"      Lin K, Barnhart K. The clinical rationale for menses-free contraception. J Womens Health (Larchmt) 2007; 16:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/2\">",
"      den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999; 59:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/3\">",
"      Andrist LC, Arias RD, Nucatola D, et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 2004; 70:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/4\">",
"      Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002; 186:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/5\">",
"      Schneider MB, Fisher M, Friedman SB, et al. Menstrual and premenstrual issues in female military cadets: a unique population with significant concerns. J Pediatr Adolesc Gynecol 1999; 12:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/6\">",
"      Frankovich RJ, Lebrun CM. Menstrual cycle, contraception, and performance. Clin Sports Med 2000; 19:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/7\">",
"      Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/8\">",
"      American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. ACOG Committee Opinion No. 448: Menstrual manipulation for adolescents with disabilities. Obstet Gynecol 2009; 114:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/9\">",
"      Braunstein JB, Hausfeld J, Hausfeld J, London A. Economics of reducing menstruation with trimonthly-cycle oral contraceptive therapy: comparison with standard-cycle regimens. Obstet Gynecol 2003; 102:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/10\">",
"      Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000; 95:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/11\">",
"      Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997; 89:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/12\">",
"      Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003; 68:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/13\">",
"      Anderson FD, Gibbons W, Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. Am J Obstet Gynecol 2006; 195:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/14\">",
"      Kaunitz, AM, Reape, KZ, Portman, D, Hait, H. The impact of altering the hormone free interval on bleeding patterns in users of a 91-day extended regimen oral contraceptive. Abstract presented at Reproductive Health 2007, Annual Meeting of the Association of Reproductive Health Professionals, Minneapolis, MN, September 27, 2007. Contraception 2009; 76:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/15\">",
"      Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception 2006; 73:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/16\">",
"      Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 2006; 74:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/17\">",
"      Teichmann A, Apter D, Emerich J, et al. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception 2009; 80:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/18\">",
"      Johnson JV, Grubb GS, Constantine GD. Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g. Contraception 2007; 75:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/19\">",
"      Davis AR, Kroll R, Soltes B, et al. Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive. Fertil Steril 2008; 89:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/20\">",
"      Barnhart K, Mirkin S, Grubb G, Constantine G. Return to fertility after cessation of a continuous oral contraceptive. Fertil Steril 2009; 91:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/21\">",
"      Sulak PJ, Kuehl TJ, Coffee A, Willis S. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol 2006; 195:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/22\">",
"      Machado RB, de Melo NR, Maia H Jr. Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study. Contraception 2010; 81:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/23\">",
"      Stewart FH, Kaunitz AM, Laguardia KD, et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol 2005; 105:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/24\">",
"      van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception 2005; 72:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/25\">",
"      Miller L, Verhoeven CH, Hout Ji. Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet Gynecol 2005; 106:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/26\">",
"      Guazzelli CA, Barreiros FA, Barbosa R, et al. Extended regimens of the vaginal contraceptive ring: cycle control. Contraception 2009; 80:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/27\">",
"      Barreiros FA, Guazzelli CA, Barbosa R, et al. Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects. Contraception 2010; 81:223.",
"     </a>",
"    </li>",
"    <li>",
"     Speroff, L, Darney, P. A Clinical Guide for Contraception, 4th ed. Philadelphia: Lippincott Williams &amp; Wilkins, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/29\">",
"      Nilsson CG, L&auml;hteenm&auml;ki PL, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device. Fertil Steril 1984; 41:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/30\">",
"      Lukes AS, Reardon B, Arepally G. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Fertil Steril 2008; 90:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/31\">",
"      Kaunitz AM. Long-acting contraceptive options. Int J Fertil Menopausal Stud 1996; 41:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/32\">",
"      Kaunitz AM. Injectable contraception. New and existing options. Obstet Gynecol Clin North Am 2000; 27:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/33\">",
"      Roxburgh DR, West MJ. The use of norethisterone to suppress menstruation in the intellectually severely retarded woman. Med J Aust 1973; 2:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3832/abstract/34\">",
"      Irvine GA, Campbell-Brown MB, Lumsden MA, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998; 105:592.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5423 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.1.191.153-8DAC4F1F78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3832=[""].join("\n");
var outline_f3_47_3832=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BENEFITS OF MENSTRUAL SUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Medical benefits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Convenience",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Special populations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cost savings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      THERAPEUTIC OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Estrogen-progestin regimens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Cyclic contraceptive pills",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Extended and continuous use of contraceptive pills",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Transdermal and transvaginal estrogen-progestin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Levonorgestrel intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Depot medroxyprogesterone acetate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Progestin implant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Norethindrone acetate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - GnRH analogues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Progesterone receptor antagonists and modulators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Danazol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5423\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5423|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/35/31291\" title=\"table 1\">",
"      Ideal menstrual frequency poll",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=related_link\">",
"      Chronic menorrhagia or anovulatory uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39751?source=related_link\">",
"      Clinical manifestations and diagnosis of premenstrual syndrome and premenstrual dysphoric disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=related_link\">",
"      Depot medroxyprogesterone acetate for contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35433?source=related_link\">",
"      Estrogen-associated migraine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8761?source=related_link\">",
"      Gonadotropin releasing hormone agonists for long-term treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37285?source=related_link\">",
"      Heavy or irregular uterine bleeding during chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/25/20887?source=related_link\">",
"      Initial approach to the premenopausal woman with abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22698?source=related_link\">",
"      Management of unscheduled bleeding in women using contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=related_link\">",
"      Overview of intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=related_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=related_link\">",
"      Overview of treatment of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/60/39879?source=related_link\">",
"      Primary dysmenorrhea in adult women: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25866?source=related_link\">",
"      Therapeutic use and adverse effects of progesterone receptor antagonists and selective progesterone receptor modulators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=related_link\">",
"      Transdermal contraceptive patch",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3241?source=related_link\">",
"      Treatment of premenstrual syndrome and premenstrual dysphoric disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28233?source=related_link\">",
"      Treatment of primary dysmenorrhea in adult women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/16/32005?source=related_link\">",
"      Use of GnRH agonists in the treatment of hyperandrogenism and hirsutism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_47_3833="Principles of ultrasound-guided venous access";
var content_f3_47_3833=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of ultrasound-guided venous access",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Erica Mitchell, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Lauren W Averill, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Allan B Wolfson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3833/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/47/3833/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing venous access is critically important and is sometimes technically challenging. Among the many indications for bedside ultrasound, ultrasound-guided venous catheter placement is well described and increasingly used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The principles of ultrasound-guided venous access will be reviewed here. General considerations and techniques for central venous access at specific sites are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=see_link\">",
"     \"Overview of central venous access\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"     \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link\">",
"     \"Placement of femoral venous catheters\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link\">",
"     \"Placement of subclavian venous catheters\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link\">",
"     \"Placement of jugular venous catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393761\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials and observational studies in children and adults have found that real-time ultrasound imaging during needle placement reduces time to venous cannulation and reduces the risk of complications during central venous and peripheral venous access [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. The level of benefit varies depending upon operator skill and the anatomic site.",
"   </p>",
"   <p>",
"    Ultrasound-guided venous access is indicated in any patient for whom central vascular access via the internal jugular vein or femoral vein is necessary when equipment and operator expertise is available [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. Static vein localization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dynamic ultrasound guidance is also helpful for identifying or confirming a patent vein site prior to central vein catheter or peripherally-inserted central catheter (PICC) placement, or for establishing peripheral intravenous access in adults and children when difficulty is expected or when the traditional blind technique has failed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393924\">",
"    <span class=\"h2\">",
"     Central venous access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon randomized trials, we recommend that when equipment and expertise are available, children and adults undergoing central venous access at internal jugular or femoral access sites have the procedure guided by dynamic ultrasound rather than using the landmark technique alone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3-6\">",
"     3-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When ultrasound is not available, central catheters are placed using techniques that rely on knowledge of anatomic landmarks, but even experienced clinicians are encouraged to learn ultrasound-guided techniques.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393281\">",
"    <span class=\"h3\">",
"     Internal jugular vein",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of ultrasound technology permits localization of the internal jugular vein and internal carotid artery during needle access and results in increased success rates for internal jugular vascular access in both adults and children, with lower rates of inadvertent arterial puncture and other complications [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3,10\">",
"     3,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Support for the use of ultrasound for internal jugular cannulation is provided by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of randomized trials included 608 adults and 167 infants undergoing internal jugular cannulation. The benefits were noted with dynamic ultrasound guidance compared with the landmark technique [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3,10\">",
"       3,10",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The rate of successful placement was significantly higher (99 versus 78 percent) in both adults and infants [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3,10\">",
"       3,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Failed internal jugular cannulation on the first attempt was significantly reduced from 57 to 33 percent in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      On average, there were significantly fewer total numbers of attempts in adults and infants (1.5 and 2 mean fewer needle passes, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Complications, primarily arterial puncture, were significantly reduced from 16 to 5 percent in adults and from 30 to 6 percent in infants [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An observational study of internal jugular catheter placement using dynamic ultrasound guidance in 282 adults receiving care in the emergency department found that successful cannulation occurred in 89 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/11\">",
"       11",
"      </a>",
"      ]. Adverse events included unsuccessful placement (11 percent), hematoma (7 percent), and arterial puncture (2 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective case series of 500 children with a median age of 44 months, who were undergoing internal jugular cannulation with ultrasound guidance performed by pediatric surgeons in the operating room, described successful tunneled internal jugular vein line placement in 99.8 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/12\">",
"       12",
"      </a>",
"      ]. Perioperative complications occurred in 2.4 percent of patients and included failure to cannulate in one patient, arterial puncture in five patients, and line revision within 30 days of initial insertion in six patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393340\">",
"    <span class=\"h3\">",
"     Femoral vein",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the femoral vein, support for an ultrasound-guided approach is provided by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial of dynamic ultrasound versus the landmark technique evaluated the placement of 40 femoral lines (one using each technique) in 20 adults undergoing cardiopulmonary resuscitation in the emergency department [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/13\">",
"       13",
"      </a>",
"      ]. The ultrasound technique had a higher success rate (90 versus 65 percent, p = 0.06), significantly fewer attempts (mean 2.3 versus 5.0 needle passes), and a significantly lower rate of inadvertent arterial punctures (0 versus 20 percent).",
"     </li>",
"     <li>",
"      An observational study of ultrasound-guided femoral line placement or landmark technique in 66 adults undergoing acute hemodialysis found a high success rate with both types of localization (100 and 90 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/14\">",
"       14",
"      </a>",
"      ]. However, dynamic ultrasound guidance was associated with a significantly higher success rate on the first attempt (93 versus 55 percent).",
"     </li>",
"     <li>",
"      A randomized trial of dynamic ultrasound versus the landmark technique in 48 children who were 12 years of age or younger and were undergoing cardiac surgery demonstrated a 96 percent success rate for femoral vein cannulation in both groups [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/15\">",
"       15",
"      </a>",
"      ]. Patients in the ultrasound group had a significantly higher rate of successful cannulation on the first pass (75 versus 25 percent) and a significantly shorter time to complete cannulation (median time 155 versus 370 seconds).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393399\">",
"    <span class=\"h3\">",
"     Subclavian vein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dynamic ultrasound has been used for subclavian line placement, but the benefits are less clear compared with other central venous access sites [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/16\">",
"     16",
"    </a>",
"    ]. The standard approach and, more recently, an axillary approach to the subclavian vein have been evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The available evidence suggests that an ultrasound-guided technique may not improve the success rate for subclavian line placement in adults, and increases the length of time for the procedure compared with the landmark technique when the infraclavicular approach is used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One trial in 52 adults found a significantly reduced failure rate for subclavian vein placement by dynamic ultrasound guidance versus the landmark technique (55 versus 8 percent) when performed by inexperienced operators [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/20\">",
"     20",
"    </a>",
"    ]. In the hands of experienced operators, the failure rate for the landmark technique ranges from 9 to 13 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/10,18\">",
"     10,18",
"    </a>",
"    ]. In a later trial of 401 adults in a medical intensive care unit, the cannulation rate for subclavian venous access was significantly higher in the ultrasound group compared with a landmark approach (100 versus 87.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/18\">",
"     18",
"    </a>",
"    ]. The average access time and number of attempts were also significantly reduced in the ultrasound group. No differences were seen in the rate of catheter misplacements, but incidence of complications (eg, hematoma, hemothorax, pneumothorax) was increased in the landmark group.",
"   </p>",
"   <p>",
"    Ultrasound may have a role for subclavian line placement in small children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3,10\">",
"     3,10",
"    </a>",
"    ]. A small observational study of 25 ultrasound-guided subclavian punctures found a success rate at first attempt of 84 percent, which increased to 100 percent after two attempts [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393406\">",
"    <span class=\"h2\">",
"     Peripheral intravenous access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound guidance has also proven useful in the placement of peripherally-inserted central catheters (PICC) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], and peripheral intravenous catheters in adults with difficult access, with reported success rates of 90 percent or higher [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/8,24,25\">",
"     8,24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An observational study of 60 adults in whom emergency department nurses could not achieve IV access after at least three attempts found that success rates for peripheral intravenous cannulation increased significantly with ultrasound guidance compared with the traditional blind technique (97 versus 33 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon these findings, we suggest that, when equipment and operator expertise are available, adults with difficult vascular access undergo peripheral intravenous catheter placement using dynamic ultrasound guidance rather than a blind technique.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232393436\">",
"    <span class=\"h3\">",
"     Use in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;In young children, static ultrasound can be used to localize potential peripheral veins for cannulation. Dynamic ultrasound can be hampered by the small size of the child's extremity and lack of cooperation during the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In one trial, 40 children were randomly assigned to undergo peripheral access with or without ultrasound guidance. In the ultrasound-guided group, the median time to cannulation was significantly shorter (63.5 versus 420.5 seconds), and the median number of punctures was less (1 versus 2.5). Ultrasound is commonly employed to place peripherally-inserted central catheters (PICC) via the brachial or basilic vein in sedated neonates and children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/23,28,29\">",
"     23,28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1382363008\">",
"    <span class=\"h2\">",
"     Intraosseous access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound has also been used to confirm intraosseous (IO) needle placement in adults. The efficacy of this approach was illustrated in a human cadaver study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/30\">",
"     30",
"    </a>",
"    ]. Detection of Doppler flow within the marrow cavity when the ultrasound probe was placed cephalad to the IO site correctly predicted appropriate IO placement in all instances, and was superior to visualizing drops from the intravenous (IV) fluid bag into the IV tubing reservoir.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232394188\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS AND PRECAUTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound-guided access can be difficult and time consuming and should",
"    <strong>",
"     not",
"    </strong>",
"    supplant intraosseous access in a life-threatening situation when peripheral or central access by landmark techniques is not rapidly successful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=see_link\">",
"     \"Intraosseous infusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"     \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sound waves transmit poorly through adipose tissue. Thus, vascular structures in morbidly obese patients are harder to localize and access. Other contraindications or precautions are the same as for traditional vascular access procedures (",
"    <a class=\"graphic graphic_table graphicRef71716 \" href=\"UTD.htm?1/53/1885\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of central venous access\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several settings in which ultrasound identification of venous structures may be difficult:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The subclavian vein is more difficult to localize than the femoral or internal jugular vein because of the proximity of the clavicle.",
"     </li>",
"     <li>",
"      Moderate to severe volume depletion may interfere with ultrasound localization of venous structures. Doppler ultrasound depends upon blood flow, and may not adequately display the vein in states of severe shock or low pulse pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232394654\">",
"    <span class=\"h1\">",
"     ULTRASOUND EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The level of sophistication of ultrasound equipment varies widely, but even the most basic models are usually sufficient for the purposes of ultrasound-guided venous access.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232394739\">",
"    <span class=\"h2\">",
"     Modes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Requirements for vessel identification and localization for cannulation include B-mode and Doppler mode. B-mode (brightness mode) refers to the standard two-dimensional gray-scale image of the tissue, while Doppler mode relies on the flow of blood either toward or away from the transducer to provide velocity information.",
"   </p>",
"   <p>",
"    Doppler ultrasound can provide velocity information presented as colors superimposed on a gray scale image (color Doppler). Alternatively, velocities can be presented graphically on a timeline (spectral or pulsed Doppler). Duplex Doppler refers to the simultaneous display of a color Doppler image and the spectral waveform. The clinician should keep in mind that both color and spectral Doppler are insensitive when the vessel is oriented 90 degrees to the transducer, since the flow toward the transducer and away from the transducer are equal. If the operator encounters difficulty identifying flow with color or spectral Doppler, tilting the probe so that the vessel is not horizontally oriented in the image may help achieve a more advantageous angle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232394747\">",
"    <span class=\"h2\">",
"     Transducers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper probe selection is critical for achieving high image quality. For vascular access, a high frequency (5 to 12 MHz) linear transducer is usually best (",
"    <a class=\"graphic graphic_picture graphicRef59421 \" href=\"UTD.htm?37/41/38545\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A high frequency linear transducer (5 to 12 MHz) is most commonly used (",
"      <a class=\"graphic graphic_picture graphicRef59421 \" href=\"UTD.htm?37/41/38545\">",
"       picture 1",
"      </a>",
"      ). The high frequency permits greater resolution of tissues close to the skin surface. A linear (flat) shape is ideal for imaging veins because it allows the operator to apply even compression when distinguishing arteries from veins (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72691 \" href=\"UTD.htm?14/5/14418\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61917 \" href=\"UTD.htm?4/58/5029\">",
"       image 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A curved transducer with a lower frequency range may be useful in obese patients for increased penetration of tissues (",
"      <a class=\"graphic graphic_picture graphicRef59421 \" href=\"UTD.htm?37/41/38545\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A \"hockey-stick\" transducer, a type of linear transducer, is appropriate for tight locations such as the neck in a small child (",
"      <a class=\"graphic graphic_picture graphicRef59421 \" href=\"UTD.htm?37/41/38545\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ULTRASOUND ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomic landmarks for traditional venous access may be used as a starting point for ultrasound probe placement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link&amp;anchor=H85542669#H85542669\">",
"     \"Placement of jugular venous catheters\", section on 'Approaches to the internal jugular vein'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link&amp;anchor=H662981166#H662981166\">",
"     \"Placement of subclavian venous catheters\", section on 'Approaches to the subclavian vein'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link&amp;anchor=H662986351#H662986351\">",
"     \"Placement of femoral venous catheters\", section on 'Approach to the femoral vein'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"     \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When seen with ultrasound, all vessels should be anechoic (black) tubular structures, while the surrounding tissues will be some level of gray. Veins are distinguished from arteries on ultrasound because they have thinner walls, are more easily compressed, and lack arterial pulsations (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72691 \" href=\"UTD.htm?14/5/14418\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61917 \" href=\"UTD.htm?4/58/5029\">",
"     image 2",
"    </a>",
"    ). In addition, veins usually distend with maneuvers that impede or augment venous return, such as application of limb tourniquets, the Valsalva maneuver, and putting the patient in the Trendelenburg position. In contrast, the arterial diameter will remain the same during these maneuvers. If the artery overlies the vein, re-positioning the patient may help. If vein remains obscured, another site may need to be used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link&amp;anchor=H105076091#H105076091\">",
"     \"Placement of jugular venous catheters\", section on 'Positioning'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link&amp;anchor=H58338655#H58338655\">",
"     \"Placement of subclavian venous catheters\", section on 'Positioning'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link&amp;anchor=H58340216#H58340216\">",
"     \"Placement of femoral venous catheters\", section on 'Positioning'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    If the gray-scale appearance of a vessel is not convincingly a vein based upon the above criteria, Doppler ultrasound can provide added reassurance. Arterial flow is generally clearly pulsatile with a sharp \"whoosh\" corresponding to systole. Conversely, venous flow produces a steadier \"hum\" that often becomes more pulsatile the closer the vein is to the heart. With color Doppler, be aware that the red and blue colors are arbitrary, indicating only the direction of flow relative to the transducer location, not the type of vessel. By convention, red is defined as flow toward the transducer and blue represents flow away from the transducer, but this orientation can be switched using the control panel on the ultrasound machine or reversing the orientation of the probe.",
"   </p>",
"   <p>",
"    Spectral Doppler refers to the waveform depiction of flow (see",
"    <a class=\"local\" href=\"#H1232394739\">",
"     'Modes'",
"    </a>",
"    above), which can also be helpful in distinguishing artery from vein. Similar to the sound produced by the ultrasound machine, arteries produce a waveform with a sharp upstroke (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79020 \" href=\"UTD.htm?37/7/38002\">",
"     image 3",
"    </a>",
"    ). Veins, on the other hand, produce an undulating waveform that shows mild variation with the respiratory and cardiac cycles (",
"    <a class=\"graphic graphic_waveform graphicRef54834 \" href=\"UTD.htm?37/18/38181\">",
"     waveform 1",
"    </a>",
"    ). The degree of variation will depend upon the depth of breathing as well as the proximity of the vein to the right atrium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13563724\">",
"    <span class=\"h2\">",
"     Probe orientation",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important that the operator orient the probe properly, since having the probe oriented backwards may lead to complications. By convention, structures beneath the left aspect of the ultrasound probe marker (denoted by a light or a notch on the side of the probe) are always displayed on the left side of the imaging screen. Probes usually have markings to assist proper probe orientation, but these markings may be obscured. Movement of the probe left or right while observing the image should help confirm the proper orientation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When working from beside the patient, as for femoral vein central line or peripherally-inserted central catheter (PICC) insertion, this marker should be oriented to the patient's right on transverse views. Using this orientation, the patient's right will be displayed on the left-hand side of the ultrasound monitor, and the operator's needle movements in the transverse view will make intuitive sense. Any movement of the needle to the patient's right (operator's left) will be displayed to the left on the monitor.",
"   </p>",
"   <p>",
"    By contrast, when working from the head of the bed, as is often done for internal jugular vein access, the probe marker should be oriented towards the operator's left (also the patient's left) for both right and left internal jugular vein access. This orientation ensures that the neck anatomy on the ultrasound monitor corresponds directly to the probe location and movement on the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1486558433\">",
"    <span class=\"h2\">",
"     Views",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician can use either the transverse",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    longitudinal views to localize and cannulate the selected vein [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1486558440\">",
"    <span class=\"h3\">",
"     Transverse (short axis) view",
"    </span>",
"    &nbsp;&mdash;&nbsp;To obtain the transverse view, place the probe at a 90 degree angle to the course of the vein. The vessels appear in cross-section in this view. Veins are generally oval-shaped with thin walls that are more easily compressed with light pressure, while arteries are generally circular with thicker walls and less easily compressed (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72691 \" href=\"UTD.htm?14/5/14418\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Vein cannulation with the transverse view is easiest for two reasons. First, distinguishing the vein from an adjacent artery with compression technique is best performed with transverse orientation of the probe. The operator can slide off axis from the vessel during compression with a long axis approach, rather than truly compressing the vessel. Second, the transverse approach allows the operator to easily correct the trajectory of the needle during insertion through the tissues prior to venipuncture. The time to successful cannulation may be shorter with the transverse technique [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/31\">",
"     31",
"    </a>",
"    ]. However, for inexperienced operators, the needle tip is less easily seen with the transverse approach than with the longitudinal approach [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1486558447\">",
"     'Longitudinal (long axis) view'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1486558447\">",
"    <span class=\"h3\">",
"     Longitudinal (long axis) view",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before attempting the longitudinal view, the clinician should identify the location of the vein using the transverse view. The probe should then be rotated 90 degrees so that its long axis is parallel to the course of the vein (",
"    <a class=\"graphic graphic_waveform graphicRef54834 \" href=\"UTD.htm?37/18/38181\">",
"     waveform 1",
"    </a>",
"    ). This view typically permits direct observation of needle penetration into the vein and passage of the J-wire (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50251 \" href=\"UTD.htm?11/34/11811\">",
"     image 4",
"    </a>",
"    ). In a simulated model of ultrasound-guided vascular access, the needle tip was seen in 24 of 39 cannulations using the longitudinal view [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potentially important limitation is that the longitudinal view is technically more difficult to perform and to maintain the center of the vessel in view during vascular access procedures.",
"   </p>",
"   <p>",
"    Needle guidance systems may be used to help facilitate the longitudinal approach. These systems typically use a sterile plastic guide for the needle which snaps onto the probe. The apparatus snaps apart after the target is reached, freeing the needle. One study of anesthesia residents showed that the use of a needle guidance system significantly increased needle tip visibility compared with longitudinal free-hand technique or transverse technique [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/31\">",
"     31",
"    </a>",
"    ]. However, the number of needle sticks and needle redirections did not differ.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232389864\">",
"    <span class=\"h1\">",
"     PATIENT PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;For ultrasound-guided venous access, preparatory steps are the same as with any vascular access procedure, with the added step of ultrasound equipment preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link&amp;anchor=H2#H2\">",
"     \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\", section on 'General approach'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=see_link&amp;anchor=H3104738#H3104738\">",
"     \"Overview of central venous access\", section on 'Preparation'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H16\">",
"     'Ultrasound machine preparation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Preparation specific to individual access sites is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link&amp;anchor=H1316646382#H1316646382\">",
"     \"Placement of jugular venous catheters\", section on 'General preparation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link&amp;anchor=H105074744#H105074744\">",
"     \"Placement of subclavian venous catheters\", section on 'General preparation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link&amp;anchor=H3099802#H3099802\">",
"     \"Placement of femoral venous catheters\", section on 'General preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the placement of central catheters, pre-procedure ultrasound imaging should evaluate vein patency in those who have a history of prior deep vein thrombosis in the region of the proposed access site. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27050?source=see_link&amp;anchor=H37#H37\">",
"     \"Catheter-induced upper extremity venous thrombosis\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ULTRASOUND MACHINE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should gain familiarity with the specific functions of the ultrasound machine in use at their own institution. The following are the typical steps involved in using the ultrasound:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Turn on and warm up the ultrasound machine.",
"     </li>",
"     <li>",
"      Enter patient data.",
"     </li>",
"     <li>",
"      Choose the appropriate examination preset, which is critical. The preset optimizes parameters such as velocity scale, which can impact image quality. The \"peripheral vascular, venous\" or &ldquo;superficial vascular, venous&rdquo; setting is usually ideal.",
"     </li>",
"     <li>",
"      Choose an appropriate transducer (",
"      <a class=\"graphic graphic_picture graphicRef59421 \" href=\"UTD.htm?37/41/38545\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1232394747\">",
"       'Transducers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Apply ultrasound gel to the transducer.",
"     </li>",
"     <li>",
"      Localize the vessel to be cannulated in the transverse",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      longitudinal plane, and ensure proper orientation of the probe position marker depending upon the view and vascular access site. (See",
"      <a class=\"local\" href=\"#H1486558433\">",
"       'Views'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13563724\">",
"       'Probe orientation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the selected vein is in view, the operator can fine-tune the image. Modify the position of the patient or route of access depending upon the ultrasound findings. Adjust the image parameters, as needed, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Gain, which refers to the brightness of the gray-scale image, analogous to volume on a radio.",
"     </li>",
"     <li>",
"      Depth, which refers to the depth of tissue included in the field of view. An appropriate depth includes the vein to be cannulated and a small amount of deeper tissue (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81876 \" href=\"UTD.htm?37/58/38819\">",
"       image 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Focal zone, which refers to the depth level at which the sounds waves will be most tightly focused and will produce the best image resolution. Position the focal zone at the level of the vein.",
"     </li>",
"     <li>",
"      Color",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spectral Doppler, if needed. Color Doppler ultrasound can be turned on with a single button and its parameters can be adjusted. If an appropriate preset is chosen, probably only the color gain will need to be adjusted. Spectral Doppler is also activated with a single button. The operator needs to steer the gate (the small cross-hatched area used to obtain the waveform) over the vessel by moving the trackball slowly back and forth, analogous to moving the cursor on a computer screen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1232392861\">",
"    <span class=\"h1\">",
"     ULTRASOUND-GUIDED TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound can be used to guide placement of central venous catheters or peripheral intravenous catheters. Depending upon the available equipment, static or dynamic ultrasound can be used, but dynamic ultrasound is preferred for guiding central venous access. In either case, the use of an echogenic needle improves the ability to see the needle within the tissues during ultrasound-guided procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Static ultrasound can be used to identify the target vein, confirm its patency, and mark its position just prior to access. Patients with a prior history of central catheter placement, prior central vein thrombosis, and those at risk for pneumothorax (thin or cachectic) or bleeding (coagulopathy) may benefit from a formal pre-procedure duplex (in the vascular lab by a vascular technician) to assess vein patency and anatomic relationships [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=see_link&amp;anchor=H3103787#H3103787\">",
"     \"Overview of central venous access\", section on 'Site selection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=see_link&amp;anchor=H177533298#H177533298\">",
"     \"Overview of central venous access\", section on 'Use of ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When dynamic ultrasound equipment is not available, static ultrasound can be used to identify the internal jugular or femoral vein, confirm patency, and mark vein position just prior to access using standard techniques, which are discussed elsewhere. When static ultrasound is used, the target vein needs to be distinguished from the associated artery as discussed above (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72691 \" href=\"UTD.htm?14/5/14418\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61917 \" href=\"UTD.htm?4/58/5029\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Ultrasound anatomy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link&amp;anchor=H437918651#H437918651\">",
"     \"Placement of jugular venous catheters\", section on 'Internal jugular vein cannulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link&amp;anchor=H58349363#H58349363\">",
"     \"Placement of subclavian venous catheters\", section on 'Subclavian vein cannulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link&amp;anchor=H58340713#H58340713\">",
"     \"Placement of femoral venous catheters\", section on 'Femoral vein cannulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Dynamic ultrasound to guide vein cannulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dynamic ultrasound guidance allows the needle to be seen during puncture of the vessel and wire passage, and requires a greater degree of experience when the person performing venous access also operates the ultrasound machine. Less experienced operators may wish to have an assistant localize and maintain the view of the vein.",
"   </p>",
"   <p>",
"    When using ultrasound for real-time monitoring during catheter placement (as opposed to localization and skin marking prior to catheter placement), take steps to ensure the sterility of the ultrasound probe. Commercially available sterile plastic sleeves are available for this purpose. Alternatively, a sterile glove or sterile plastic drape can be wrapped around the probe. To prepare the probe for sterile use:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apply ultrasound gel to the head of the probe.",
"     </li>",
"     <li>",
"      Place the probe into the sterile covering or sleeve.",
"     </li>",
"     <li>",
"      Force any air out. Air bubbles trapped in the probe cover may lead to poor image quality.",
"     </li>",
"     <li>",
"      Secure the sterile cover with a rubber band. A snug fit of the cover over the transducer is desirable.",
"     </li>",
"     <li>",
"      Squeeze any excess gel up the sleeve, above the level of the rubber band.",
"      <strong>",
"      </strong>",
"     </li>",
"     <li>",
"      Apply additional sterile conductive medium, such as sterile lubricant gel or povidone-iodine, between the wrapped probe and the surface of the skin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once the vein site has been prepared and draped, the following steps should be performed in sequence for dynamic ultrasound-guided venous access.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Center the target vein on the ultrasound screen (transverse view) (",
"      <a class=\"graphic graphic_picture graphicRef54501 \" href=\"UTD.htm?2/3/2096\">",
"       picture 2",
"      </a>",
"      ), or obtain a longitudinal view using care to distinguish veins from arteries (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72691 \" href=\"UTD.htm?14/5/14418\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61917 \" href=\"UTD.htm?4/58/5029\">",
"       image 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Ultrasound anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13563724\">",
"       'Probe orientation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anesthetize the puncture site (eg, 1%",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      ). Ultrasound guidance during local anesthesia administration helps prevent inadvertent puncture of the artery or vein, or excessive administration that might distort the anatomy.",
"     </li>",
"     <li>",
"      After the puncture site is anesthetized, make a small nick in the skin using a scalpel blade or a larger hypodermic needle (eg, 14 gauge), insert the needle on the syringe and advance slowly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If using the transverse view and visualization of the needle tip is difficult, the needle can be jiggled up and down within the tissues to better see it. While maintaining negative pressure on the syringe, the needle is slowly advanced toward the vein until a free flow of blood return occurs. Although the tip of the needle may not always be seen, the depth of the vessel can be measured on the ultrasound monitor, which should help guide the depth of needle.",
"     </li>",
"     <li>",
"      If using the longitudinal view, the needle should be seen to penetrate the vein on the ultrasound monitor (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50251 \" href=\"UTD.htm?11/34/11811\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is important to focus on the tip of the needle rather than the needle shaft, which can be facilitated by &ldquo;rocking&rdquo; the probe fore and aft so the tip &ldquo;flashes&rdquo; in and out on the screen. Failure to adequately identify the tip of the needle may allow it to advance to a deeper level than is desired which can lead to inadvertent injury.",
"     </li>",
"     <li>",
"      Once the vein has been accessed, remove the transducer and place the catheter using standard techniques. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link\">",
"       \"Placement of jugular venous catheters\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link\">",
"       \"Placement of subclavian venous catheters\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link\">",
"       \"Placement of femoral venous catheters\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"       \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PITFALLS AND COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incorrect use of the ultrasound machine can make it difficult to identify vascular structures. A common pitfall is applying too much pressure with the transducer, thus collapsing the vein and rendering it invisible. A second problem is using incorrect settings on the ultrasound machine.",
"   </p>",
"   <p>",
"    No complications unique to ultrasound-guided vascular access have been reported. The risk of complications inherent in vascular access such as hematoma, inadvertent puncture of nearby vessels or nerves, or unsuccessful cannulation is reduced with the use of ultrasound guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/3\">",
"     3",
"    </a>",
"    ]. In addition, ultrasound guidance shortens the time to successful cannulation of the internal jugular vein or femoral vein. (See",
"    <a class=\"local\" href=\"#H1232393281\">",
"     'Internal jugular vein'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H1232393340\">",
"     'Femoral vein'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;High-quality instructional videos of ultrasound-guided internal jugular and peripheral vein access are available elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3833/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasound-guided venous access is indicated for any adult or child patient for whom central venous access via the internal jugular vein or femoral vein is necessary, and when equipment and operator expertise are available. Dynamic ultrasound guidance is helpful for establishing peripheral vascular access in adults when difficulty is expected or when the traditional landmark technique has failed. &nbsp;(See",
"      <a class=\"local\" href=\"#H1232393761\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasound-guided access should not supplant intraosseous access in a life-threatening situation when peripheral or central access by landmark techniques is not rapidly successful. (See",
"      <a class=\"local\" href=\"#H1232394188\">",
"       'Contraindications and precautions'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=see_link\">",
"       \"Intraosseous infusion\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=see_link\">",
"       \"Vascular (venous) access for pediatric resuscitation and other pediatric emergencies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other contraindications or precautions are the same as for traditional vascular access procedures (",
"      <a class=\"graphic graphic_table graphicRef71716 \" href=\"UTD.htm?1/53/1885\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=see_link&amp;anchor=H86781613#H86781613\">",
"       \"Placement of jugular venous catheters\", section on 'Contraindications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=see_link&amp;anchor=H86790402#H86790402\">",
"       \"Placement of subclavian venous catheters\", section on 'Contraindications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=see_link&amp;anchor=H3099788#H3099788\">",
"       \"Placement of femoral venous catheters\", section on 'Contraindications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The key anatomical aspects, preparation, and necessary steps to successfully perform ultrasound-guided venous access are described above. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Ultrasound anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1232389864\">",
"       'Patient preparation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1232394654\">",
"       'Ultrasound equipment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Ultrasound machine preparation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1232392861\">",
"       'Ultrasound-guided techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that, when equipment and expertise are available, children and adults undergoing central line placement in the internal jugular vein have the procedure guided by ultrasonography rather than the landmark technique (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1232393281\">",
"       'Internal jugular vein'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that, when equipment and expertise are available, children and adults undergoing central line placement in the femoral vein have the procedure guided by ultrasonography rather than the landmark technique (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1232393340\">",
"       'Femoral vein'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that, when equipment and operator expertise are available, adults with difficult vascular access (eg, no peripheral access after three attempts by an experienced clinician) undergo peripheral intravenous catheter placement using ultrasound guidance (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1232393406\">",
"       'Peripheral intravenous access'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29868092\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/1\">",
"      Troianos CA, Hartman GS, Glas KE, et al. Special articles: guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society Of Cardiovascular Anesthesiologists. Anesth Analg 2012; 114:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/2\">",
"      Levy JA, Noble VE. Bedside ultrasound in pediatric emergency medicine. Pediatrics 2008; 121:e1404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/3\">",
"      Hind D, Calvert N, McWilliams R, et al. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003; 327:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/4\">",
"      Rabindranath KS, Kumar E, Shail R, Vaux E. Use of real-time ultrasound guidance for the placement of hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 2011; 58:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/5\">",
"      Rabindranath KS, Kumar E, Shail R, Vaux EC. Ultrasound use for the placement of haemodialysis catheters. Cochrane Database Syst Rev 2011; :CD005279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/6\">",
"      Sigaut S, Skhiri A, Stany I, et al. Ultrasound guided internal jugular vein access in children and infant: a meta-analysis of published studies. Paediatr Anaesth 2009; 19:1199.",
"     </a>",
"    </li>",
"    <li>",
"     Rothschild, JM. Ultrasound guidance of central vein catheterization. In: Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence Report/Technology Assessment, No. 43, Shojania, KG, Duncan, BW, McDonald, KM, et al (Eds), Agency for Healthcare Research and Quality, Rockville, MD 2001. p.245. file://www.ahrq.gov/clinic/ptsafety/chap21.htm (Accessed on September 26, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/8\">",
"      Keyes LE, Frazee BW, Snoey ER, et al. Ultrasound-guided brachial and basilic vein cannulation in emergency department patients with difficult intravenous access. Ann Emerg Med 1999; 34:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/9\">",
"      Doniger SJ, Ishimine P, Fox JC, Kanegaye JT. Randomized controlled trial of ultrasound-guided peripheral intravenous catheter placement versus traditional techniques in difficult-access pediatric patients. Pediatr Emerg Care 2009; 25:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/10\">",
"      Calvert N, Hind D, McWilliams RG, et al. The effectiveness and cost-effectiveness of ultrasound locating devices for central venous access: a systematic review and economic evaluation. Health Technol Assess 2003; 7:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/11\">",
"      Fragou M, Kouraklis G, Dimitriou V, Karakitsos D. Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department. Acad Emerg Med 2011; 18:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/12\">",
"      Arul GS, Lewis N, Bromley P, Bennett J. Ultrasound-guided percutaneous insertion of Hickman lines in children. Prospective study of 500 consecutive procedures. J Pediatr Surg 2009; 44:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/13\">",
"      Hilty WM, Hudson PA, Levitt MA, Hall JB. Real-time ultrasound-guided femoral vein catheterization during cardiopulmonary resuscitation. Ann Emerg Med 1997; 29:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/14\">",
"      Kwon TH, Kim YL, Cho DK. Ultrasound-guided cannulation of the femoral vein for acute haemodialysis access. Nephrol Dial Transplant 1997; 12:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/15\">",
"      Aouad MT, Kanazi GE, Abdallah FW, et al. Femoral vein cannulation performed by residents: a comparison between ultrasound-guided and landmark technique in infants and children undergoing cardiac surgery. Anesth Analg 2010; 111:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/16\">",
"      Griswold-Theodorson S, Farabaugh E, Handly N, et al. Subclavian central venous catheters and ultrasound guidance: policy vs practice. J Vasc Access 2012; 0:0.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/17\">",
"      Abboud PA, Kendall JL. Ultrasound guidance for vascular access. Emerg Med Clin North Am 2004; 22:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/18\">",
"      Fragou M, Gravvanis A, Dimitriou V, et al. Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med 2011; 39:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/19\">",
"      O'Leary R, Ahmed SM, McLure H, et al. Ultrasound-guided infraclavicular axillary vein cannulation: a useful alternative to the internal jugular vein. Br J Anaesth 2012; 109:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/20\">",
"      Gualtieri E, Deppe SA, Sipperly ME, Thompson DR. Subclavian venous catheterization: greater success rate for less experienced operators using ultrasound guidance. Crit Care Med 1995; 23:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/21\">",
"      Pirotte T, Veyckemans F. Ultrasound-guided subclavian vein cannulation in infants and children: a novel approach. Br J Anaesth 2007; 98:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/22\">",
"      Pittiruti M, Hamilton H, Biffi R, et al. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 2009; 28:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/23\">",
"      Sofocleous CT, Schur I, Cooper SG, et al. Sonographically guided placement of peripherally inserted central venous catheters: review of 355 procedures. AJR Am J Roentgenol 1998; 170:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/24\">",
"      Costantino TG, Parikh AK, Satz WA, Fojtik JP. Ultrasonography-guided peripheral intravenous access versus traditional approaches in patients with difficult intravenous access. Ann Emerg Med 2005; 46:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/25\">",
"      Brannam L, Blaivas M, Lyon M, Flake M. Emergency nurses' utilization of ultrasound guidance for placement of peripheral intravenous lines in difficult-access patients. Acad Emerg Med 2004; 11:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/26\">",
"      Schnadower D, Lin S, Perera P, et al. A pilot study of ultrasound analysis before pediatric peripheral vein cannulation attempt. Acad Emerg Med 2007; 14:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/27\">",
"      Bair AE, Rose JS, Vance CW, et al. Ultrasound-assisted peripheral venous access in young children: a randomized controlled trial and pilot feasibility study. West J Emerg Med 2008; 9:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/28\">",
"      Metz RI, Lucking SE, Chaten FC, et al. Percutaneous catheterization of the axillary vein in infants and children. Pediatrics 1990; 85:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/29\">",
"      Donaldson JS, Morello FP, Junewick JJ, et al. Peripherally inserted central venous catheters: US-guided vascular access in pediatric patients. Radiology 1995; 197:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/30\">",
"      Stone MB, Teismann NA, Wang R. Ultrasonographic confirmation of intraosseous needle placement in an adult unembalmed cadaver model. Ann Emerg Med 2007; 49:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/31\">",
"      Ball RD, Scouras NE, Orebaugh S, et al. Randomized, prospective, observational simulation study comparing residents' needle-guided vs free-hand ultrasound techniques for central venous catheter access. Br J Anaesth 2012; 108:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/32\">",
"      Stone MB, Moon C, Sutijono D, Blaivas M. Needle tip visualization during ultrasound-guided vascular access: short-axis vs long-axis approach. Am J Emerg Med 2010; 28:343.",
"     </a>",
"    </li>",
"    <li>",
"     Kost, SI. Ultrasound-assisted venous access. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King, C, Henretig, FM (Eds), Lippincott Williams and Wilkins, Philadelphia 2008. p.1255.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/34\">",
"      Hebard S, Hocking G. Echogenic technology can improve needle visibility during ultrasound-guided regional anesthesia. Reg Anesth Pain Med 2011; 36:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/35\">",
"      Deam RK, Kluger R, Barrington MJ, McCutcheon CA. Investigation of a new echogenic needle for use with ultrasound peripheral nerve blocks. Anaesth Intensive Care 2007; 35:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/36\">",
"      Ortega R, Song M, Hansen CJ, Barash P. Videos in clinical medicine. Ultrasound-guided internal jugular vein cannulation. N Engl J Med 2010; 362:e57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3833/abstract/37\">",
"      Joing S, Strote S, Caroon L, et al. Videos in clinical medicine. Ultrasound-guided peripheral i.v. placement. N Engl J Med 2012; 366:e38.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6315 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-221.179.173.170-9A4DD99832-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3833=[""].join("\n");
var outline_f3_47_3833=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393761\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393924\">",
"      Central venous access",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393281\">",
"      - Internal jugular vein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393340\">",
"      - Femoral vein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393399\">",
"      - Subclavian vein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393406\">",
"      Peripheral intravenous access",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1232393436\">",
"      - Use in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1382363008\">",
"      Intraosseous access",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232394188\">",
"      CONTRAINDICATIONS AND PRECAUTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232394654\">",
"      ULTRASOUND EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1232394739\">",
"      Modes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1232394747\">",
"      Transducers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ULTRASOUND ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13563724\">",
"      Probe orientation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1486558433\">",
"      Views",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1486558440\">",
"      - Transverse (short axis) view",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1486558447\">",
"      - Longitudinal (long axis) view",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232389864\">",
"      PATIENT PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ULTRASOUND MACHINE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1232392861\">",
"      ULTRASOUND-GUIDED TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Dynamic ultrasound to guide vein cannulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PITFALLS AND COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29868092\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/6315\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/6315|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/5/14418\" title=\"diagnostic image 1\">",
"      Ultrasound neck vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/58/5029\" title=\"diagnostic image 2\">",
"      Ultrasound femoral vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/7/38002\" title=\"diagnostic image 3\">",
"      Doppler US artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/34/11811\" title=\"diagnostic image 4\">",
"      Ultrasound view needle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/58/38819\" title=\"diagnostic image 5\">",
"      Ultrasound depth selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/6315|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/41/38545\" title=\"picture 1\">",
"      Ultrasound probes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/3/2096\" title=\"picture 2\">",
"      Direct US IV placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/6315|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/53/1885\" title=\"table 1\">",
"      Advantages and disadvantages of central vein approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/6315|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?37/18/38181\" title=\"waveform 1\">",
"      Doppler US vein",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27050?source=related_link\">",
"      Catheter-induced upper extremity venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/51/40761?source=related_link\">",
"      Intraosseous infusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44553?source=related_link\">",
"      Overview of central venous access",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/11/36024?source=related_link\">",
"      Placement of femoral venous catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/14/3306?source=related_link\">",
"      Placement of jugular venous catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/27/1466?source=related_link\">",
"      Placement of subclavian venous catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/55/8057?source=related_link\">",
"      Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_47_3834="Neurologic complications of cardiac surgery";
var content_f3_47_3834=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Neurologic complications of cardiac surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Michael L McGarvey, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Albert T Cheung, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Mark M Stecker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Gabriel S Aldea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/47/3834/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/47/3834/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic complications are second only to heart failure as a cause of morbidity and mortality following cardiac surgery, and the presence of neurologic sequelae significantly increases the likelihood of requiring long-term care [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The neurologic complications of cardiac surgery in adults will be reviewed here. Methods to prevent these complications, issues related to coronary artery bypass grafting (CABG) in patients with known carotid artery disease, and an overview of all early complications following CABG and are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link\">",
"     \"Prevention of neurologic complications of cardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6617?source=see_link\">",
"     \"Coronary artery bypass grafting in patients with cerebrovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=see_link\">",
"     \"Early noncardiac complications of coronary artery bypass graft surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most neurologic problems following cardiac surgery can be divided into three categories (",
"    <a class=\"graphic graphic_table graphicRef68206 \" href=\"UTD.htm?16/33/16925\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stroke",
"     </li>",
"     <li>",
"      Neuropsychiatric abnormalities or encephalopathy",
"     </li>",
"     <li>",
"      Peripheral neuropathies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A retrospective report from the Society of Thoracic Surgery (STS) National Cardiac Database, of over 400,000 cardiac surgeries between 1996 and 1997, reported an overall incidence of a new neurologic event (stroke, transient ischemic attack, or unexplained coma lasting more than 24 hours) of 3.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/6\">",
"     6",
"    </a>",
"    ]. A prospective study evaluated 2108 patients undergoing coronary artery bypass graft surgery (CABG) at 24 hospitals in the United States between 1991 and 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2\">",
"     2",
"    </a>",
"    ]. Overall, 6.1 percent suffered a cerebral complication, roughly equally divided between stroke and encephalopathy. Increased age was a dominant risk factor, and adverse events were associated with increased mortality, longer hospitalization, and a higher rate of discharge to chronic care facilities compared with those without neurologic sequelae (",
"    <a class=\"graphic graphic_figure graphicRef68686 \" href=\"UTD.htm?14/21/14685\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STROKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of stroke related to cardiac operations ranges from 0.4 to 14 percent in different series, depending upon patient populations and specific procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/1,2,7-12\">",
"     1,2,7-12",
"    </a>",
"    ]. The type and number of procedures that are performed during cardiac surgery may have an impact on stroke incidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For coronary artery bypass graft surgery (CABG), reported perioperative stroke rates most commonly fall between 0.8 and 5.2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/11-21\">",
"       11-21",
"      </a>",
"      ]. In a review of a STS database of patients from 2002 to 2006, 774,881 patients underwent isolated CABG with a reported stroke incidence of 1.4 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/22\">",
"       22",
"      </a>",
"      ]. One database from a single center reported that stroke rates after CABG had declined over time since 1988, with an estimated stroke risk in 2009 of 1.6 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 109,759 isolated valve surgeries in the same database and time period, the stroke rate was 1.6 percent; isolated mitral valve procedures were associated with a 2.1 percent incidence of stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Combined valve and CABG procedures were associated with a 2.9 percent stroke incidence; combined mitral valve and CABG procedures were associated with a 3.9 percent stroke incidence [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The timing of most perioperative strokes is variously reported. Approximately 30 to 40 percent of strokes occur intraoperatively, according to large prospective reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/7,21\">",
"     7,21",
"    </a>",
"    ]. Most strokes occur in the first one to two days after surgery and are uncommon after the first week [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/7,16,21,25\">",
"     7,16,21,25",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The burden of cerebral ischemic injury may be underestimated by the incidence of clinical stroke. Neuroimaging studies suggest that there is an even higher incidence of so-called silent cerebral ischemia after cardiac surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Different mechanisms are thought to be responsible for early onset or intraoperative ischemic stroke versus delayed ischemic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Intraoperative stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral hypoperfusion and atheroembolization are understood to be the major mechanisms underlying intraoperative stroke:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral hypoperfusion can result from intraoperative hypotension",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diminished cardiac output. Furthermore, it is hypothesized that decreased blood flow during surgery results in diminished washout of embolic material from blood vessels in the brain, particularly in borderzone (watershed) areas along the boundaries of major vascular territories, predisposing to ischemia in these regions [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/27\">",
"       27",
"      </a>",
"      ]. These mechanisms may combine to increase the cumulative risk of injury in cardiac surgery and explain the presence of postoperative strokes identified as having multiple mechanisms [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/16\">",
"       16",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      While mean arterial pressures of 50 to 70 mmHg are common and typically well tolerated by patients during cardiopulmonary bypass (CPB), higher mean arterial blood pressure may decrease both cardiac and neurologic complications [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/28\">",
"       28",
"      </a>",
"      ]. This and other techniques to avoid intraoperative cerebral hypoperfusion are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link&amp;anchor=H11#H11\">",
"       \"Prevention of neurologic complications of cardiac surgery\", section on 'Blood pressure'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arterial emboli can cause transient or permanent occlusion of cerebral vessels and produce cerebral ischemia. This appears to be the predominant cause of intraoperative stroke, as is supported by the finding that most patients with stroke have multiple cerebral infarcts in different arterial territories on neuroimaging studies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Three major types of emboli occur during cardiac operations: thromboemboli, atheroemboli, and air emboli [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/29\">",
"       29",
"      </a>",
"      ]. Thrombi or atheromatous debris can be released from complex aortic plaques during clamping and unclamping of the ascending aorta, constructing the proximal coronary artery bypass graft anastomoses in the ascending aorta, excising severely calcified and diseased cardiac valves, or by turbulent high velocity blood flow from the aortic cannula within a diseased aorta. Transcranial Doppler (TCD) monitoring of the middle cerebral artery blood flow detects arterial microemboli entering the cerebral circulation during cardiac surgery; these are most frequent during placement and removal of the aortic cross-clamp and the aortic cannula [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link&amp;anchor=H13#H13\">",
"       \"Prevention of neurologic complications of cardiac surgery\", section on 'Intraoperative monitoring'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Gaseous emboli enter the arterial circulation via open cardiac chambers, vascular cannulation sites, or arterial anastomoses. These may be the most common type of embolic material seen during CBP; however, the impact that these have on neurologic injury and outcome is unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/32\">",
"       32",
"      </a>",
"      ]. The size of the gaseous emboli may be important, with larger emboli-causing strokes and smaller emboli resulting in endothelial injury in the brain's vasculature. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=see_link&amp;anchor=H9#H9\">",
"       \"Embolism from aortic plaque: Thromboembolism\", section on 'Cardiovascular procedures'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=see_link\">",
"       \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=see_link\">",
"       \"Air embolism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Postoperative stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke that is noted after an initial uneventful neurologic recovery from surgery is most likely to be due to cardiogenic embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/26\">",
"     26",
"    </a>",
"    ]. Atrial fibrillation, a common postoperative complication, is believed to contribute to a significant proportion of delayed postoperative strokes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/16,33\">",
"     16,33",
"    </a>",
"    ]. Underlying heart disease also likely plays an important role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient-specific risk factors for perioperative stroke that have been identified in some studies include [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/1,2,4,6-15,21,34-44\">",
"     1,2,4,6-15,21,34-44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prior stroke or transient ischemic attack",
"     </li>",
"     <li>",
"      Significant atherosclerosis of the proximal or ascending aorta, carotid",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      intracranial cerebral arteries",
"     </li>",
"     <li>",
"      Advanced age",
"     </li>",
"     <li>",
"      Diabetes",
"     </li>",
"     <li>",
"      Renal failure",
"     </li>",
"     <li>",
"      Low cardiac output syndrome",
"     </li>",
"     <li>",
"      Peripheral artery disease",
"     </li>",
"     <li>",
"      Hypertension",
"     </li>",
"     <li>",
"      Postoperative atrial fibrillation",
"     </li>",
"     <li>",
"      Female sex",
"     </li>",
"     <li>",
"      Recent myocardial infarction or unstable angina",
"     </li>",
"     <li>",
"      Moderate or severe left ventricular dysfunction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The history of a clinical stroke is a consistent risk factor for perioperative stroke among studies, with an associated increased odds ratio of 3.2 to 4.5 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,44\">",
"     2,44",
"    </a>",
"    ]. One study also found that the presence of stroke detected by MRI preoperatively was also a risk factor for perioperative stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aortic atherosclerosis is also an important risk factor with an associated odds ratio of 4.5 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2\">",
"     2",
"    </a>",
"    ]. In a review of 921 consecutive patients who underwent cardiac surgery, the incidence of stroke was 8.7 percent in those with aortic atherosclerosis compared to 1.8 percent in those without this abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/39\">",
"     39",
"    </a>",
"    ]. The Among patients with aortic atherosclerosis, the risk of stroke is greatest in those with aortic arch atheromas that are mobile or protrude &ge;5 mm into the aortic lumen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/40,46\">",
"     40,46",
"    </a>",
"    ]. Large atheromas are more likely to occur at the site of new aortic injury during surgical clamping and cannulation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/41\">",
"     41",
"    </a>",
"    ]. Large or mobile atheromas are also risk factors for stroke in patients not undergoing surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=see_link\">",
"     \"Embolism from aortic plaque: Thromboembolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The data associated carotid with perioperative stroke in patients is more limited. This is discussed in detail separaetly (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6617?source=see_link\">",
"     \"Coronary artery bypass grafting in patients with cerebrovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of any one risk factor for stroke is not considered a contraindication [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/44\">",
"     44",
"    </a>",
"    ]. A number of risk models have been developed to predict stroke after cardiac surgery (usually CABG) using preoperative risk factors. While these models vary substantively, they emphasize the additive affect that individual risk factors have on perioperative stroke risk [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/13-16\">",
"     13-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Operative factors are also important [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Closed chamber procedures, such as CABG, have a lower risk than open chamber procedures, such as valve replacement [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. This difference was demonstrated in a multicenter prospective trial of 273 patients in which the rate of cerebral complications (predominantly stroke) was 6 percent in patients undergoing CABG compared with 16 percent in patients undergoing intracardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/48\">",
"     48",
"    </a>",
"    ]. Combined or complex surgical procedures, including those that are prolonged and involve manipulation of the ascending aorta, increase the risk of neurologic complications [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Increasing the temperature of cardiopulmonary bypass (CPB) may also augment the risk of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The methods that can be used to minimize neurologic risk are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link\">",
"     \"Prevention of neurologic complications of cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Intracranial hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary intracranial hemorrhage in patients is a rare complication of cardiac surgery; most intracranial hemorrhage in this setting occurs as a complication of ischemic infarction.",
"   </p>",
"   <p>",
"    Although 5 percent of patients with perioperative ischemic strokes have some hemorrhagic transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/49\">",
"     49",
"    </a>",
"    ], the incidence of sizable hemorrhages with mass effect is much smaller. The risk factors for significant hemorrhage include large infarcts, anticoagulation within 12 hours of an infarction, or the presence of an infarct that is already hemorrhagic [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/50\">",
"     50",
"    </a>",
"    ]. In any patient with prior intracranial hemorrhage undergoing a cardiac operation, it is imperative to perform a neurologic examination as soon as possible postoperatively to determine whether there is clinical evidence of increasing hemorrhage that might require neurosurgical intervention.",
"   </p>",
"   <p>",
"    Patients with endocarditis often have ongoing neurologic injury, which puts them at greater risk of intracranial hemorrhage during anticoagulation for cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/51\">",
"     51",
"    </a>",
"    ]. This risk may be reduced by delaying the operation for two to three weeks while antibiotic therapy is initiated; however, hemodynamic instability may preclude delay [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/51\">",
"     51",
"    </a>",
"    ]. Another method to reduce bleeding risk is to perform cardiac surgery with a heparin-bonded CPB circuit, which permits reduced systemic heparinization [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ophthalmologic complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial emboli can cause symptomatic ophthalmologic complications. Intraoperative",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    angiography demonstrated transient microvascular occlusion in all 21 patients studied in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/54\">",
"     54",
"    </a>",
"    ]. In a larger series of 312 patients undergoing CABG, 26 percent experienced neuroophthalmologic sequelae, including 17 percent with retinal infarctions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/55\">",
"     55",
"    </a>",
"    ]. Visual loss due to ischemic optic neuropathy is uncommon, occurring in approximately 0.1 percent of patients undergoing CPB [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A supranuclear gaze palsy is another described complication of cardiac surgery, particularly aortic valve replacement and repair of an ascending aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/58-61\">",
"     58-61",
"    </a>",
"    ]. This is probably under-recognized as the patient's complaints are often somewhat vague, and demonstration of the neurologic deficit requires specific examination of vertical and horizontal saccades. Spastic dysarthria, emotional lability, and gait disorder are frequent accompanying abnormalities. The presumed mechanism is ischemic injury to the midbrain, or elsewhere in the brainstem, but this has not been specifically documented.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnosis and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients stable enough to undergo brain magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI) is very sensitive and accurate for the diagnosis of acute ischemic events [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/16\">",
"     16",
"    </a>",
"    ]. In addition to confirming the presence of a cerebral infarction, it is useful to identify additional, otherwise unsuspected areas of infarction and may hint at the underlying mechanism, that is, embolism versus watershed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17290?source=see_link\">",
"     \"Neuroimaging of acute ischemic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is also important to confirm the timing of the stroke. A stroke that occurs postoperatively suggests the potential for recurrent events due to ongoing risk factors, such as atrial fibrillation, cerebrovascular disease, intramural thrombus in the heart, or inadequate anticoagulation for a mechanical valve prosthesis. An intraoperative stroke is less likely to recur.",
"   </p>",
"   <p>",
"    Potential interventions for the treatment of stroke after cardiac surgery are discussed in detail separately but include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of blood pressure in acute stroke has not been well studied. In other settings (not postoperative), blood pressure lowering is not recommended unless in excess of 220 mmHg systolic or 120 mmHg diastolic [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/62\">",
"       62",
"      </a>",
"      ], or unless the patient is suffering from, or at risk of, aortic dissection, acute myocardial infarction, heart failure, or other adverse effects. After cardiac surgery, surgeons may recommend somewhat lower blood pressures. Hypotension should be avoided and treated if it occurs using supine posture and an intravenous fluid bolus. If these measures are insufficient, a pressor such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"       phenylephrine",
"      </a>",
"      at low dose may be useful. Although there is no support in the literature for blood pressure augmentation in normotensive patients, it is our general practice to treat these patients with judicious use of volume expansion to improve brain perfusion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link&amp;anchor=H14#H14\">",
"       \"Initial assessment and management of acute stroke\", section on 'Blood pressure management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with hypoxia should receive supplemental oxygen to bring saturations to levels &ge;92 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/62\">",
"       62",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"       \"Initial assessment and management of acute stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyperglycemia after stroke has been associated with worse outcomes; treatment may improve outcome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"       \"Initial assessment and management of acute stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fever has also been associated with worse outcomes in the acute stroke setting; antipyretics are generally recommended to lower fever in patients after stroke. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link&amp;anchor=H12#H12\">",
"       \"Initial assessment and management of acute stroke\", section on 'Fever'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Use of intravenous tissue plasminogen activator is associated with significant risk of bleeding in the postoperative period and is contraindicated in patients after cardiac surgery. Mechanical thrombolysis may be considered in specific cases where the time of onset can be identified and therapy is instituted within an eight-hour time window. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41098?source=see_link\">",
"       \"Reperfusion therapy for acute ischemic stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anticoagulation has not been shown to be effective in acute stroke treatment, regardless of etiology. In patients with acute stroke following cardiac surgery, it carries the additional risks of systemic complications such as hemopericardium. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31688?source=see_link&amp;anchor=H6#H6\">",
"       \"Antithrombotic treatment of acute ischemic stroke and transient ischemic attack\", section on 'Parenteral anticoagulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of antiplatelet therapy following CABG has been shown to be safe and effective in decreasing neurological complications [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/63\">",
"       63",
"      </a>",
"      ], and has also been shown to improve outcomes following acute stroke [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/64\">",
"       64",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      is recommended for all patients following cardiac surgery except those with absolute contraindications. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H2#H2\">",
"       \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Aspirin'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=see_link&amp;anchor=H6#H6\">",
"       \"Medical therapy to prevent complications after coronary artery bypass graft surgery\", section on 'Platelet P2Y12 receptor blocker therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other therapies, such as cerebral protection or hyperbaric oxygen, may be of value in the appropriate circumstances [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/65,66\">",
"       65,66",
"      </a>",
"      ]. Hyperbaric oxygenation is of special value in otherwise stable patients with suspected air emboli. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=see_link\">",
"       \"Hyperbaric oxygen therapy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Outcome after stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have a perioperative stroke have a poorer outcome compared with those without a stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/12,16\">",
"     12,16",
"    </a>",
"    ]. As an example, 35,733 consecutive patients were followed after CABG; 1.6 percent had a perioperative stroke. Patients with stroke had one, five, and ten-year survival rates of 83, 59, and 27 percent, respectively, representing a 3-fold increased risk of death compared with patients without stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/67\">",
"     67",
"    </a>",
"    ]. Similar findings were noted in other reports [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/10,16,68\">",
"     10,16,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The biggest differences in mortality are seen early and stabilize over time [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/11,67\">",
"     11,67",
"    </a>",
"    ]. In-hospital mortality rates for stroke after CABG range from 14 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/11,12,14\">",
"     11,12,14",
"    </a>",
"    ] and appear to be higher in patients with intraoperative versus postoperative stroke (41 versus 13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have had a stroke are also likely to have functional deficits limiting independence and to be discharged to locations other than home [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ENCEPHALOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major neuropsychiatric abnormalities associated with cardiac surgery are neurocognitive dysfunction, seizures, and delirium. At times, coma is seen. Rather than distinct entities, these represent a spectrum of neurologic dysfunction with overlapping clinical features and pathogeneses. Premorbid or perioperative stroke and other vascular mechanisms may also play a role in some patients with postoperative encephalopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Delirium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delirium after cardiac surgery occurs in 3 to 32 percent of patients, particularly those with preexisting organic mental disorders, significant prior alcohol consumption, advanced age, or intracranial cerebral artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,38,69-71\">",
"     2,38,69-71",
"    </a>",
"    ]. The wide incidence range indicates the difficulty of attributing delirium specifically to the surgical procedure, rather than to opiates, anesthetics, and sedative agents administered during and immediately following surgery. Other causes of postoperative delirium in the cardiac surgery patient include renal failure, hepatic failure, and thyroid abnormalities. Strokes, particularly right parietal lesions, can also present as delirium.",
"   </p>",
"   <p>",
"    Treatment of postoperative delirium requires a search for, and correction of, potentially reversible causes. The EEG is usually abnormal in postoperative delirium, but not in a primary psychiatric illness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/1/36889?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/33/28185?source=see_link\">",
"     \"Prevention and treatment of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postcardiotomy delirium may persist for more than one week and overlaps with more persistent postoperative neurocognitive dysfunction (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Cognitive impairment'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    One prospective study found that delirium after CABG was a risk factor for late mortality, particularly in younger patients (&lt;65 years old), in whom the associated hazard ratio was 2.4 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 0.5 to 3.5 percent of patients experience seizures after CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,38\">",
"     2,38",
"    </a>",
"    ]. Causes include hypoxemia, metabolic disturbances (eg, hyponatremia, hypoglycemia), drug toxicity (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ), and structural brain injury such as stroke .",
"   </p>",
"   <p>",
"    Electroencephalography (EEG) should be considered in patients who are unresponsive 18 to 24 hours after surgery to detect possible nonconvulsive seizure activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=see_link\">",
"     \"Status epilepticus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Coma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coma infrequently complicates cardiac surgery and results from diffuse global anoxic injury, strokes (large hemispheric, brainstem, or multi-focal infarcts), intracerebral hemorrhages, seizures, or severe metabolic derangements.",
"   </p>",
"   <p>",
"    Coma as a result of anoxic or structural injury carries an extremely poor prognosis. Patients with severe anoxic injury and coma may also exhibit post-anoxic myoclonus and seizures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cognitive impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disturbances in memory, executive function, motor speed, attention, and other cognitive functions can be detected in 3 to 79 percent of patients in the first several weeks after CABG when formal neuropsychiatric testing is performed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,4,73-78\">",
"     2,4,73-78",
"    </a>",
"    ]. The severity can range from subtle deficits detectable only sophisticated neuropsychiatric testing to clinically overt delirium as described above.",
"   </p>",
"   <p>",
"    The wide variation in the reported incidence of postoperative cognitive problems is probably related to several factors, including variability in CABG procedures, constraints reducing participation in cognitive studies, different methodologies used to assess neurocognitive dysfunction, variations in the follow-up time interval, and a paucity of studies with control groups [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/4,16,78,79\">",
"     4,16,78,79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of control groups has been illustrated in two studies. One compared neurocognitive function at baseline, three months, and 12 months after CABG using two different control groups: those with coronary disease but no surgery and those who were heart healthy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/80\">",
"     80",
"    </a>",
"    ]. At baseline, patients with heart disease had lower cognitive scores than the heart-healthy patients. At baseline and at follow-up, the cognitive test performance of CABG patients did not differ from control groups with heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Mechanisms and risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;While this syndrome has been called \"post perfusion syndrome\", \"post pump syndrome\", and \"pump-head\" these terms imply a mechanism of action that is speculative and that may not be a factor in some patients with neurocognitive dysfunction after cardiac surgery.",
"   </p>",
"   <p>",
"    The incidence of neuropsychiatric deficits in patients undergoing cardiac operations exceeds that of corresponding patients undergoing operations for peripheral vascular disease, suggesting that some specific features of cardiac operations, such as cerebral microemboli, may cause neuropsychiatric disturbances [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/31,73\">",
"     31,73",
"    </a>",
"    ]. The following observations support this hypothesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Platelet microemboli may be important, as supported by transcranial Doppler and neuropathologic studies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/81\">",
"       81",
"      </a>",
"      ]. However, an extensive literature review could not confirm a causal association between postoperative cognitive outcome and the detection of microemboli [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/82\">",
"       82",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link&amp;anchor=H13#H13\">",
"       \"Prevention of neurologic complications of cardiac surgery\", section on 'Intraoperative monitoring'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Another investigation found that neurocognitive decline after cardiac surgery is more severe in patients with the PIA2 allele of the platelet glycoprotein IIIa receptor, a prothrombotic risk factor [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/83\">",
"       83",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=see_link&amp;anchor=H9#H9\">",
"       \"The role of platelets in coronary heart disease\", section on 'Polymorphisms of platelet glycoprotein receptor genes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In another series of 40 patients undergoing intracardiac surgery, comparison of preoperative and postoperative MRI scans and neuropsychologic testing demonstrated that postoperative decline in cognitive function was associated with the presence and severity of new ischemic lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intraoperative hypotension may also contribute to cerebral injury and subsequent neurocognitive decline. In one small study a drop in mean arterial blood pressure of 27 mmHg or greater (compared to preoperative baseline) was associated with a decrease in the mini-mental status examination score of 1.4 points [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other identified risk factors for cognitive impairment after cardiac surgery may be identified preoperatively and overlap with those for stroke, further implicating an underlying vascular mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/2,4,14,16,45\">",
"     2,4,14,16,45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypertension",
"     </li>",
"     <li>",
"      Carotid disease",
"     </li>",
"     <li>",
"      Advanced age",
"     </li>",
"     <li>",
"      Previous stroke (clinical event or detected on MRI)",
"     </li>",
"     <li>",
"      Underlying pulmonary disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Temperature is a modulator of experimental cerebral injury and postoperative hyperthermia may be related to the development of cognitive dysfunction. In one study of 300 patients, the maximum postoperative temperature was associated with a greater amount of dysfunction at six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/86\">",
"     86",
"    </a>",
"    ]. This suggests that interventions to avoid postoperative hyperthermia may be beneficial for improving cerebral outcome after CABG.",
"   </p>",
"   <p>",
"    On-pump CABG does not appear to be associated with a higher risk for cognitive or neuropsychological impairment compared with off pump CABG according to a meta-analysis and subsequently performed clinical trial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=see_link&amp;anchor=H7#H7\">",
"     \"Prevention of neurologic complications of cardiac surgery\", section on 'Minimally invasive surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postoperative encephalopathy is associated with poor short-term outcomes. In one series, the length of stay was 14 days for those with encephalopathy, versus an average of eight days for patients without this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/31\">",
"     31",
"    </a>",
"    ]. These patients also had a three times greater in-hospital mortality and were less likely to be discharged to home.",
"   </p>",
"   <p>",
"    Neurocognitive deficits usually resolve gradually. Most patients return to their preoperative baseline by 3 to 12 months after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Late cognitive decline",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some believe that post-CABG patients are at higher risk for long-term cognitive decline. In one study, serial neurocognitive testing was performed in 261 patients after CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/76\">",
"     76",
"    </a>",
"    ]. A decline in neurocognitive function was defined as a drop of &ge;1 SD, representing a decline of approximately 20 percent. The incidence of neurocognitive decline at discharge, six weeks, six months, and five years was 53, 36, 24, and 42 percent, respectively. The main predictor of cognitive decline at five years were neurocognitive deficits at discharge.",
"   </p>",
"   <p>",
"    However, accumulating evidence suggests that the cause of late decline in cognitive function occurring one to five years after CABG is progression of underlying cerebrovascular disease or vascular dementia rather than CABG or cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/4,78\">",
"     4,78",
"    </a>",
"    ]. A number of longitudinal studies have compared cognitive changes among post-CABG patients to a control group of patients with coronary disease with no surgery, revealing similar rates of cognitive decline [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/80,87-90\">",
"     80,87-90",
"    </a>",
"    ]. A case-control study comparing 557 patients with incident dementia with nondemented controls found similar rates of CABG history in both groups [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PERIPHERAL NEUROPATHY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Upper extremity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper extremity peripheral nerve injury follows cardiac operations in 2 to 15 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/8,47,92-94\">",
"     8,47,92-94",
"    </a>",
"    ]. Putative mechanisms of injury include brachial plexus traction, brachial plexus compression between the clavicle and the first rib during sternal retraction, and nerve injury during internal mammary artery dissection, hypothermia, and hemodynamic changes during cardiopulmonary bypass. In one case series, hypertension, tobacco use, and diabetes were risk factors for nerve injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peripheral neuropathy typically presents with numbness, weakness, pain, diminished reflexes, and discoordination of one upper extremity. The presence of pain suggests a peripheral rather than central injury, while confusion, cranial nerve involvement, or hemiparesis suggests a central injury.",
"   </p>",
"   <p>",
"    Sensory symptoms are most frequent in the 4th and 5th fingers. Although this distribution is expected with ulnar nerve injury at the elbow, similar symptoms are associated with injury to the lower (medial) brachial plexus elements. Overall, brachial plexus injury is more common than isolated ulnar nerve deficits after cardiac surgery.",
"   </p>",
"   <p>",
"    Weakness in muscles supplied by the lower cervical nerve roots but not the ulnar nerve, such as the extensor indicis and abductor pollicis brevis, indicates a plexopathy. Following intraaortic balloon pump insertion, femoral nerve injury may occur due to local trauma, vascular occlusion, pseudoaneurysm formation, or emboli.",
"   </p>",
"   <p>",
"    In most neuropathies related to cardiac surgery, symptoms improve or resolve within three weeks, suggesting a neuropraxic injury caused by disruption of the myelin sheath. Given this good prognosis, conservative treatment, consisting of physical therapy to improve strength and flexibility in the affected muscles, is indicated.",
"   </p>",
"   <p>",
"    Axonal injury is much less common and is associated with neurologic symptoms lasting for an extended period. Thus, failure to improve within three weeks following cardiac surgery should prompt electromyography and nerve conduction studies to confirm the diagnosis, delineate the site of injury and the extent of nerve disruption, and provide an accurate prognosis for recovery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Phrenic nerve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phrenic nerve injury occurs with cooling of the heart by iced slush. The reported frequency with which it occurs has varied widely from 1 to 30 percent, depending in part upon whether it is diagnosed by radiographic evidence of diaphragmatic dysfunction, which is not always due to phrenic nerve dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/95\">",
"     95",
"    </a>",
"    ], or phrenic nerve conduction studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/93,95-97\">",
"     93,95-97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients have unilateral phrenic nerve injury, typically on the same side as the internal mammary graft with CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/96,97\">",
"     96,97",
"    </a>",
"    ]. Patients with bilateral phrenic nerve dysfunction generally require prolonged mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/97\">",
"     97",
"    </a>",
"    ]. Most affected patients recover fully within one year, but recovery may be delayed for two years or more [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/96,98\">",
"     96,98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of phrenic nerve injury has declined dramatically with changes in surgical technique. These include a reduction in the use of iced slush and the use of foam insulation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Intercostal nerve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Harvesting of the internal thoracic artery may be associated with injury to the anterior intercostal nerves. This nerve injury can present with numbness, tenderness, light-touch evoked pain, or constant burning pain over the sternum and left anterolateral chest wall. In one study of 37 patients, for example, 81 percent reported protracted postoperative symptoms; although this usually subsided by four months,15 percent had symptoms that persisted for 5 to 28 months after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     OTHERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dyskinetic movement disorder, so-called post pump chorea may complicate cardiac surgery in a small number of children with congenital heart disease. This has also been described in a single case series of five adult patients who underwent pulmonary endarterectomy with CABG and hypothermic circulatory arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?3/47/3834/abstract/100\">",
"     100",
"    </a>",
"    ]. Symptoms presented between one and three days postoperatively and subsequently remitted over several weeks to months. Two patients had persistent mild symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link&amp;anchor=H21#H21\">",
"     \"Hyperkinetic movement disorders in children\", section on 'Post pump chorea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic complications of cardiac surgery are not rare; there is an estimated 6 percent incidence of combined central nervous system complications (stroke, encephalopathy).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most strokes that occur in the setting of cardiac surgery are clinically apparent within 24 to 48 hours. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Valvular repairs and combined coronary artery bypass (CABG) and valvular repairs, particularly those involving the mitral valve, appear to have a significantly higher risk of stroke than CABG alone. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mechanisms of intraoperative and postoperative ischemic stroke include cerebral hypoperfusion, artery-to-artery embolism, and cardiogenic embolism. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanisms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traditional atherosclerosis risk factors, prior cerebrovascular disease, and atherosclerotic disease affecting the coronary or peripheral arteries are among the risk factors for perioperative ischemic stroke (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Risk factors'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Management of perioperative ischemic stroke in the setting of cardiac surgery is similar to that in other settings EXCEPT that use of intravenous tissue plasminogen activator is contraindicated in patients after cardiac surgery. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"       \"Initial assessment and management of acute stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      More diffuse cerebral involvement after cardiac surgery may manifest as a delirium, seizures, and sometimes even coma. The mechanisms underlying this complication are likely multifactorial. A minority of patients will have persistent neurocognitive dysfunction. Evaluation in these patients focuses on excluding a cerebrovascular event and reversible toxic and metabolic conditions. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Encephalopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Peripheral nerve complications of cardiac surgery are uncommon and most patients improve, although recovery can sometimes take months to occur. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Peripheral neuropathy'",
"      </a>",
"      above.). Specific syndromes include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Brachial plexopathy with motor-sensory deficits in the upper extremity",
"     </li>",
"     <li>",
"      Phrenic neuropathy with prolonged ventilator dependence",
"     </li>",
"     <li>",
"      Intercostal neuropathy with pain and dysesthesia in a localized distribution in the lateral chest wall",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/1\">",
"      Gardner TJ, Horneffer PJ, Manolio TA, et al. Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg 1985; 40:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/2\">",
"      Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/3\">",
"      Boyd, WC, Hartman, GS. Neurologic dysfunction in cardiac surgery. New Horiz 1999; 7:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/4\">",
"      Selnes OA, Gottesman RF, Grega MA, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med 2012; 366:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/5\">",
"      Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM. Neurobehavioural sequelae of cardiopulmonary bypass. Lancet 1999; 353:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/6\">",
"      Hogue CW Jr, Barzilai B, Pieper KS, et al. Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. Circulation 2001; 103:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/7\">",
"      Hogue CW Jr, Murphy SF, Schechtman KB, D&aacute;vila-Rom&aacute;n VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999; 100:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/8\">",
"      Cheung, AT, Stecker, MM. Neurologic complications of cardiac surgery. Prog Anaesthesiol 1998; 12:3.",
"     </a>",
"    </li>",
"    <li>",
"     The Society of Thoracic Surgeons. www.sts.org (Accessed on March 7, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/10\">",
"      Puskas JD, Winston AD, Wright CE, et al. Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann Thorac Surg 2000; 69:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/11\">",
"      Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/12\">",
"      Anyanwu AC, Filsoufi F, Salzberg SP, et al. Epidemiology of stroke after cardiac surgery in the current era. J Thorac Cardiovasc Surg 2007; 134:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/13\">",
"      Charlesworth DC, Likosky DS, Marrin CA, et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 2003; 76:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/14\">",
"      McKhann GM, Grega MA, Borowicz LM Jr, et al. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction. Arch Neurol 2002; 59:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/15\">",
"      Ascione R, Reeves BC, Chamberlain MH, et al. Predictors of stroke in the modern era of coronary artery bypass grafting: a case control study. Ann Thorac Surg 2002; 74:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/16\">",
"      McKhann GM, Grega MA, Borowicz LM Jr, et al. Stroke and encephalopathy after cardiac surgery: an update. Stroke 2006; 37:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/17\">",
"      McKhann GM, Goldsborough MA, Borowicz LM Jr, et al. Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg 1997; 63:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/18\">",
"      Martin WR, Hashimoto SA. Stroke in coronary bypass surgery. Can J Neurol Sci 1982; 9:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/19\">",
"      Coffey CE, Massey EW, Roberts KB, et al. Natural history of cerebral complications of coronary artery bypass graft surgery. Neurology 1983; 33:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/20\">",
"      Breuer AC, Furlan AJ, Hanson MR, et al. Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients. Stroke 1983; 14:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/21\">",
"      Tarakji KG, Sabik JF 3rd, Bhudia SK, et al. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA 2011; 305:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/22\">",
"      Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/23\">",
"      O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/24\">",
"      Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/25\">",
"      Likosky DS, Marrin CA, Caplan LR, et al. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke 2003; 34:2830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/26\">",
"      Barbut D, Grassineau D, Lis E, et al. Posterior distribution of infarcts in strokes related to cardiac operations. Ann Thorac Surg 1998; 65:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/27\">",
"      Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/28\">",
"      Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/29\">",
"      Blauth CI. Macroemboli and microemboli during cardiopulmonary bypass. Ann Thorac Surg 1995; 59:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/30\">",
"      Barbut D, Hinton RB, Szatrowski TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke 1994; 25:2398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/31\">",
"      Clark RE, Brillman J, Davis DA, et al. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995; 109:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/32\">",
"      Abu-Omar Y, Balacumaraswami L, Pigott DW, et al. Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg 2004; 127:1759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/33\">",
"      Lahtinen J, Biancari F, Salmela E, et al. Postoperative atrial fibrillation is a major cause of stroke after on-pump coronary artery bypass surgery. Ann Thorac Surg 2004; 77:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/34\">",
"      Brener BJ, Brief DK, Alpert J, et al. The risk of stroke in patients with asymptomatic carotid stenosis undergoing cardiac surgery: a follow-up study. J Vasc Surg 1987; 5:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/35\">",
"      Mickleborough LL, Walker PM, Takagi Y, et al. Risk factors for stroke in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 112:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/36\">",
"      Almassi GH, Sommers T, Moritz TE, et al. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg 1999; 68:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/37\">",
"      Rihal CS, Sutton-Tyrrell K, Guo P, et al. Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation. Circulation 1999; 100:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/38\">",
"      Yoon BW, Bae HJ, Kang DW, et al. Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgery. Stroke 2001; 32:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/39\">",
"      van der Linden J, Hadjinikolaou L, Bergman P, Lindblom D. Postoperative stroke in cardiac surgery is related to the location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol 2001; 38:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/40\">",
"      Stern A, Tunick PA, Culliford AT, et al. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J 1999; 138:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/41\">",
"      Ura M, Sakata R, Nakayama Y, Goto T. Ultrasonographic demonstration of manipulation-related aortic injuries after cardiac surgery. J Am Coll Cardiol 2000; 35:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/42\">",
"      Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of tias and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum 1999; 2:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/43\">",
"      Hogue CW Jr, De Wet CJ, Schechtman KB, D&aacute;vila-Rom&aacute;n VG. The importance of prior stroke for the adjusted risk of neurologic injury after cardiac surgery for women and men. Anesthesiology 2003; 98:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/44\">",
"      M&eacute;rie C, K&oslash;ber L, Olsen PS, et al. Risk of stroke after coronary artery bypass grafting: effect of age and comorbidities. Stroke 2012; 43:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/45\">",
"      Goto T, Baba T, Honma K, et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2001; 72:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/46\">",
"      Katz ES, Tunick PA, Rusinek H, et al. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992; 20:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/47\">",
"      Vahl CF, Carl I, M&uuml;ller-Vahl H, Struck E. Brachial plexus injury after cardiac surgery. The role of internal mammary artery preparation: a prospective study on 1000 consecutive patients. J Thorac Cardiovasc Surg 1991; 102:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/48\">",
"      Wolman RL, Nussmeier NA, Aggarwal A, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999; 30:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/49\">",
"      Libman RB, Wirkowski E, Neystat M, et al. Stroke associated with cardiac surgery. Determinants, timing, and stroke subtypes. Arch Neurol 1997; 54:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/50\">",
"      Yatsu FM, Hart RG, Mohr JP, Grotta JC. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology 1988; 38:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/51\">",
"      Gillinov AM, Shah RV, Curtis WE, et al. Valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996; 61:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/52\">",
"      Aldea GS, Doursounian M, O'Gara P, et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 1996; 62:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/53\">",
"      Aldea GS, O'Gara P, Shapira OM, et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 1998; 65:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/54\">",
"      Blauth CI, Arnold JV, Schulenberg WE, et al. Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. J Thorac Cardiovasc Surg 1988; 95:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/55\">",
"      Shaw PJ, Bates D, Cartlidge NE, et al. Neuro-ophthalmological complications of coronary artery bypass graft surgery. Acta Neurol Scand 1987; 76:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/56\">",
"      Kalyani SD, Miller NR, Dong LM, et al. Incidence of and risk factors for perioperative optic neuropathy after cardiac surgery. Ann Thorac Surg 2004; 78:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/57\">",
"      Sweeney PJ, Breuer AC, Selhorst JB, et al. Ischemic optic neuropathy: a complication of cardiopulmonary bypass surgery. Neurology 1982; 32:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/58\">",
"      Solomon D, Ramat S, Tomsak RL, et al. Saccadic palsy after cardiac surgery: characteristics and pathogenesis. Ann Neurol 2008; 63:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/59\">",
"      Mokri B, Ahlskog JE, Fulgham JR, Matsumoto JY. Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology 2004; 62:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/60\">",
"      Devere TR, Lee AG, Hamill MB, et al. Acquired supranuclear ocular motor paresis following cardiovascular surgery. J Neuroophthalmol 1997; 17:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/61\">",
"      Leigh RJ, Tomsak RL. Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology 2004; 63:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/62\">",
"      Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/63\">",
"      Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/64\">",
"      Coull BM, Williams LS, Goldstein LB, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology 2002; 59:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/65\">",
"      Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986; 64:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/66\">",
"      Ziser A, Adir Y, Lavon H, Shupak A. Hyperbaric oxygen therapy for massive arterial air embolism during cardiac operations. J Thorac Cardiovasc Surg 1999; 117:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/67\">",
"      Dacey LJ, Likosky DS, Leavitt BJ, et al. Perioperative stroke and long-term survival after coronary bypass graft surgery. Ann Thorac Surg 2005; 79:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/68\">",
"      Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003; 75:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/69\">",
"      Smith LW, Dimsdale JE. Postcardiotomy delirium: conclusions after 25 years? Am J Psychiatry 1989; 146:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/70\">",
"      Bucerius J, Gummert JF, Borger MA, et al. Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg 2004; 127:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/71\">",
"      Rolfson DB, McElhaney JE, Rockwood K, et al. Incidence and risk factors for delirium and other adverse outcomes in older adults after coronary artery bypass graft surgery. Can J Cardiol 1999; 15:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/72\">",
"      Gottesman RF, Grega MA, Bailey MM, et al. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol 2010; 67:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/73\">",
"      Shaw PJ, Bates D, Cartlidge NE, et al. Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987; 18:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/74\">",
"      Mahanna EP, Blumenthal JA, White WD, et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg 1996; 61:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/75\">",
"      van Dijk D, Keizer AM, Diephuis JC, et al. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000; 120:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/76\">",
"      Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/77\">",
"      Van Dijk D, Jansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. JAMA 2002; 287:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/78\">",
"      Selnes OA, McKhann GM. Neurocognitive complications after coronary artery bypass surgery. Ann Neurol 2005; 57:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/79\">",
"      Rudolph JL, Schreiber KA, Culley DJ, et al. Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiol Scand 2010; 54:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/80\">",
"      McKhann GM, Grega MA, Borowicz LM Jr, et al. Is there cognitive decline 1 year after CABG? Comparison with surgical and nonsurgical controls. Neurology 2005; 65:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/81\">",
"      Emmrich P, Hahn J, Ogunlade V, et al. [Neuropathological findings after cardiac surgery-retrospective study over 6 years]. Z Kardiol 2003; 92:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/82\">",
"      Kruis RW, Vlasveld FA, Van Dijk D. The (un)importance of cerebral microemboli. Semin Cardiothorac Vasc Anesth 2010; 14:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/83\">",
"      Mathew JP, Rinder CS, Howe JG, et al. Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Ann Thorac Surg 2001; 71:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/84\">",
"      Barber PA, Hach S, Tippett LJ, et al. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke 2008; 39:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/85\">",
"      Gottesman RF, Hillis AE, Grega MA, et al. Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol 2007; 64:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/86\">",
"      Grocott HP, Mackensen GB, Grigore AM, et al. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke 2002; 33:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/87\">",
"      van Dijk D, Moons KG, Nathoe HM, et al. Cognitive outcomes five years after not undergoing coronary artery bypass graft surgery. Ann Thorac Surg 2008; 85:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/88\">",
"      Selnes OA, Grega MA, Bailey MM, et al. Neurocognitive outcomes 3 years after coronary artery bypass graft surgery: a controlled study. Ann Thorac Surg 2007; 84:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/89\">",
"      Selnes OA, Grega MA, Bailey MM, et al. Cognition 6 years after surgical or medical therapy for coronary artery disease. Ann Neurol 2008; 63:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/90\">",
"      Selnes OA, Grega MA, Bailey MM, et al. Do management strategies for coronary artery disease influence 6-year cognitive outcomes? Ann Thorac Surg 2009; 88:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/91\">",
"      Knopman DS, Petersen RC, Cha RH, et al. Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. Neurology 2005; 65:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/92\">",
"      Roy RC, Stafford MA, Charlton JE. Nerve injury and musculoskeletal complaints after cardiac surgery: influence of internal mammary artery dissection and left arm position. Anesth Analg 1988; 67:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/93\">",
"      Sharma AD, Parmley CL, Sreeram G, Grocott HP. Peripheral nerve injuries during cardiac surgery: risk factors, diagnosis, prognosis, and prevention. Anesth Analg 2000; 91:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/94\">",
"      Welch MB, Brummett CM, Welch TD, et al. Perioperative peripheral nerve injuries: a retrospective study of 380,680 cases during a 10-year period at a single institution. Anesthesiology 2009; 111:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/95\">",
"      DeVita MA, Robinson LR, Rehder J, et al. Incidence and natural history of phrenic neuropathy occurring during open heart surgery. Chest 1993; 103:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/96\">",
"      Abd AG, Braun NM, Baskin MI, et al. Diaphragmatic dysfunction after open heart surgery: treatment with a rocking bed. Ann Intern Med 1989; 111:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/97\">",
"      Laub GW, Muralidharan S, Chen C, et al. Phrenic nerve injury. A prospective study. Chest 1991; 100:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/98\">",
"      Katz MG, Katz R, Schachner A, Cohen AJ. Phrenic nerve injury after coronary artery bypass grafting: will it go away? Ann Thorac Surg 1998; 65:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/99\">",
"      Mailis A, Umana M, Feindel CM. Anterior intercostal nerve damage after coronary artery bypass graft surgery with use of internal thoracic artery graft. Ann Thorac Surg 2000; 69:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/47/3834/abstract/100\">",
"      de Bie RM, Surie S, Kloek JJ, et al. Chorea in adults after pulmonary endarterectomy with deep hypothermia and circulatory arrest. Ann Intern Med 2008; 149:842.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1660 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-199.231.185.123-2733C36ADC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3834=[""].join("\n");
var outline_f3_47_3834=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STROKE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Intraoperative stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Postoperative stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Intracranial hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ophthalmologic complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Outcome after stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ENCEPHALOPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Delirium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Coma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cognitive impairment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Mechanisms and risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Late cognitive decline",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PERIPHERAL NEUROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Upper extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Phrenic nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Intercostal nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      OTHERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1660\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1660|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/21/14685\" title=\"figure 1\">",
"      Impact of age on adverse cerebral outcomes after CABG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1660|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/33/16925\" title=\"table 1\">",
"      Neurologic complications of cardiac surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/1/36889?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=related_link\">",
"      Air embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/60/31688?source=related_link\">",
"      Antithrombotic treatment of acute ischemic stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6617?source=related_link\">",
"      Coronary artery bypass grafting in patients with cerebrovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10809?source=related_link\">",
"      Embolism from aortic plaque: Thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=related_link\">",
"      Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=related_link\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=related_link\">",
"      Hyperkinetic movement disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40360?source=related_link\">",
"      Medical therapy to prevent complications after coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/56/17290?source=related_link\">",
"      Neuroimaging of acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/33/28185?source=related_link\">",
"      Prevention and treatment of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/7/2168?source=related_link\">",
"      Prevention of neurologic complications of cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41098?source=related_link\">",
"      Reperfusion therapy for acute ischemic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4167?source=related_link\">",
"      The role of platelets in coronary heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_47_3835="ILD with BAL lymphocytosis";
var content_f3_47_3835=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Interstitial lung disease associated with BAL lymphocytosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Hypersensitivity pneumonitis (60 to 80 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis (Acute - 40 to 60 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic pulmonary fibrosis (15 to 30 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Berylliosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granite workers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amiodarone pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphoma/Pseudolymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary Langerhans cell histiocytosis (Early)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BAL: bronchoalveolar lavage.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3835=[""].join("\n");
var outline_f3_47_3835=null;
var title_f3_47_3836="Staging of HL in pregnancy";
var content_f3_47_3836=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81526&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Staging studies in pregnant women with Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History and physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Blood tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete blood count with differential",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte sedimentation rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum creatinine concentration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liver enzymes, including LDH and alkaline phosphatase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV serology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Evaluation for supradiaphragmatic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Single posterior/anterior view chest x-ray with adequate abdominal shielding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnetic resonance imaging (if abnormalities seen on chest x-ray)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Computerized tomography (if MRI not available)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Evaluation for intraabdominal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnetic resonance imaging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ultrasound (if MRI not available)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Computerized tomography (if MRI and ultrasound not available)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Bone marrow biopsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A unilateral bone marrow biopsy should be performed for patients with B symptoms; clinical stage IIB to IV disease; and for patients with anemia, leukopenia, or thrombocytopenia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Not indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gallium scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PET scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone scan",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3836=[""].join("\n");
var outline_f3_47_3836=null;
var title_f3_47_3837="Disorders that can mimic SIDS";
var content_f3_47_3837=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Disorders that can mimic SIDS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            General",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sepsis (including meningococcemia)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asphyxiation (accidental or deliberate)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anaphylaxis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metabolic decompensation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hyperthermia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Poisoning (with toxic effects on&nbsp;kidney, liver and/or brain)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Inborn errors of metabolism (may affect liver, muscle, and/or brain)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Blood",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sickle cell disease in crisis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Heart",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Subendocardial fibroelastosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital heart disease (especially aortic stenosis)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Myocarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Lungs",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tracheobronchitis, severe",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspiration or airway obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Idiopathic pulmonary hypertension",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Kidney",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pyelonephritis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Gastrointestinal tract",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Enterocolitis with Salmonella, Shigella, or pathogenic E. coli",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Liver",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Pancreas",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pancreatitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Boric acid poisoning",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cystic fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Adrenal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital adrenal hyperplasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Brain",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Encephalitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trauma (skull fracture, cerebral edema, subdural hemorrhage)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Arteriovenous malformation with bleeding",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SIDS: sudden infant death syndrome.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3837=[""].join("\n");
var outline_f3_47_3837=null;
var title_f3_47_3838="Extraocular muscle entrapment";
var content_f3_47_3838=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extraocular muscle entrapment associated with an orbital floor fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 109px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This adolescent patient was hit in the left eye with a baseball. The photograph demonstrates limitation of left upward gaze due to entrapment of the inferior rectus muscle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mark Neuman, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3838=[""].join("\n");
var outline_f3_47_3838=null;
var title_f3_47_3839="B dermatitidis wet mount";
var content_f3_47_3839=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blastomyces dermatitidis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wet mount from a patient infected with Blastomyces dermatitidis shows multinucleate yeast cells with thick refractile cell walls.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stanley W Chapman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_47_3839=[""].join("\n");
var outline_f3_47_3839=null;
